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ABSTRACT 
The first part of the thesis was a study of the role of tropomyosin in cardiac 
myofibrillogenesis. The model used was the Mexican axolotl, Ambystoma mexicanum. 
This animal model is very useful for the study of heart development as it has a naturally 
occurring mutant, the cardiac (c/c) lethal, in which the embryos lack organised myofibrils 
and have low levels of tropomyosin. Antisense oligonucleotides specific to axolotl 
tropomyosin disrupted myofibril formation in normal heart, whereas sense 
oligonucleotides encouraged myofibrillogenesis in the mutant hearts, demonstrating the 
importance of tropomyosin in cardiac muscle development and the effectiveness of 
cationic liposome transfection system.  
 
A novel isoform of the human tropomyosin-encoding gene TPM1 gene, designated TPM1κ 
was discovered and found to be cardiac specific in humans. Interestingly, ectopic 
expression of GFP.TPM1κ fusion protein promoted myofibrillogenesis in the cardiac 
mutant axolotl heart. The TMP1κ isoform was then found to be expressed in amphibians 
too and transfection of antisense oligonucleotide blocked TMP1κ expression in whole 
embryonic hearts of the wild type axolotl. 
 
Previous investigations found that extending the N- or C-terminus of the tropomyosin 
molecule does not affect cardiac myofibrillogenesis. In this study both ends of 
tropomyosin were extended simultaneously using the expression construct 
pEGFP.TPM4α.E-L-FLAG and transfected into the cardiac mutant. The modified 
tropomyosin formed organised myofibrils in the embryonic axolotl heart. 
 
The second part of this thesis involved the neuroanatomical and cardiorespiratory study of 
neotenous, metamorphosing and metamorphosed axolotls. Using the retrograde neural 
tracer Fluorogold, vagal preganglionic neurones (VPN) were found in the dorsal vagal 
nucleus (DVN) area in all three developmental stages (neotenous, metamorphosing and 
metamorphosed. However, the neotenous VPN cells were small and appeared spherical, 
perhaps due to apparent lack of differentiation. The metamorphosing hind brain had more 
mature looking cells and some appeared to be migratory. The metamorphosed axolotl had 
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cells that looked like stereotypical nerve cells and some that were migratory too. The VPN 
were found in two distinct areas, the DVN and in a ventral-lateral position from the DVN. 
Of all the VPN found in the metamorphosed 18% were located ventro-laterally. This 
change is hypothesised to be related to the change from predominantly gill ventilation to 
committed lung ventilation. This was investigated physiologically. 
 
Cardiac and ventilatory behaviour of neotenous and metamorphosed axolotls was 
examined using electrocardiograms (ECG). The heart rate and ventilation rate of the 
metamorphosed was higher than that of the neotenous. Atropine raised the heart rate in 
both, indicating the presence of parasympathetic vagal control, and propranolol lowered 
the heart rate in both, indicative of sympathetic control via adrenaline.  
 
Neotenous ventilation rate generally followed heart rate but was varied in the 
metamorphosed axolotl. Preliminary power spectral analysis indicated a cyclic variability 
in heart rate with respiration in the metamorphosed axolotl, but not in the neotenous. 
 
Heart rate variability in the metamorphosed axolotl is hypothesised to be associated with 
becoming a committed lung breather, and that it may be the functional role of the VPN 
relocation. The ventral lateral area in humans is called the nucleus ambiguus and it is 
involved in cardiorespiratory control. Hence, the VPN in the ventrolateral location in the 
axolotl may be a primordial nucleus ambiguus.  
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It is not the strongest of  
the species that survives,  
nor the most intelligent that  
survives.  
 
 
It is the one that is  
the most adaptable 
 to change. 
 
 
 
Charles Darwin  
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CHAPTER ONE 
 
GENERAL INTRODUCTION 
 
1.0 SETTING THE SCENE 
The central theme of this thesis was looking at cardiac function from different 
perspectives, using the Mexican axolotl, Ambystoma mexicanum. The first part of the 
thesis looked at the role of tropomyosin in myofibrillogenesis, especially since axolotls 
have a naturally occurring cardiac mutant strain in which there is cardiac dysfunction 
thought to be caused by aberrant myofibrillogenesis. The second part of the thesis was the 
study of the autonomic control of the heart in the gill breathing, neotenous axolotl and the 
committed lung breathing, metamorphosed form. The work in the thesis was, therefore 
split into two parts for clarity. Part I was the study of tropomyosin in cardiac 
myofibrillogenesis and Part II was the study of autonomic changes associated with the 
change from essentially a gill breather to an obligate lung breather.  
 
Vertebrate heart development is a complex and highly ordered process that is both spatially 
and temporally regulated. It involves the migration and differentiation of several 
embryonic cell types and requires precise interactions between them. For instance, neural 
crest cells not only form parts of the heart itself, but are also involved in development of 
the parasympathetic nervous system that innervates the heart. Congenital heart defects, 
which are the most frequent congenital defects in humans, result when there is a failure in 
the formation of the various structures of the heart, or when formation occurs at the wrong 
time. The embryonic heart is fully formed before it becomes innervated. The density of 
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innervation is high in the sino-atrial (SA) and atrio-ventricular (AV) nodes (Navaratnam, 
1987), which are situated within the right atrium.  
 
 
1.1 HEART DEVELOPMENT  
1.1a Heart morphogenesis 
The heart is a hollow muscular organ, which by rhythmic contractions, pumps blood 
around the body. Without it the body would be deprived of nutrients, oxygen, hormones, 
etc., and poisoned by accumulation of waste products. Accordingly, it is among the first 
organs to develop a functional role.  
 
The heart and great vessels derive from two distinct populations of cells. The four 
chambers of the heart originate from anterior lateral plate mesoderm (LPM), whereas parts 
of the outflow tract and great arteries are derived from the so-called 'cardiac' neural crest 
cells (located in the caudal hind-brain between rhombomeres 6, 7 & 8; somites 1-3 in 
chicks). In amphibians, the embryological events associated with heart development have 
been extensively characterised. In Xenopus (Drysdale et al., 1994) and Ambystoma 
(Lemanski, 1973a) the mesodermal tissue lies in a deep equatorial ring prior to 
gastrulation. Fate maps of this ring have shown that heart is derived from two patches of 
the most anterior lateral plate mesoderm which lie on either side of the prechordal plate. 
These patches of precardiac mesoderm involute at the lateral edges of the dorsal blastopore 
lip during gastrulation, penetrating between the ectoderm and endoderm, and eventually 
become positioned on either side of the head.  
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In Ambystoma mexicanum the mid-ventral anterior/pharyngeal endoderm is a potent 
inductor of heart-forming mesoderm differentiation (Smith & Armstrong, 1991). This 
initial inductive interaction generates the heart field, which is the region of the embryo that 
has the potential to form heart. However, the heart field is larger than the actual heart 
primordium, and thus there must be a mechanism which separates the specified region into 
heart-forming and non-heart-forming areas (Easton, Armstrong & Smith, 1994). As 
development proceeds, however, the actual size of the heart field decreases.  
 
In all vertebrates, the bilateral precardiac regions of the LPM migrate toward the 
embryonic midline. Here the primordia fuse to form the heart tube. The heart begins 
sporadic contractions before the formation of the tubular heart is complete, and 
simultaneous with the completion of the heart tube are rhythmic pulsations (Lemanski, 
1973a), although the onset of nervous control occurs much later. Spontaneous 
depolarisation is initially seen in the caudal region of the straight heart tube; a region that 
later forms the SA node, the pacemaker of the heart (Olson & Srivastava, 1996). Initially, 
the heart is a straight tube and does not exhibit chambered subdivisions. During 
development the tube flexes into an S-shaped structure by rightward looping, and becomes 
intermittently constricted and dilated. These movements result in relocations of the heart 
regions and the formation of four main subdivisions:- (i) sinus venosus; (ii) atrium; (iii) 
ventricle; and (iv) bulbus cordis. Figure 1-1 depicts the main anatomical events of cardiac 
looping morphogenesis and chamber formation. Cardiac looping is a complex 
morphogenetic event in all vertebrates that brings the cardiac chambers into the correct 
alignment and allows the morphogenesis of valves and septa. 
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The hearts of bony fish have four chambers: the sinus venosus, atrium, ventricle, and conus 
arteriosus which are arranged in series so there is no separation of respiratory and systemic 
circulation. The deoxygenated blood flows from the sinus venosus towards the conus 
arteriosus direction, then to the gills to be oxygenated. Amphibians possess a single 
ventricle which pumps blood to both the lungs and the rest of the body. Oxygenation of the 
blood is also achieved cutaneously. The atrium of the axolotl is divided into two by a 
septum, although it was found to be incompletely divided in the axolotl at hatching (body 
length 1.5 cm) (Melinek & Mirolli, 1988) and also in early tadpole stage in Xenopus laevis 
(Mohun et al., 2000).  
 
Cardiac neural crest cells migrate through the circumpharyngeal region to populate the 
pharyngeal and aortic arches as well as the cardiac outflow tract and proximal great 
vessels. They form a sheath around the persisting aortic arch arteries and comprise the 
aorticopulmonary septation complex. Neural crest cells are also involved in the formation 
of the truncal cushion and membranous portion of the interventricular septum, and 
development of the semi-lunar valves. In human and mouse embryos the cardiac neural 
crest cells also appear give rise to the parasympathetic (vagal) postganglionic neurons of 
the heart (the cardiac ganglia) (Larsen, 1997; Waldo, Lo, & Kirby, 1999).  
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Figure 1-1. Anatomical events of cardiac morphogenesis.  
 
The tubular heart (A) initiates rhythmic contractions at about day 23 in human and then 
undergoes rightward looping (B), which is the first indication of left-right asymmetry in 
the embryo. The S-shaped structure (C) flexes to bring the left atrium above and behind the 
left ventricle (D), forming the four-chambered heart (E). The arrows outside the heart 
depict the direction of twisting of the embryonic heart during development. Note, the 
diagram is of human heart formation, having a left and right ventricle; amphibians only 
have one ventricle. (Although, mammalian ontogeny also show one ventricle before they 
become two).             
Modified from Gilbert (1994) 
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The role of the cardiac neural crest in heart development has been demonstrated by studies 
with chick embryos. Cardiac neural crest ablation in these embryos produces a variety of 
cardiac defects, mostly of the conotruncus and aortic arch, including persistent truncus 
arteriosus (Nishibatake, Kirby, & Van Mierop, 1987) and interrupted aortic arch (Kirby & 
Waldo, 1995). These abnormalities resemble those seen in DiGeorge syndrome, a human 
congenital syndrome believed to arise from neural crest defects. 
 
 
1.2 NEUROANATOMICAL OVERVIEW OF THE VAGUS NERVE 
The way in which the embryonic brain develops is remarkably constant throughout the 
vertebrates. This constancy is most evident in the parts of the brain which develops first 
that could be regarded as most primitive or unspecialised. The summary recapitulation of 
evolution which occurs during ontogeny has proved invaluable in understanding brain 
morphology. 
 
In vertebrate embryos the nervous system is one of the earliest groups of tissues to 
develop. A neural tube is formed by the closure of the neural grove in the dorsal mid-line 
of the early embryo. The anterior thickening of this tube which occurs, to form the brain, is 
indicative of the cephalisation of both sense organs and integrative centres which has 
occurred in vertebrates. Outgrowths of this early nervous system and connections with 
nervous tissue outside the neural tube form the spinal and cranial nerves. These are the 
routes by which the animal receives information from its own tissues and the environment, 
and relays commands to muscles, glands and sense organs through which a response is 
mediated. 
7 
 
 
The anterior thickening of the neural tube develops into three distinguishable components: 
the forebrain, midbrain and hindbrain (Figure 1-2). 
 
 
 
 
 
 
Figure 1-2. The dorsal surface of the adult axolotl brain. 
The forebrain, midbrain and hind brain are clearly visible as separate bulges in the axolotl 
brain. The forebrain contains the following structures: thalamus, hypothalamus, cerebral 
cortex, hippocampus, basal ganglia & other subcortical structures. The midbrain contains 
the tectum, tegmentum, superior colliculus, inferior colliculus, substantia nigra. The 
hindbrain is composed of the medulla oblongata, pons and cerebellum.  
 
 
1.2a The hindbrain 
The hindbrain is the most posterior part of the brain and consists of the medulla, the pons 
and the cerebellum. The medulla oblongata is the enlargement where the spinal cord enters 
the brain and is located in the skull. Through the cranial nerves emanating from the reflex 
centres, the medulla controls a number of vital reflexes, such as breathing, heart rate, 
vomiting, salivation, coughing and sneezing. The cranial nerves include both sensory and 
motor components, although some include just one or the other (see Table 1-1). The 
branches of cranial nerve X, the vagus nerve, supply organs in the thoracic and abdominal 
Prosencephalon 
(forebrain) Mesencephalon 
(midbrain) 
Rhombencephalon 
(hindbrain) 
© Aruna Narshi 
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cavities. The vagus nerve is the major nerve of the parasympathetic nervous system. Each 
cranial nerve originates in a nucleus or „centre‟ (a cluster of neurons within the central 
nervous system) that integrates the sensory information and regulates the motor output. 
The cranial nerve nuclei for nerves V through XII are located in the medulla and pons of 
the hindbrain. Those for cranial nerves I through IV are located in the midbrain and 
forebrain.  
 
Table 1-1. Functions of the cranial nerves of humans. 
 
Number and Name Function of sensory Component Function of Motor Component 
I Olfactory Smell (no motor nerve) 
II Optic Vision (no motor nerve) 
III Ocularmotor Sensations from eye muscles Eye movements, pupil constriction 
IV Trochleur Sensations from eye muscles Eye movements 
V Trigeminal 
Sensations from skin of face, nose, 
and mouth 
Chewing, swallowing 
VI Abducens Sensations from eye muscles Eye movements 
VII Facial 
Taste from the anterior two-thirds of 
the tongue, visceral sensations from 
the head 
Facial expressions, crying, 
salivation, and dilation of blood 
vessels in the head 
VIII Statoacoustic Hearing, equilibrium (no motor nerve) 
IX Glossopharyngeal 
Taste and other sensations from throat 
and posterior third of tongue 
Swallowing, salivation, dilation of 
blood vessels 
X Vagus 
Taste and sensations from neck, 
thorax, and abdomen 
Swallowing, control of larynx, 
parasympathetic nerves to heart 
and viscera 
XI Accessory (no sensory nerve) 
Movement of shoulders and head; 
parasympathetic to viscera 
XII Hypoglossal Sensation from tongue muscles Movement of tongue 
  
The pons lies anterior to the medulla; like the medulla, it contains the nuclei for several 
cranial nerves. The term „pons‟ is Latin for „bridge‟; the name reflects the fact that many 
axons in the pons cross from the left side of the brain to the right, or from the right to the 
left. The medulla and pons also contain the reticular formation and the raphe system. These 
systems send axons diffusely thought the forebrain, controlling the overall state of nervous 
arousal. 
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The cerebellum is an outgrowth of the medulla oblongata. It is best known for its 
contributions to the control of motor activity associated with limb movement, maintaining 
posture, and spatial orientation. The relative size of the cerebellum can vary among the 
vertebrata. Birds and mammals have a large cerebellum which is a reflection of complex 
locomotor patterns and a common evolutionary history of limb development of phylogeny 
as terrestrial vertebrates (Yopak et al., 2010). Amphibians often have a rudimentary 
cerebellum, reflecting their relatively simple locomotor patterns (Taylor et al., 1995).  
 
1.2b The tenth cranial nerve 
The cranial nerve nuclei form in the periventricular zone within the medial (motor) and 
lateral (sensory) regions in the developing brain of vertebrates. Autonomic preganglionic 
parasympathetic neurons develop in the periventricular grey. This region is the future 
dorsal vagal motor nucleus (DVN) and in some cases, they migrate out to a ventrolateral 
position to form the future nucleus ambiguus (nA) (Macchi et al., 2002; Friedland et al., 
1995; Brown, 1990). Branchiomeric (muscles derived from gill arches) motor nuclei 
initially develop in the periventricular grey too and then they migrate to occupy the 
ventrolateral position, nA, in the adult. In adults the nA consists of a thin column of motor 
neurons in the medulla oblongata. (see Figure 1-3 for relative location of DVN and nA). 
Detailed images of these areas in the axolotl brain are recorded in Chapter 7).  
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Figure 1-3. A schematic diagram of a traverse section through the medulla oblongata, at 
the vagal nerve location, showing the site of cell bodies of vagal preganglionic motor 
neurons in the dorsal motor nucleus (DVN) and nucleus ambiguus (nA). Note nA is 
ventrolateral of the DVN which is in a dorsal medial location.  
 
In humans, and in most other vertebrates, the vagus nerve has sensory axons leading to the 
brain as well as motor axons leading to the heart and smooth muscles of the visceral organs 
in the thorax and abdomen. The word „vagus‟ arises from the word „vagrant‟ which means 
wandering from place to place. Its wandering course commences from the brain stem and 
through organs in the neck, thorax and abdomen. The nerve exits the brain stem through 
rootlets in the medulla oblongata. As stated earlier the branchial-motor component of the 
vagus nerve originates in the medulla in the nA and the viscero-motor (parasympathetic 
component) of the vagus nerve originates from the DVN in the dorsal medulla. These cells 
give rise to axons that travel in the vagus nerve. The viscera-motor part of the vagus 
innervates ganglionic neurons which are located in or adjacent to each target organ.  
 
Nucleus 
ambiguus
Dorsal vagal motor 
nucleus
Vagus  
nerve X
Fourth 
ventricle
White matterGrey matter
© Aruna Narshi 
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The target organs for the axons originating from the nA are in the head-neck and include 
glands of the pharynx and larynx (via the pharyngeal and internal branches). The nA is 
thought to be important in the regulation of airways (Dergacheva et al., 2010; Kohn et al., 
2009; Chen et al., 2007). The DVN acts, through branches entering the thorax, on the lungs 
for bronchoconstriction, the oesophagus for peristalsis, and the heart for slowing of heart 
rate. In the abdomen branches enter the stomach, pancreas, small intestine, large intestine 
and colon for secretion and constriction of smooth muscle. The viscero-sensory 
components of the vagus are derived from nerves that have receptors in the abdominal 
viscera, oesophagus, heart and aortic arch, lungs, bronchia and trachea. The chemo- and 
baroreceptor inputs reach the nucleus solitarius (an area lateral to DVN) bringing and 
processing sensory visceral inputs to cranial nerve nuclei of X and IX (e.g. from the carotid 
body and sinus) via the solitary tract. So it can be seen that the vagus nerve is composed of 
both motor and sensory fibres.  
 
 
1.3 OVERVIEW OF THE VERTEBRATE NERVOUS SYSTEM 
1.3a Central nervous system 
All vertebrate the nervous systems have some fundamental similarities in central and 
peripheral elements and a high degree of cephalisation. The brain and the spinal cord make 
up the central nervous system (CNS). The brain is important in integrating information 
transmitted from the surrounding environment through an array of sensitive receptors and 
is housed and protected within the skull. The spinal cord is protected in the vertebral 
column and it too is involved in relaying messages to and from the brain to the rest of the 
body. The spinal cord can also by-pass the brain completely and elicit spinal reflexes that 
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serve important survival value. An example of this is the withdrawal reflex when we are 
subjected to a sudden painful stimulus. 
 
Axons within the CNS are located in well-defined tracts. They have myelin sheaths which 
give them a whitish appearance, hence the name white matter in the brain. The grey matter 
of the CNS is where nerve cell bodies, dendrites, and un-myelinated axons can be found. 
The narrow central canal of the spinal cord is continuous with cerebrospinal fluid-filled 
spaces, called the ventricles, in the brain (see Figure 1-3). 
 
1.3b Peripheral nervous system 
The cranial nerves discussed earlier, along with spinal nerves, form the peripheral nervous 
system (PNS). These nerves and associated ganglia innervate the whole body. See Table 1-
1 for the functions of the cranial nerves of humans. Mammals have 12 pairs of cranial 
nerves and 31 pairs of spinal nerves; hence the complexity of the PNS is subdivided into a 
hierarchy of components based on function (Figure 1-4). 
 
 
13 
 
 
 
Figure 1-4. Functional hierarchy of the peripheral nervous system.  
The nerves and ganglia of the vertebrate PNS convey information throughout the body. 
Sensory and motor divisions of the PNS are organised into a functional hierarchy.  
 
1.3c Autonomic nervous system  
The autonomic nervous system (ANS) is a set of neurones that receives information from 
and sends commands to the heart, intestines, and other organs. It is composed of two parts: 
the sympathetic and parasympathetic divisions. The sympathetic nervous system consists 
of two paired chains of ganglia lying just to the left and right of the spinal cord in its 
central regions (the thoracic and lumbar regions) and connected by axons to those spinal 
cord regions. Postganglionic axons extend from the sympathetic ganglia to the body‟s 
organs. The sympathetic nervous system prepares the body for „fight or flight‟ activities by 
increasing heart and breathing rates and decreasing digestive activity. 
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The parasympathetic nervous system has functions that are related to, and generally 
opposite to, those of the sympathetic nervous system. The sympathetic and 
parasympathetic systems are usually active at the same time to varying degrees. However, 
at times parts of one system may be highly active along with parts of the other system. 
Table 1-2 illustrates the main differentiating characteristics of the sympathetic and 
parasympathetic divisions. 
 
Sympathetic and parasympathetic preganglionic fibres release the same neurotransmitter, 
acetylcholine (ACh), but the postganglionic endings of these two systems release different 
neurotransmitters (the neurotransmitters that influence the effector organs). 
Parasympathetic postganglionic fibres release ACh and thus are called cholinergic fibres, 
along with all autonomic preganglionic fibres. Most sympathetic postganglionic fibres, in 
contrast, release noradrenaline and are called adrenergic fibres. 
 
Postganglionic autonomic fibres do not end in a single terminal swelling like a synaptic 
knob. Instead, the terminal branches of autonomic fibres contain numerous swellings, or 
varicosities, that simultaneously release neurotransmitter over a large area of the 
innervated organ rather than on single cells. Thus whole organs instead of discrete cells are 
influenced by the autonomic activity, especially since the diffuse release of 
neurotransmitter is coupled with the fact that any resulting change in electrical activity is 
spread throughout a smooth- or cardiac-muscle mass via gap junctions. 
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Table 1-2. Distinguishing features of the sympathetic and parasympathetic nervous 
systems 
Feature Sympathetic system Parasympathetic system 
Origin of preganglionic 
fibre 
Thoracic and lumbar regions of 
spinal cord 
Brain and sacral region of spinal cord 
Origin of postganglionic 
fibre (location of ganglion) 
Sympathetic ganglion chain (near 
spinal cord) or collateral ganglia 
(about halfway between spinal cord 
and effector organs) 
Terminal ganglia (in or near effector 
organs) 
Length and type of fibre 
Short cholinergic preganglionic 
fibres 
Long adrenergic postganglionic 
fibres (most) 
Long cholinergic postganglionic 
fibres (few) 
Long cholinergic preganglionic fibres 
 
Short cholinergic postganglionic 
fibres 
Effector organs innervated 
Cardiac muscle, almost all smooth 
muscle, most exocrine glands, and 
some endocrine glands 
Cardiac muscle, most smooth 
muscle, most exocrine glands, and 
some endocrine glands 
Types of receptors for 
neurotransmitters 
α, β1, β2 Nicotinic, muscarinic 
Postganglionic 
neurotransmitter 
Mostly noradrenaline  
Few acetylcholine  
Acetylcholine  
Dominance 
Dominates in emergency „fight or 
flight‟ situations; prepares body for 
strenuous physical activity 
Dominates in quiet, relaxed 
situations; promotes „general 
housekeeping‟ activities such as 
digestion 
Types of discharge 
Frequently mass discharge of whole 
system; may involve only discrete 
organs 
Normally involves discrete organs 
rather than mass discharge 
 
 
1.3d Development of cardiac neural control 
The heart cannot be described as a fully functional unit until it has been innervated (with 
the exception of hagfish whose hearts are generally thought to be aneural (Augustinsson et 
al., 1956; Carlson, 1904; Green, 1902; Jensen, 1965) although Hirsch et al. (1964) showed 
contradictory findings). Innervation of the heart permits regulation of cardiac cycle in tune 
with the rest of the body. The heart is innervated by the autonomic division of the 
peripheral nervous system, which develops from neural crest cells. All of the 
postganglionic neurons of the autonomic nervous system are derived from neural crest 
cells which migrate extensively during development and give rise to many different cell 
populations. The heart derives innervation from three sources (see Figure 1-5):  
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 The postganglionic parasympathetic innervation to the developing chick heart is via the 
cardiac ganglia. These can be identified around the fifth day of incubation in the bulbar 
region of the heart.  In chicks, cardiac ganglia originate from cranial region (somites 1-
2) of the vagal neural crest (somites 1-7) (Kirby, & Stewart, 1983).   
 
 Sympathetic innervation is via the first to fourth thoracic sympathetic ganglia, which, 
again is derived entirely from neural crest. 
 
 Sensory innervation of the heart is from the nodose ganglion (also called the inferior 
vagal ganglion), which is the distal cranial ganglion of the vagus nerve. It is derived 
from cells of the nodose placode (cellular thickening of the ectoderm) and is located 
laterally and slightly anteriorly to the cardiac neural crest. 
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Figure 1-5. Diagram mapping the origin of the various components of the cardiac 
innervation.  
 
The parasympathetic postganglionic cholinergic neurons (cardiac ganglia) arise from 
cardiac neural crest; sympathetic postganglionic adrenergic neurons arise from trunk neural 
crest (somites 10-20); sensory innervation arises from the nodose placode. 
Taken from Kirby (1988) 
 
There are a number of factors that have been implicated in the development of the 
peripheral autonomic nervous system. These include glial-derived neurotrophic factor 
(Moore et al., 1996); transcription factor Mash1 (Hirsch et al., 1998), and the homeobox 
containing transcription factor Phox2b (Pattyn et al., 1999) which are necessary for the 
differentiation and survival of subsets of autonomic neurons.  
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The ontogenetic development of autonomic innervation of the heart has been studied in 
most detail in the developing chick embryo (Pappano, 1977; Kirby, McKenzie & 
Weidman, 1980). They have shown that the heart is responsive to adrenaline and 
acetylcholine several stages before functional innervation (in Fritsche, 1997). It appears 
that the adrenergic- and acetylcholine-sensitive receptors differentiate long before effective 
innervation. It may be that the receptors guide the developing nerve fibres to form 
postganglionic autonomic varicosities. Observing the development of innervation when the 
receptors are blocked or activated could test this hypothesis. Interesting experiments to this 
effect have been carried out by Wang and Halvorsen (1998) who suggest that ciliary 
neurotrophic factor and its receptor may be involved in the formation of parasympathetic 
synapses in chick atria.  
 
The chronological sequence of the development of parasympathetic innervation of the 
chick embryo heart begins with the appearance of receptors for acetylcholine and the 
activating enzyme acetyl-cholinesterase on day two. On day six the cholinergic neurons 
grow within the sino-atrial node and the release of acetylcholine is first detected on day 
ten. It is on day 12 that functional vagal transmission and the appearance of the 
acetylcholine synthesising enzyme, choline acetyltransferase, is observed. On day 21 the 
chick hatches (Pappano, 1977). The development of the sympathetic cardiac innervation 
follows the same sequence as the parasympathetic innervation, except that effective 
neurotransmission occurs later when compared with the parasympathetic system (Kirby, 
McKenzie & Weidman, 1980; Verberne et al., 1999). This would mean that the heart rate 
was only controlled by parasympathetic discharge in the early embryonic stages, or by 
circulating catecholamines, rather than neurogenic. However, it was found that, in 
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embryonic chicks, the vagus played no role in CV control and so it appears that CV 
development occurs in the absence of tonic vagal input (Crossley & Altimiras, 2000). 
Furthermore, blockade of β-adrenergic receptors resulted in bradycardia in the absence of 
functional sympathetic efferents to the heart, supporting the idea of there being circulating 
catecholamines that results in embryonic chicks developing under β-adrenergic tone 
(Crossley & Altimiras, 2000).  
 
In humans and other animals a similar chronological sequence of autonomic development 
occurs. The embryonic period in humans lasts eight weeks. During the fourth week neural 
crest cells begin to migrate away from the neural tube. Although innervation of the heart 
occurs from about 6-7 weeks gestation (Larsen, 1997), a functional cardiac nerve supple is 
not present at this time. Effective neurotransmission of the heart occurs from around 4 
months gestation (Navaratnam, 1965) and, as in the chick and other animal species, 
parasympathetic neurotransmission occurs prior to the sympathetic. 
 
The development of cardiac innervation in Ambystoma mexicanum has been studied by 
Melinek & Mirolli (1988) (see Figure 1-6 for heart morphology). They looked at axolotls 
from hatchling to 12-months of age and noted that there were marked changes in the 
pattern of innervation with age. Both cholinergic (parasympathetic) and catecholaminergic 
(sympathetic) staining were absent before hatching. A few days after hatching cholinergic 
fibres and neurons stained, which was considerably earlier than for catecholaminergic fibre 
staining. However, both the cholinergic and catecholaminergic innervation of the heart are 
poorly developed at hatching and only reach their mature state after a few months. The 
catecholamine found was norepinephrine (approximately 0.5 μg/g in the atria; 0.6 μg/g in 
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the sinus venosus; 0.2 μg/g in the ventricle), and was confirmed by the presence of its 
precursor dopamine at the expected concentrations. No neurons containing 5-
hydroxytryptamine was found. The number and arborisations of both sets of preganglionic 
fibres increase during the first 3 months post-hatching. The number of postganglionic 
parasympathetic neurons also increased considerably during this period. It is unclear if the 
increase in fibres and neurons is due to a continuous migration of neuroblasts into the heart 
or whether all or some of the neuroblasts present in the earliest developmental stages 
continue to divide after hatching. Indeed, both factors may be operating as described in 
Xenopus (Heathcote & Sargent, 1984). Thus, it appears that the development of the 
innervation of the axolotl heart follows the same pattern as that known for other 
vertebrates, including mammals (Pappano, 1977).  
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Figure 1-6. Ventral view of a young larval axolotl heart.  
 
The heart consists of four chambers in series: sinus venosus (sv), atrium (a), ventricle (v) 
and continuous with this, the conus arteriosus (ca). A thin sheet of connective tissue (ts) is 
found between the sinus venosus and the ventricle and the posterior wall of the 
pericardium. The cardiac ganglion is found in the tissue sheet and in the dorsal wall of the 
sinus venosus. The ventral side of the sinus venosus is mainly composed of muscular tissue 
and contains the pacemaker region. The shaded area indicates the position of the large 
hepatic vein which opens directly into the atrium. The authors found that the atrium was 
incompletely divided into two chambers by a thin muscular septum in the young axolotl 
(body length 1.5 cm).                                              Modified from Melinek & Mirolli (1988) 
 
Intriguingly, the changes in cardiac innervation associated with amphibian metamorphosis 
appear not to have been studied. Yet, metamorphosis is a very important developmental 
process. Knowledge of the control of the cardio-respiratory system in larval and adult 
amphibians could help in understanding the major evolutionary conversions that occur in 
the control of ventilation between fish with gills and mammals with lungs. In the 
unmetamorphosed axolotl, the animal relies on its gills for gas exchange. Post 
metamorphosis, the axolotl is no longer aquatic and uses mainly its lungs for ventilation. 
Thus, there may indeed be differences in heart innervation, especially since changes in the 
ca 
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cardio-respiratory centres of the brainstem, before and after metamorphosis, have already 
been noted; The cell bodies of preganglionic neurons of the vagus have shown to relocate 
ventro-laterally after metamorphosis (Taylor et al., 2001), topologically similar to some 
lung breathers, thereby suggesting that this relocation may be associated with the 
predominantly lung ventilation.  
 
 
1.4 NERVOUS CONTROL OF HEART 
The following section predominantly relates to the mammalian heart, but is also true for 
most vertebrates. There are some relevant differences and these are highlighted and / or 
detailed in „The nervous control of the heart of vertebrates‟ section. 
 
Before the heart is innervated, it has a tendency to beat at an intrinsic rate, known as 
myogenic rhythmicity. This relates to heart muscle contractions which originate in the 
sino-atrial (SA) node, which is the pacemaker and driving force of the heart. The electrical 
signal travels across both atria causing them to contract almost simultaneously. Conduction 
then reaches the atrio-ventricular node (AV-node), down the Purkinje fibres of the bundle 
of His and along the right and left branches, down the ventricular septum to enter the 
Purkinje network that ramifies throughout the ventricles. Because of the extensive 
branching of the Purkinje network in the ventricles, excitation reaches all parts of both 
ventricles rapidly causing them to contract simultaneously.  
 
The cardiovascular (CV) centres in the brain alter the intrinsic discharge rate of the SA-
node by the dual innervation by antagonistic limbs of the autonomic nervous system 
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(Samaan, 1935; Glick & Braunwald, 1965). Both the sympathetic and parasympathetic 
limbs of the autonomic nervous system innervate the SA-node. The postganglionic 
sympathetic fibres release the neurotransmitter noradrenaline, and adrenaline is released 
from the adrenal medulla in response to increased sympathetic activity. These bind to β1-
adrenoceptors on plasma membranes of cardiac cells in the SA-node. Sympathetic 
stimulation results in an increase in heart rate and a rise in the force of cardiac contraction. 
Acetylcholine, the transmitter released by the parasympathetic fibres, acts on M2-
muscarinic cholinoceptors in the SA-node and causes a decrease in heart rate and a fall in 
cardiac contractility. Other parts of the heart also receive sympathetic and parasympathetic 
fibres. For instance, the Purkinje fibres and ventricular muscle receive mainly sympathetic 
innervation. See Table 1-3 for a summary of the autonomic control of the heart rate.  
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Table 1-3. Effects of the autonomic system on the heart and structures that influence 
the heart. 
 
Area affected 
Effect of parasympathetic 
stimulation 
Effect of sympathetic stimulation 
SA node 
Decreases rate of depolarisation to 
threshold; decreases heart rate 
Increases rate of depolarisation to 
threshold; increases heart rate 
AV node 
Decreases excitability; increases AV 
nodal delay 
Increases excitability; decreases AV 
nodal delay 
Ventricular conduction 
pathway 
No effect 
Increases excitability; hastens 
conduction through bundle of His 
and Purkinje cells 
Atrial muscle 
Decreases contractility; weakens 
contraction 
Increases contractility; strengthen 
contraction 
Ventricular muscle No effect 
Increases contractility; strengthen 
contraction 
Adrenal medulla No effect 
Promotes adrenomedullary secretion 
of adrenaline, which augments the 
sympathetic nervous system‟s actions 
on the heart 
Veins  No effect 
Increases venous return, which 
increases strength of cardiac 
contraction through the Frank-
Starling mechanism 
 
 
The parasympathetic nerve fibres project to the heart in the vagus nerve, and thus their 
normal activity is often referred to as vagal tone. Bradycardia, for example during sleep, 
can be due to an increase in parasympathetic discharge and a decrease in, or absence of, 
sympathetic discharge. In mammals, vagal dominance often predominates and varies under 
the influence of central and peripheral inputs so that the heart beats at a rate generally 
slower and more variable than the intrinsic pacemaker rate. The opposite changes in 
autonomic activity lead to tachycardia, which may occur during stress. Alterations in heart 
rate are referred to as chronotropy, and a positive chronotrope, such as atropine, increase 
the heart rate by acting on the SA-node, whereas as propranolol is an example of a 
negative chronotrope. Propranolol is also a negative inotrope as it blocks β-adrenergic 
receptors. Inotropes alter the force of muscle contraction and so beta blockers weaken the 
force of muscular contractions of the heart. 
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The changes in activity and the associated demands of the tissues are reflected in the 
relatively large variation in heart rate and cardiac output. The medullary control of the 
autonomic nervous system has various cardiovascular reflexes that alter heart rate 
accordingly. For instance, the baroreceptor reflex acts as a buffer which protects the body 
from excessive swings in systemic arterial pressure. These baroreceptors are located in the 
carotid sinus and aorta. When there is a rise in pressure the baroreceptors elicit an 
inhibitory effect on the cardiovascular system which promotes a fall in blood pressure. In 
amphibians, baroreceptors that trigger a cardioinhibitory reflex reside in the carotid 
labyrinth and in the pulmocutaneous artery (Figure 1-7) from which sensory fibres run in 
the laryngeal nerve (Jones & Milsom, 1982). In humans there are also chemoreceptors 
located in the carotid and aortic bodies which detect changes in oxygen, carbon dioxide 
and pH in the circulation. Chemoreceptors in amphibians have been unequivocally 
demonstrated within the complex vasculature of the carotid labyrinth (Smith et al., 1981). 
The effect of chemoreceptors is primarily on the respiratory system, which will be 
discussed later. While baroreceptor reflexes directly affect the generation of blood pressure 
in the vertebrates, the chemoreceptor reflexes are to a major extent, involved in ventilatory 
control mechanisms. Both central and peripheral receptor sites have been demonstrated in 
a number of vertebrate groups, but out knowledge of their relationship with the efferent 
(autonomic) pathways is rudimentary in the non-mammalian groups. 
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Figure 1-7. General cardiovascular reflexes in amphibia.  
Highly schematic diagram illustrating two of the major autonomic pathways involved in 
circulatory control: the vagal, cholinergic cardioinhibitory pathway and the spinal 
autonomic vasomotor pathway. Amphibian baro- and chemoreceptor input affecting these 
pathways is also outlined. 
 
The heart itself has receptors that reflexively alter its rate. At the junction of the vena cava 
and right atrium are atrial mechano- (stretch) receptors that detect atrial distension. When 
stimulated they cause tachycardia via vagal afferent and sympathetic efferent pathways, a 
phenomenon known as the Bainbridge reflex (Bainbridge, 1915).  These receptors, when 
activated lead to reflex diuresis which regulates blood volume. Bainbridge found that 
baroreceptor stimulation, upon a fall in blood pressure, resulted in a decrease in heart rate 
in dogs. The Bainbridge reflex is also known to be involved in respiratory sinus arrhythmia 
(RSA) where the heart rate rises due to an increase in intrathoracic pressure upon 
Chemoreceptor input from 
pulmocutaneous artery & carotid labyrinth 
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inspiration. Furthermore, the heart has an intrinsic ability to increase the force of 
contraction when the cardiac muscle is stretched. For instance, when there is an increased 
volume of blood entering the ventricle, the cardiac muscle contracts more forcefully. This 
is known as the Frank-Starling law. Of course, heart rate changes occur during integrated 
processes too, such as during physical exercise, emotion, digestion, and hormonal 
influences. These changes are mediated by more complex mechanisms with interactions 
between higher brain centres, centres in the mid-brain, and control centres in the medulla, 
which is detailed later. Thus, variation in heart rate may be considered a good indicator of 
the functioning of the physiological system. 
 
1.4a Innervation of vertebrate hearts 
In all vertebrates, with the exception of the myxinoids (hagfish), the heart is innervated by 
branches from the vagus nerve. However, the way in which the vagus nerve controls the 
heart differs considerably between the vertebrate groups. It is useful to start with the heart 
of cyclostomes when studying the evolution of sympathetic and parasympathetic cardiac 
innervation. 
 
1.4a.i Cyclostomes 
Cyclostomes are lampreys (lampetroids) and hagfish (myxinoids). The myxinoids have 
neither a sympathetic nor a parasympathetic supply (Green, 1902; Carlson, 1904; 
Augustinsson et al., 1956; Jensen, 1965) and are insensitive to drugs which exert marked 
cardiac effects in other vertebrates. Although the Pacific hagfish (Eptatretus stoutii) may 
be an exception as nerves in the heart and adjacent to it have been reported (Hirsch et al., 
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1964). The lampetroid heart is innervated by a branch of the vagus nerve (Ransom and 
Thompson, 1886; Augustinsson et al., 1956) like all other fish hearts. 
 
Unusually amongst vertebrates, vagal stimulation and its subsequent release of 
acetylcholine, results in an acceleration of the heart with an accompanying decrease in the 
force of contraction (Falck et al., 1966) in lampetroids. The same effect results from 
nicotinic cholinoceptor agonists, such as nicotine (Augustinsson et al., 1956; Falck et al., 
1966). Nicotinic cholinoceptor antagonists such as tubocurarine and hexamethonium can 
be used to block the excitatory effect of vagal stimulation or nicotinic agonists 
(Augustinsson et al., 1956; Falck et al., 1966; Lukomskayo & Michelson, 1972). Drugs 
adrenaline, noradrenaline, isoprenaline and tyramine also stimulate the lampetroid heart, 
although the effects are less pronounced than that of acetylcholine. Since the effect of the 
adrenergic agonists is blocked by propranolol in lampetroids, this suggests that the effect 
must be through β-adrenoceptors as in the higher vertebrates (Augustinsson et al., 1956; 
Nayler & Howells, 1965; Falck et al., 1966). 
 
1.4a.ii Elasmobranchs 
Elasmobranchs (cartilaginous fishes, e.g., sharks, dogfishes, skates and rays) are the 
earliest group of vertebrates in which there is an inhibitory vagal innervation of the heart. 
There are two pairs of cardiac nerves that supply the heart; one from the fourth branchial 
branch of the vagus and the other one arises close to the origin of the visceral branch of the 
vagus. The two cardiac vagi run closely together into the ductus Cuveri and then break up 
into an interwoven plexus on the sinus venosus, terminating at the junction with the atrium 
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(Young, 1933). In elasmobranchs the site of the pacemaker appears to be at the sino-atrial 
node (Rybak & Cortok, 1956; Satchell, 1971). 
 
There is no sympathetic innervation on the heart. However, it is thought that an adrenergic 
influence may be exerted by specialised catecholamine-storing endothelial cells in the 
sinus venosus and atrium. These cells are innervated by cholinergic vagal fibres 
(Saetersdal et al., 1975; Pettersson and Nilsson, 1979). The stimulation of the vagus nerve 
has an inhibitory effect on the heart rate. The effect appears to be mediated by muscarinic 
cholinoceptors as in higher vertebrates. The effects of adrenaline and noradrenaline in the 
elasmobranch heart are variable. 
 
1.4a.iii Teleosts 
Teleosts may be considered as the earliest group of vertebrates in which there is both 
sympathetic and parasympathetic control of the heart. As the in the elasmobranchs the 
cardiac branches of the vagi follow the ductus Cuveri to the sinus venosus and atrium. The 
vagal fibres do not reach the ventricle. As in all vertebrates, with the exception of 
cyclostomes, the vagus is cardio-inhibitory and releases acetylcholine onto muscarinic 
cholinoceptors. Studies have found that the level of resting vagal tone decreases with 
increasing temperature, with adrenergic mechanisms taking over the cardio-acceleratory 
function at higher temperatures (Priede, 1974; Wood et al., 1979). The positive 
chronotropic effects of adrenergic agonists and adrenergic nerves are mediated via β-
adrenoceptor mechanisms (Randall & Stevens, 1967). 
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1.4a.iv Amphibians 
The amphibian heart is innervated by vagal fibres and by fibres from the sympathetic chain 
ganglia that join near the cranium to form „vagosympathetic trunks‟. On each side of the 
animal the cardiac nerve leaves the visceral branch of the vagus nerve and reaches the 
atrial septum. The cholinergic vagal fibres have a negative chronotropic and inotropic 
effect in urodeles and anurans (Bidder, 1868; Gaskell, 1884; Kirby & Burnstock, 1969; 
Campbell et al., 1982).  Vagal tone on the heart seems to be seasonally regulated (Butler & 
Jones, 1982; Nilsson, 1983), with the toad having vagal inhibition during winter 
(Iriuchijima, 1959). The spinal autonomic fibres that enter the „vagosympathetic trunk‟ of 
the amphibians are adrenergic and produce positive chronotropic and inotropic effects on 
the heart (Gaskell, 1884; Elliot, 1905; Loewi, 1921). 
 
1.4a.v Reptiles 
Reptilian hearts have inhibitory cholinergic vagal innervation, thus upon stimulation, 
negative chronotropic and inotropic effects are observed. These effects are mimicked by 
acetylcholine and blocked by muscarinic cholinoceptor antagonists such as atropine 
(Gaskell, 1884; Berger & Burnstock, 1979). Positive chronotropic and inotropic effects are 
mediated by adrenergic fibres of spinal autonomic origin that innervate the heart also. 
 
1.4a.vi Birds 
The avian heart has vagal and sympathetic innervation (Bolton, 1971; Bennett, 1974). The 
vagal fibres are cholinergic and, as in most vertebrates, they mediate negative chronotropic 
and inotropic effects on the heart. The adrenergic fibres work through the β-adrenoceptor 
mechanism and mediate positive chronotropic and inotropic effects on the heart (Johansen 
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& Reite, 1964; Bolton & Raper, 1966; Yamauchi, 1969; Bennett, 1974). Schwaber & 
Cohen (1978) have found that there are a greater proportion of mylinated fibres in avian 
cardiac nerves compared mammalian cardiac nerves. Also, when comparing birds with 
other vertebrates of similar size, the avian heart rate is very high. 
 
1.4a.vii Mammals 
Vagal nerves regulate cardiac rate and rhythm. There is variation in the anatomy of the 
peripheral cardiac nerves between different mammalian species (Randall & Armour, 
1977). The mammalian heart has inhibitory cholinergic vagal innervation that have 
negative chronotropic and inotropic effects. These cholinergic fibres occur in the 
pacemaker region (SA-node) and in the atria, and are very scarce or absent in the 
ventricles, depending on species (Bolton & Raper, 1966). The level of vagal tone on the 
heart varies between different species. For instance, the cat has a relatively low level of 
vagal tone (Spyer, 1982). 
 
Adrenergic fibres innervate the SA- and AV-nodes, atria and ventricles. In some species, 
as in the cat, the ventricle is richly innervated. In other species, particularly in hibernating 
mammals, the ventricular innervation is sparse (Nielsen & Owman, 1968). These fibres 
enter the heart mainly along the cardiac nerves from the sympathetic chains. However, 
there is also a substantial contribution by fibres entering the vagi from the superior cervical 
ganglia (Nielsen et al., 1969; Campbell 1970; Prioloa et al., 1981). The adrenergic fibres 
mediate positive chronotropic and inotropic responses on the mammalian heart via β1 and 
β2 adrenoceptors (Hedburg et al., 1980). 
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1.5 OVERVIEW OF VERTEBRATE RESPIRATORY SYSTEMS  
 
Aquatic vertebrates can rely on, or use a combination of, cutaneous body surface, external 
filamentous gills, or internal lamellar gills for gas exchange. Some salamanders (and other 
vertebrates, such as crabs etc.) use bimodal breathing, which is the ability to exchange 
gases simultaneously with both air and water. They can use gills for water breathing and 
lungs for air breathing.  
 
In those animals that made the evolutionary transition between aquatic and terrestrial 
habitats, bimodal breathing was an important respiratory adaptation. The transition from 
water- to air-breathing was accompanied by fundamental changes in the structure and 
function of the respiratory organs. Air-breathing terrestrial vertebrates have lungs instead 
of gills. 
 
1.5a Cutaneous exchange 
Cutaneous gas exchange is carried out to supplement gill or lung ventilation by some 
aquatic vertebrates (such as aquatic turtles, salamanders with lungs, snakes, fish and 
mammals).  
 
Most amphibians (e.g., frogs, toads, lungless salamander, and newts) have highly 
developed cutaneous exchange. In frogs, a uniform capillary network lies in a plane 
directly beneath the epidermis (Feder & Burggren, 1985; Moalli et al, 1980). This vascular 
arrangement facilitates gas exchange between the capillary bed and the environment by 
both diffusion and convection.  
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To facilitate this exchange, amphibian skin is kept moist and is protected from injury, thus 
potential infection, by a slimy, mucous layer (Parakkal & Matoltsy, 1964; Ramsey et al., 
2010).  
 
1.5b Gills 
A gill is a respiratory organ of many aquatic animals (e.g. crustaceans, fishes, amphibians), 
a plate like or filamentous outgrowth well supplied with blood vessels at which gas 
exchange between water and blood occurs. Larval forms of a few fishes and amphibians 
have external gills projecting from their body (Figure 1-8), whereas adult fishes have 
internal gills. 
 
Gas exchange in internal gills occurs as blood and water move in opposite direction. 
Behind the protective operculum are feathery internal gills. Each gill arch consists of many 
filaments. These filaments have capillaries within lamellae. The countercurrent flow allows 
the maximal amount of oxygen to be extracted from the water. 
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Figure 1-8. External gills of the neotenic axolotl. The enlarged section shows the fern-
like fimbriae (gill filaments) on the 3 rami (stalks). The elaborate external gills have a large 
surface area for gas exchange. 
    
http://upload.wikimedia.org/wikipedia/commons/0/00/Axolotl_ganz.jpg 
 
 
1.5c Lungs 
A lung is an internal organ that is specialised for the respiratory uptake of oxygen directly 
from the air. In vertebrates, lungs are present in air-breathing fishes (the lungfishes, 
Dipnoi), and tetrapods. In mammals the lungs are a paired mass of spongy tissue made up 
of finely divided airways lined with moist epithelium extending from the bronchi and 
ending in small sacs, the alveoli, providing a large surface area for gas exchange between 
air and bloodstream.  
 
The evolution of the structurally complex lung has paralleled the evolution of the large 
body sizes and high metabolic rates found in endothermic vertebrates (birds and 
mammals), which necessitated an increase in lung surface area for gas exchange, compared 
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to the smaller body size and lower metabolic rates found in the ectothermic vertebrates. 
However it must be noted that the lungs of birds and mammals are quite different in form 
and function as detailed below and described by Torday et al. (2007) and West et al. 
(2007).  
 
1.5c.i Lung ventilation 
Vertebrates breathe to ventilate their lungs, the purpose of which is to maintain maximum 
oxygen concentration and minimum carbon dioxide concentration within the alveoli. There 
are two phases of pulmonary ventilation: inhalation and exhalation. 
 
 1.5c.ii Positive pressure breathing 
Frogs have muscles that lower the floor of the buccal cavity, causing it to enlarge, and to 
draw air in through the nares. The nares and mouth close and the floor of the buccal cavity 
rises thereby forcing air down the trachea. Hence frogs ventilate their lungs by actually 
pushing air down the windpipe and this is called positive pressure breathing (Brainerd & 
Owekowicz, 2006). During exhalation the air is forced back out by elastic recoil of the 
lungs and compression by the muscles of the body wall.  
 
 1.5c.iii Negative pressure breathing 
Mammals ventilate by pulling air, instead of pushing it, down into the lungs. This is known 
as negative pressure breathing. The result is changes in the volume of the lungs (as 
opposed to the buccal cavity seen in frogs). During inspiration, external intercostal muscle 
contraction lifts the ribs up and out and the diaphragm, the major inspiratory muscle, 
contracts and flattens (Milsom et al., 2004; Klein and Owerkowicz, 2006). The diaphragm 
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is a sheet of skeletal muscle that is innervated by the phrenic nerve and the intercostal 
muscles are innervated by intercostal nerves. In the relaxed state the diaphragm is dome 
shaped protruding upwards. These movements increase the size of the thoracic cavity and 
decrease the pressure to below that of the atmosphere (barometric) around the lungs. This 
negative pressure causes air to rush into the lungs and they inflate. Expiration follows 
relaxation of the rib cage and diaphragm muscles, as the increased pressure in the thoracic 
cavity forces the air out of the lungs. This is achieved by the elastic lungs contracting and 
compressing the air in the alveoli. With this compression, the alveolar pressure becomes 
greater than atmospheric pressure causing air to be expelled from the lungs. So lung the air 
moves down a pressure gradient. 
 
 1.5c.iv Ventilation in birds 
Birds have lungs and eight or nine air sacs, some of which are posterior to the small pair of 
lungs (abdominal air sacs), and others that are anterior to the lungs (thoracic).The air sacs 
act as bellows that keep air flowing though the lungs. The lungs and air sacs are ventilated 
when the bird inhales and exhales. The main bronchus that runs through each lung is 
connected to air sacs, as well as to the lung. During inhalation and exhalation, the air flows 
through the interconnected system in a circuit that passes through the lungs in one direction 
only. For instance, during inhalation the posterior air sac fills, causing the air that was in 
there to move to the lung, and the air that was in the lung moves into the anterior air sac 
that is empty (after the previous exhalation). During exhalation the air that was in the 
anterior air sac is expelled into the air and the cycle begins again. Therefore, two full 
breathing cycles are needed to move the volume of gas taken in during a single inhalation 
though the entire system out of the body.   
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1.6 AUTONOMIC CONTROL OF BREATHING 
Hearts have intrinsic pacemaker cells that enable it to generate its own rhythm. The brain 
serves only to modify the rate and strength of contraction. In contrast, the pacemaker 
activity that establishes the rhythmicity of breathing resides in the respiratory control 
centres in the brain and not in the lung or respiratory muscle themselves. Therefore, nerve 
supply to the respiratory system is essential in maintaining breathing cycles which are 
achieved by a central rhythm generator within the respiratory centres (Figure 1-9).  
 
 
Figure 1-9. Respiratory control centres in the brain stem. 
 
The diaphragm and the muscles between the ribs are activated by the phrenic nerve and 
spinal motoneurons respectively. They receive inputs from groups of neurons that 
constitute the medullary respiratory centres. There are three distinct components to the 
neural control of respiration: 
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1.6a (1) Alternating inspiration / expiration rhythm. 
In the pons there are two other respiratory centres, the apneustic and pneumotaxic (Figure 
1-10). These pontine centres have an influence on the output from the medullary 
respiratory centre.  
 
Figure 1-10. Diagram of the medulla oblongata showing the topographical proximity of 
the main nuclei that are involved in cardiorespiratory interactions. The pneumotaxic and 
apneustic centres are located in the pons (around where the large black arrowhead is 
pictured). 
 
(Modified from Mittal & Balaban, 1997) 
 
The dorsal respiratory group (DRG) in the medullary respiratory system consist of mostly 
inspiration neurons that have fibres to the inspiratory muscles. These neurons have a 
pacemaker activity that undergoes self-induced action potentials similar to that of the SA 
node of the heart. The firing of DRG causes inspiration, and when firing ceases, expiration 
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occurs. Thus the DRG is responsible for the basic rhythm of ventilation. However, the rate 
of inspiratory nerve firing is influenced by various inputs from other areas of the brain and 
the rest of the body.  
 
The DRG is interconnected with the ventral respiratory group (VRG) which are composed 
of inspiratory and expiratory neurons. However, these neurons are inactive during normal 
quiet breathing, and come into action when there is an increased demand for ventilation. 
When this is the case the DRG sends impulses to the expiration neurons in the VRG which 
fire and stimulate the motor neurons supplying the abdominal and internal intercostal 
muscles. This occurs only when there is active expiration. Likewise, the DRG stimulates 
the inspiration neurons in the VRG to increase the rate and force of inspiratory activity 
when ventilation demands are high, for example, during exercise. In mammals DRG and 
VRG have projections to the pre-Bötzinger complex, an area found to contain the 
pacemaker neurons and so thought to be the central respiratory-rhythm generator (Smith et 
al., 1991; Feldman and DelNegro, 2006). It is thought that respiratory rhythm may be 
generated by interconnected or group-pacemaker cells (Rekling & Feldman, 1998; 
Feldman et al., 2003). Anatomically, the pre-Bötzinger complex is found rostral to the 
VRG (Figure 1-11).  
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Figure 1-11. Dorsal view of medulla oblongata and spinal cord indicating regions involved 
in control of breathing. 
 
 
 
BötC, Bötzinger Complex; preBotC, preBötzinger Complex; rVRG, rostral ventral 
respiratory group; cVRG, caudal ventral respiratory group. 
(Modified from Rekling & Feldman, 1998) 
 
Rhythm activity is maintained by neurons in the pneumotaxic centre. These neurons send 
impulses to the DRG which inhibit the inspiratory neurons, thus limiting inspiration 
duration. The apneustic centre acts in the opposite direction and prevents inspiration 
neuron inhibition. Since the pneumotaxic centre is dominant over the apneustic centre 
inspiration is halted which allows expiration to occur. 
 
In addition to the „protective‟ effect of the pneumotaxic effect, there is also the Hering-
Breur reflex, which is triggered when tidal volume is large. The reflex prevents over-
inflation of the lungs. Activated pulmonary stretch receptors, located within the smooth 
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muscles of the airways, send action potentials through the vagal afferent fibres to the 
medullary centre and inhibit inspiratory neurons, thus prevent the lungs from becoming 
over-inflated.  
 
1.6b (2) Magnitude of ventilation  
Changes in O2, CO2, and pH can affect the rate and depth of breathing (as can sleep, 
emotions, etc.). Carotid and aortic bodies in mammals, carotid body in birds, and carotid 
labyrinth in amphibians (Figure 1-7) monitor changes in O2 and CO2 in arterial blood. In 
response, the medulla‟s breathing control centre alters the rate and depth of breathing, 
increasing both to dispose the excess CO2 or decreasing both if CO2 levels are depressed. 
The peripheral chemoreceptors in the aorta and carotid arteries also detect changes in O2 
levels in the blood and signal the medulla to increase the breathing rate when levels 
become very low. These then send nerve impulses, through the branches of either the ninth 
or tenth (vagus) cranial nerves, to the medulla. In air-breathing vertebrates CO2 levels 
dominate over O2 levels in the control of breathing.  Elevations in PCO2 cause the pH of 
cerebrospinal fluid to fall which is detected by central chemoreceptors in the medulla. The 
respiratory centre acts by increasing ventilation in an attempt to „blow-off‟ excess CO2 to 
homeostatic levels, thereby increasing the pH.  
 
1.6c (3) Modification of respiratory activity  
Modification of respiratory activity occurs to serve other purposes, such as voluntary 
control during speech, singing, whistling, or involuntary control involved in a cough or 
sneeze to expel irritant materials.  
  
42 
 
1.7 HEART RATE VARIABILITY AND RESPIRATORY SINUS ARRHYTHMIA 
Heart rate is not fixed, but shows beat-by-beat fluctuations that reflect rapidly reacting 
control systems. These control systems respond to interactive central and peripheral inputs 
that attempt to maintain circulatory homeostasis. The effectors that contribute to heart rate 
variability (HRV) include the already mentioned mechanoreceptors and chemoreceptors 
which detect cardiovascular and respiratory variables. The information is then coordinated 
in the central nervous system and the efferent pathways then regulate the cardiovascular 
system by changing heart rate, blood pressure and blood flow. In the elasmobranch, 
Scyllium canicula, Lutz (1930) pointed out that the cardiac vagus maintains the co-
ordination of heartbeat with ventilation. Therefore, HRV is indicative of cardiac function, 
representing fluctuations in vagal tone on the heart (McDonald (1980) in Taylor, 1994). 
 
In humans the main contributor of HRV is respiratory sinus arrhythmia (RSA) (Hyndman 
et al., 1971). RSA consists of an increase in heart rate during inspiration and a 
corresponding decrease during expiration. The vagus nerve, emanating from the cardiac 
vagal preganglionic neurons in the brainstem and having an efferent pathway to the SA-
node, is considered to be predominantly responsible for generating RSA. In vagotomised 
animals (Samaan, 1935; Anrep et al., 1936b) and when using cholinergic antagonists 
(Hamlin et al., 1966; Coker et al., 1984) the rhythm is abolished. HRV and RSA are 
reduced or even abolished in conditions that disrupt autonomic nervous system function, 
such as autonomic neuropathy associated with diabetes (Wheeler & Watkins, 1973; Divon 
et al., 1983). For these reasons, RSA may be used as an indicator of autonomic function 
and the integrity of the brainstem. Previously RSA was used as a reliable measure of 
parasympathetic control (Katona & Felix, 1975; Hayano et al., 1991), however more 
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recently, there is evidence that cardiac vagal tone is affected by sympathetic control which 
can alter the magnitude of RSA; and that RSA can dissociate with RSA under certain 
conditions, such as when heart rate falls to very low levels (Grossman & Taylor, 2005). 
 
When heart rate and breathing movements of premature human neonates were compared 
with term neonates, it was found that healthy term new-borns showed RSA as a major 
contributor to heart rate variability (Thompson et al. (1992) in Taylor, 1993). However, 
this was not observed in early premature neonates. Hence, the contribution of RSA to HRV 
varies with both pre- and post-natal age in healthy premature neonates. This may reflect 
maturational development of the underlying mechanisms. Therefore, the loss or absence of 
sinus arrhythmias in neonates is an important indicator of poor fetal condition, and could 
constitute a reliable indicator of abnormal brain stem development (Taylor, 1993; 1994).  
 
More recent studies have found that a reduction in HRV is linked to unfavourable health 
prospects, mainly increased risk of cardiovascular disease. Presence of low HRV has been 
used to predict mortality in diabetic patients (May & Arildsen, 2011). HRV can be reduced 
under seemingly low stress situations, such as working night shifts (Kunikullaya et al., 
2010), or simply with cognitive decline (Shah et al., 2011), with age (except after the age 
of 80, where HRV apparently increases again (Tak et al., 2010), or in patients with 
cardiovascular diseases. Ethnicity too can determine the level of HRV (Bathula et al., 
2010).   
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1.8 THE MEXICAN AXOLOTL, AMBYSTOMA MEXICANUM 
Tissue and organ morphogenesis patterns displayed by amphibians are similar to those of 
higher vertebrates, and so they are important model systems. The greatest advantage of 
using amphibian embryos over mammalian is that they can be easily studied and surgically 
manipulated owing to their external habit. The Mexican axolotl, Ambystoma mexicanum, is 
an excellent model organism since it has relatively large eggs (2.0 mm diameter versus 1.2 
mm for Xenopus egg) which develop relatively slowly so that important developmental 
stages are not missed by passing too quickly, which could be problematic when 
investigating (Armstrong & Malacinski, 1989).  
 
However, it is more significant to study the axolotl because in some cases it appears to be 
genetically closer to humans than the Xenopus, and even some mammals. For instance, 
those few sequences that have been identified in the axolotl include the ribosomal protein 
S-3 and the homeobox gene HoxA5 for which comparisons have been made; see Table 1-4. 
Hox-A5 is a sequence-specific transcription factor which is part of a developmental 
regulatory system that provides cells with specific positional identities on the anterior-
posterior axis important in anatomical patterning. As seen in the table the axolotl amino 
acid sequence for the Hox-A5 is 100% identical to human and mouse sequences, but only 
90% with Xenopus. Ribosomes are the particles that catalyse mRNA-directed protein 
synthesis in all organisms and so they too are vital. Ribosomal protein S-3 form the small 
unit of the ribosome. 
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Table 1-4. Amino acid comparisons of ribosomal protein S-3 and gene HoxA5 of axolotls 
with other vertebrates. 
 Axolotl amino acid identity / % 
 
Organism Coding regions of ribosomal  
protein S-3 
Homeodomain of HoxA5  
gene 
 
Human 
 
93.9 
 
100.0 
Mouse 94.3 100.0 
Rat 92.8 98.0 
Xenopus 93.9 90.0 
  
Data from Bhatia, Dube & 
Lemanski, 1996 
 
Data from Gaur, Lemanski & 
Dube, 1995 
 
 
Furthermore, the axolotl has been used to test the hypothesis that progressive ventro-lateral 
location of vagal preganglionic neurons relates to the evolution or development of lung 
breathing (Taylor, 1994). This is possible since the axolotl is neotenous and can be induced 
to metamorphose into a salamander-like animal by treatment with analogues of the 
hormone thyroxine (Prahlad & Delanney, 1965; Ingram, 1970). The treatment causes the 
loss of gills and forces the axolotl to leave the water to become committed lung breathers. 
In just the one study carried to date, it was found that after metamorphosis there was an 
increase in the number of vagal preganglionic neurons and about 15% were found in a 
more lateral location in the white matter of the medulla (Ihmied & Taylor, 1992). The 
relocation of vagal preganglionic neurons is thought to have functional relevance that may 
relate to the switch from gill to lung breathing. A very similar pattern is observed during 
brain development in mammalian embryos, where some neurons in the brainstem migrate 
from a dorso-medial position to their final ventro-lateral position.  
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Currently, no data exists on the embryological development of the vagal motor fibres in the 
axolotl, and it is not yet clear if there is a direct correlation between the onset of HRV and 
the migration of vagal preganglionic neurons ventro-laterally. However, the neotenous 
axolotl serves as an excellent model for determination of the timescale and control of the 
migration of vagal preganglionic neurons during development, since it can be induced to 
metamorphose. Measurements of heart rate, and in particularly HRV, pre- and post-
metamorphosis will allow greater understanding of the functional roles of the migration 
pattern of vagal preganglionic neurons and its relationship with vagal nerve development 
upon the heart.  
 
It can be appreciated that the axolotl provides an important model for human development 
and that its relevance has been underestimated in recent years. It is large enough to be 
studied with relative ease in comparison with small models, such as zebra fish. They can 
be induced to breed when needed, and then can be induced to become a committed lung 
breather when needed. This is a unique character that makes the axolotl a better model than 
current models. The zebrafish is solely aquatic and so it is inappropriate in lung studies 
and, or cardiorespiratory interactions; the mouse embryo in internal and so more 
sophisticated surgery procedures are required; and the Xenopus will metamorphose when it 
is at the developmental stage, and not necessarily under the researchers control. A further 
advantage of using the axolotl to study heart muscle development is the naturally occurring 
recessive mutant, the cardiac-lethal.  
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1.8a The cardiac lethal mutant 
The cardiac-lethal mutant (c) has abnormal cardio-myogenesis and morphological studies 
have shown that they lack organised sarcomeric myofibrils (Hill & Lemanski, 1979). This 
prevents the development of a contracting heart, and thus, the mutants eventually die from 
lack of circulation. However, these mutants can survive up to a fortnight after hatching in 
well-oxygenated water without a functional heart (Lemanski, 1973a). This allows a 
window of opportunity for the study of this dysfunction relatively easily in comparison 
with lethal mutants of mice or chicks. Figure 1-12 shows the relevant developmental stages 
of axolotl embryos and Figure 1-13 shows the mutant phenotype at developmental stage 
42.  
 
A team in Syracuse, New York have been working on this mutant since the 1970s (initially 
lead by Larry Lemanski, and now by Dipak Dube). They (along with Smith and Armstrong 
(1991)) found that the anterior endoderm corrected the heart defect in the cardiac mutant 
(Lemanski, Paulson, & Hill, 1979). More recently, Armstrong's team have suggested that 
the cardiac mutant may produce too much of an inhibition factor, preventing appropriate 
myofibril differentiation (Smith, & Armstrong, 1993; Armstrong, 1989). Their results 
demonstrated the presence of activator- and inhibitor-like factors in pre-cardiac mesoderm, 
which provides evidence for their hypothesis that heart development is controlled by a 
reaction-diffusion system. 
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Figure 1-12. Abbreviated developmental stage series for the Mexican axolotl 
highlighting important stages utilized in Part I 
 
(20) Cardiac determination/induction complete and the start of cardiac specific gene 
expression. (30) Bilateral mesoderm mantles have fused at the ventral midline marking the 
beginning of the structural organization of the heart. (35) Initiation of a heart beat. (38) 
Continuation of cardiac morphogenesis and the presence of a well-established heartbeat. 
(41) Embryos hatch from their clear jelly coats. (43) Early post-embryonic life and the 
latest stage, cardiac mutants are capable of surviving. Numbers in parentheses and below 
each figure represent stages. (Bordzilovskaya et al., 1989). 
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Figure 1-13. Late stage axolotl embryos.  
Stage 42 normal (A) and cardiac mutant (B) axolotl showing the gross malformation in the 
cardiac mutant animal resulting from a failure of the heart to beat. Prior to heart beat 
initiation, normal and mutant animals are indistinguishable from one another. Following 
heart beat initiation the failure of the mutant ventricles to beat results in blood pooling in 
the abdomen and accumulation of ascites fluid. The increased fluid leads to a pear shaped 
body, marked distension ofthe thorax and abdomen and poor gill formation. At the late 
developmental stage shown here, the mutant heart (h; Panel B) is only a thin strand like 
structure. This in comparison to the well-formed, robust heart in normal animal (h; Panel 
A) Despite the failure of mutant hearts to beat, mutant animals swim normally. (h) heart; 
(lv) liver; (s) stomach; (lb) limb bud (g) gills; (gb) gall bladder (i) intestine  
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Lemanski's group concentrated on general heart development in the wild-type and mutant 
axolotl, and examined the relative quantities of muscle specific proteins (e.g., 
tropomyosin) histochemically (Lemanski, 1973a, b & c; Fransen, & Lemanski, 1988). 
Since Dube, the group appear to focus on the molecular and genetic characterisations. The 
expression of myosin heavy chain transcripts have been investigated in both phenotypes 
(Ward et al., 1996). A C-protein isoform (which is thought to regulate and stabilise thick 
filaments) has been cloned, sequenced and its expression pattern has been determined in 
embryonic, juvenile and adult tissues (Ward et al., 1995), as has an isoform of cardiac α-
tropomyosin (Luque, Lemanski, & Dube, 1994; Luque et al., 1997). Alpha-tropomyosin is 
found in striated muscle and is the predominant isoform in cardiac muscle. Simultaneously, 
the team have begun a search for Hox genes, which are significant in development because 
they specify pattern formation along the antero-posterior body axis of many organisms. 
The homologue of murine HoxA5 has been identified (Gaur, Lemanski, & Dube, 1995), 
whose expression has been studied in the metamorphosing heart (Gaur et al., 1998). More 
recently, a novel homeobox gene, AxNox-1, has been cloned and sequenced (Gaur, 
Lemanski, & Dube, 1998). Interestingly, although this gene is expressed predominantly in 
neural tissue during development, lower levels are seen in heart, lung, liver, gut, and 
skeletal muscle. The authors make a tentative suggestion that expression may be seen in 
these organs because they are all innervated, and hence transcripts may be derived from 
neurons. Whiteley and Armstrong (1991) isolated a partial clone, Ahox-1, the homologue 
of the labial gene of Drosophila, which appears to be involved in the development of 
homologous structures in the axolotl. 
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While working on axolotls, the Syracuse team have developed technical skills specific for 
this organism. They have established primary cell culture protocols of cardio-myocytes 
from mutant and wild axolotl embryos (Zajdel et al., 1995). Organ cultures have been used 
since Lemanski's work in the '70s. However, the most important contribution of this team 
is the production of chimeric axolotls which produce embryos that are 100% cardiac 
mutant phenotype (Lemanski et al., 1998). Conventionally, matings between heterozygous 
axolotls for the mutant gene (+/c) result in only 25% cardiac lethals (c/c) in the progeny. 
Further, the lethals cannot be distinguished from normals siblings until late tailbud stage, 
when the heart would normally begin beating. As a consequence, it has not been possible 
to efficiently examine pre-heartbeat stages in the past. The chimeras, composed of wild 
(+/+) head heart regions grafted onto the bodies of mutant (c/c) embryos, which develop 
mutant (c/c) gonads, enable researchers to investigate perturbations at the earliest stages of 
development (Figure 1-14).  
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Figure 1-14. Creating chimeric mutant axolotls.  
Schematic diagram 
of the process used 
in making surgical 
axolotl chimera to 
create spawnings 
containing 100% 
mutant animals. 
(A) Stage 20 
embryos from 
either the same or 
different spawnings 
are bisected near 
the midline with 
hair loops, 
sharpened tungsten 
needles and 
watchmaker 
forceps (B) The 
anterior half of one 
bisected animal is 
aligned with the 
posterior half of a 
similarly bisected 
animal and allowed 
to heal. The two 
halves are pushed 
together while 
healing and 
annealing of the 
two complementary 
halves takes place 
using 10 x 5 x 1mm stainless steel plates with a half circle in one end. (C) The stainless steel plates 
are removed 3-24 hours after alignment of the two halves and the pairs maintained separately in 60 
mm agarose or parafilm lined sterile petri dishes until the phenotype of the animals can be 
determined. (D and E) Animals are grown until sexual maturity. The two animals here were created 
using two different spawnings, one white and the other pigmented. (F) Spawnings containing 100% 
mutant animals were obtained by mating pairs of animals with c/c gonads. The genotype of 
chimera animals was established by first mating animals with presumptive c/c gonads with known 
+/c animals. The resultant cross (c/c x +/c) would be expected to produce embryos where 50% are 
normal and 50% are mutant. Following this cross, 2 pairs of animals were selected and mated. 
Embryos were grown until the phenotype could be accurately determined and 100% of these 
embryos were of the mutant phenotype. (G) Digitally enlarged area outlined in (F) showing the 
characteristic blood pooling in abdomen and ascites fluid accumulation. (Bordzilovskaya et al., 
1989).  
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1.8b Tropomyosin and the cardiac lethal mutation 
Electron microscopy of the cardiac lethal mutant heart shows a few abnormal 
characteristics. It shows a lack of mature organised myofibrils in the mutant myocardium, 
which appears to cause the lack of beating, and large collections of amorphous material 
(Lemanski, 1973a). The addition of purified tropomyosin protein to these mutant hearts not 
only reduces the amorphous collections, but also leads to the formation of short 6nm 
filaments. These findings suggest that the amorphous collections are non-filamentous actin 
which fail to assemble into filamentous structures due to the lack in significant quantities 
of tropomyosin. It is now believed that the mutant hearts have reduced tropomyosin 
protein, or more likely a specific tropomyosin isoform (Lemanski et al., 1980; Lemanski et 
al., 1976; Moore and Lemanski, 1982). However, Fuldner et al. (1984) could not detect 
any difference. It may be that there is a presence of multiple tropomyosin isoforms (Lees-
Miller and Helfman, 1991) in the developing heart and that only one particular form is 
deficient. See Figure 1-15 for normal myofibrillogenesis. 
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Figure 1-15. Myofibrillogenesis.  
 
In this model of myofibrillogenesis, the pre-myofibril forms at or near the plasma 
membrane surface. It is characterized by a-actinin containing Z-bodies and short filaments 
of non-muscle myosin IIB. Z-bodies initially appear as discrete α-actinin aggregates along 
the pre-myofibril but as width of the sarcomere increases the z-bodies appear to become 
laterally aligned. The laterally aligned z-bodies continue to fuse to form Z-bands. A 
transition stage exists between pre- and mature myofibrils termed nascent myofibrils. This 
stage is marked by the addition of titin, gradual growth and fusion of the z-bodies into 
larger structures and a gradual incorporation of muscle myosin. The nascent myofibril 
therefore contains both muscle and non-muscle myosin isoforms that appear in a 
continuous pattern since they have not yet aligned in register. The nascent myofibril 
matures further with additional fusion of z-bodies to form Z-bands and a loss of non-
muscle myosin lIB. Actin thin filaments obtain their mature lengths through a yet 
undiscovered mechanism. Borrowed and adapted from Dabiri, (1997). 
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In the developing axolotl heart three tropomyosin isoforms have been described. These are 
ATmC-1 (Axolotl Tropomyosin Cardiac-1) (Luque et al., 1994), ATmC-2 (Spinner et al., 
1997b) and ATmC-3 (Spinner et al., 1997a). Messenger RNA for all three appear to be 
present in relatively equal quantities between normal and mutant hearts (Spinner et al., 
1997a). Of these, ATmC-1 and ATmC-2 appear to be products of the putative -
tropomyosin gene. Interestingly, ATmC-2 is a novel splice variant of the -tropomyosin 
gene containing the smooth muscle exon 2a instead of the typical striated muscle exon 2b 
(Spinner et al., 1997b). Furthermore, ATmC-1 is recognised by CH1 (Spinner et al., 
1997b), a monoclonal antibody against sarcomeric tropomyosin (Lin et al., 1985) but it 
does not recognise ATmC-2. ATmC-2 protein is recognised only by anti-C-2, a specific 
polyclonal antibody that was generated against a synthetic peptide derived from its exon 2 
region. ATmC-2 protein was found to be present in both normal and mutant axolotl hearts 
(Spinner et al., 1997b).  
 
ATmC-3 is likely a separate gene product (Spinner et al., 1997a) and is most homologous 
(97%) to the Xenopus cardiac TM-4 gene (Hardy, 1995). This isoform of tropomyosin is 
developmentally regulated in the axolotl. Its mRNA is detected around the time of heart 
beat initiation (stage 35) but is not detected in the adult heart (Spinner et al., 1997a), nor in 
the skeletal muscle, unlike the other two isoforms, ATmC-1 and ATmC-2 (Luque et al., 
1994; 1997). A reduction of tropomyosin mRNA using anti-sense oligonucleotides specific 
for ATmC-1, -2 and -3 suggests that ATmC-2 and ATmC-3 only are necessary to maintain 
myofibril structure in developing axolotl ventricle (Zajdel et al., 2000). ATmC-3 is 
recognised by CH1 antibody and since it is only expressed in the heart (while ATmC-1 and 
ATmC-2 are present in skeletal muscle and heart tissue) it is tempting to speculate a 
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requirement for this recently described tropomyosin isoform in cardiac myofibrillogenesis. 
Experiments suggest that the defect in the mutant axolotl is probably due to a lack of 
specific tropomyosin and that its reduction appears to inhibit the ability of myofibrils to 
form. This is supported by the recent report that ectopic expression of heterologous -
tropomyosin cDNA or the introduction of heterologous tropomyosin protein into mutant 
hearts resulted in the formation of mature myofibrils (Zajdel et al., 1998). The maturity of 
these myofibrils can be assessed using an antibody against tropomodulin which is a protein 
that has been described as a late marker for myofibrillogenesis.  
 
1.8c The model  
The capability of axolotls to retain the larval appearance, even when sexually mature, and 
the sensitivity of their tissues to exogenous thyroid hormones (Lynn & Wachowski, 1951; 
Etkin, 1964) could further investigations into the developmental cardio-neuro-biology of 
vertebrates. This will surely lead to a more comprehensive understanding of the 
relationship between the animal‟s physiological demands and the development of its 
nervous system. 
 
 
1.9 AIMS, HYPOTHESES AND OBJECTIVES  
This thesis is divided into two parts. In the first part we looked at non-beating hearts to see 
what exactly was needed or important for a functional heart that had myogenic 
rhythmicity. It was known that tropomyosin was lacking in axolotl cardiac lethal mutants 
and so the aim was to see what tropomyosin introduction would have on these 
dysfunctional hearts, and if the expression of tropomyosin was disrupted in normal, wild-
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types heart, would it lead to the cardiac mutant phenotype. Firstly, an effective delivery 
system had to be designed, liposome mediated transfection, to transfect tropomyosin 
specific oligonucleotides into whole heart organ cultures (Chapter 2). We then used this 
effective method to see if human specific tropomyosin could rescue the cardiac lethal 
mutant (Chapter 3). The research team identified a novel tropomyosin isoform that was 
found to be expressed in other organisms. Therefore the aim of Chapter 4 was to see what 
effect this isoform had on axolotl embryonic hearts. The final aim of Part I of the thesis 
was to look at the structural / functional relationship of tropomyosin in organising 
myofibrils. The tropomyosin molecule was altered at both ends then transfected into whole 
heart organ cultures, using the transfection method, to see how it would affect 
myofibrillogenesis.   
 
In the second part we took functional hearts of mature gills breathers and induced them to 
become committed lung breathers to see if they displayed heart rate variability (HRV). 
HRV is thought to be associated with the relocation of VPN in a ventrolateral position to 
the DVN. So the aim was to reassess the possible migration of VPN to this new location 
post metamorphosis in the axolotl, but this time using the retrograde cholinergic tracer 
which would not damage the nerves (like the HRP method would as used by the previous 
researcher). And then to see if there are cardiorespiratory changes associated with this 
change in VPN location.  
 
Essentially this thesis was the study of hearts that did not beat, hearts that were likely to 
display little, if any, heart rate variability, and hearts that did show heart rate variability. 
And the model used was the Mexican axolotl, Ambystoma mexicanum.  
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Part I 
The Role of Tropomyosin in Cardiac 
Myofibrillogenesis 
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CHAPTER TWO 
 
TARGETED GENE DISRUPTION IN WHOLE HEARTS BY CATIONIC 
LIPOSOME TRANSFECTION OF ANTISENSE OLIGONUCLEOTIDES 
 
 
 
 
 
 
2.0 ABSTRACT  
 
In this study cationic liposome-mediated delivery was used to introduce sense and 
antisense oligonucleotides into whole hearts of embryonic axolotls. These embryonic 
hearts provide a suitable surface area for the action of cationic liposomes owing to the fact 
that they are only one to two cells thick. The Mexican axolotl provides an uncommon, but 
particularly useful, model in which to study the role of tropomyosin protein during 
myofibril formation in the heart. In this animal model there is a naturally occurring mutant, 
the cardiac lethal, in which the embryos lack organized myofibrils and have altered 
expression of contractile proteins. Oligodeoxynucleotides specific to axolotl tropomyosin 
isoforms (namely, ATmC-1 and ATmC-3) were successfully introduced into the normal 
hearts. The antisense oligonucleotide replicated the disruption of myofibril formation seen 
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in mutant hearts, while the sense strands did not.  Antisense ATmC-3 oligonucleotide also 
disrupted heart beating.  In contrast, ATmC-1 antisense oligonucleotide did not cause a 
disruption of the myofibrillar organization of the ventricle (but did in the future outflow 
tract from the ventricle region, known as the conus). Control hearts were transfected with 
fluorescein-tagged sense oligonucleotides which demonstrated their successful 
introduction into cells of the whole intact hearts. Thus, this study showed how disruption 
of tropomyosin expression in normal hearts, by using the anti-sense oligonucleotides, 
resulted in a lack of organized myofibrillar structures, which appears to lead to loss of a 
functional heartbeat. It appears that tropomyosin is involved in the organisation of 
contractile proteins that are essential for contraction of heart muscle. Also, the ability to 
use whole hearts in this procedure is important for the study of myofibrillogenesis in 
normal hearts (at the DNA, RNA, and/or protein levels) by the use of cationic liposome 
transfection. 
 
 
2.1 INTRODUCTION 
 
Transfection (a term derived from „transformation by infection‟) is a method of 
introducing nucleic acids into eukaryotic cells which can help elucidate gene function and 
protein expression. Transfection techniques are especially useful because they allow 
transfer of nucleic acids across cell membranes which would normally be impossible 
owing to the fact that DNA and RNA backbones are negatively charged, as are cell 
membranes. The transfection method addresses the problem of negatively charged nucleic 
acids by coating the DNA in a positive charge, thereby neutralising the molecule. This can 
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be achieved by chemicals like calcium phosphate and diethylaminoethyl-dextran or with 
cationic lipid-based reagents that positively coat the negative DNA. The DNA/transfection 
reagent complex can then easily cross the membrane.  
 
A „liposome‟ is a colloidal particle that forms lipid bilayers in an aqueous medium (Sessa 
& Weissmann, 1968). Cationic liposomes have been used to facilitate introduction of DNA 
(from small oligonucleotides to relatively large yeast artificial chromosomes), RNA, and 
proteins into cultured cells (Felgner et al., 1987; Lee & Jaenisch, 1996; Malone et al., 
1989; Lin et al., 1993; Zajdel et al., 1998; 1999; 2000). The negative phosphates of the 
DNA or RNA associates with the cationic head group of the lipid compound. The 
liposome/nucleic acid complexes then enter the cell by either endocytosis or by fusing with 
the cell membrane (Gao & Huang, 1995), and are then carried in endosomes, and 
eventually into the nucleus. How the nucleic acids cross the nuclear membrane, however, 
is still not clear. The cytoplasm is the site of action for RNA, protein or antisense 
oligonucleotides that are delivered by liposomes, whereas DNA needs to enter the nucleus.   
 
Liposome techniques can be used on cells for both transient expression studies and long 
term experiments where DNA needs to integrate into the chromosome. Furthermore, this 
method of nucleic acid transfer can be used in vivo in animals and humans (Felgner et al., 
1995). Other valuable characteristics of liposome transfection include protecting DNA and 
RNA from nucleases and the ability to transport active substances to the nucleus of the 
transfected cell (Zelphati & Szoka, 1996). Perhaps the most intriguing potential use of 
cationic liposome transfection is the inhibition of gene expression that may be obtained 
with transfection of isoform-specific antisense oligonucleotides. Antisense 
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oligonucleotides would bind to the sense strands of mRNA, thereby preventing translation, 
and so no protein would be made. This study describes the use of cationic liposomes for 
transfection of an intact organ that maintains important cell-cell structure. In this way, 
targeted gene-disruption of specific tropomyosin isoforms was used to examine the effect 
on structure and function.  
 
Transfection procedures have been performed mainly on isolated cells in culture. However, 
cell culture procedures create cardiac myocytes that have an initial disruption of myofibrils 
that eventually reform. Enzymatic treatment and cell culture procedures may also have 
other unknown effects on the cardiomyocytes. Thus, one could propose that the 
maintenance of intercellular connections in a whole organ would be optimal. Initially, we 
developed transfection procedures on cultured cells using calcium phosphate (Xu et al., 
1992) and the cationic lipid reagent LIPOFECTIN
®
. However, LIPOFECTIN was more 
effective on cardiomyocytes and also could be used on whole hearts in contrast to calcium 
phosphate. Whole hearts have the advantage of maintaining intercellular connections and 
mechanical load, especially since it is essential that the cardiomyocytes synchronously 
contract with neighbouring cells in-order to function as the pumping organ. 
 
Tropomyosin is a component of the thin filament in sarcomeric myofibrils. It interacts with 
actin and the troponin complex in the thin filament, and these proteins are involved with 
contraction and relaxation of the myofibrils. Three isoforms of tropomyosin have been 
isolated for this animal model, the Mexican axolotl (Ambystoma mexicanum): ATmC-1 
(Axolotl Tropomyosin Cardiac-1) and ATmC-2 (Luque et al., 1994; 1997); and ATmC-3 
(Spinner et al., 1997). Current research in this laboratory is focused on elucidating the role 
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of these isoforms in heart. It has been found that ATmC-3 (made by TM-4 gene) is 
exclusively expressed in axolotl cardiac tissue. The gene transcript is detected between 
stages 30 (pre heart beat) and stage 35 (heart beat initiation), but not in the adult heart. Its 
amino acid sequence is 97% homologous and nucleic acid sequence 82% homologous to 
the Xenopus laevis cardiac TM-4 tropomysin isoform (Hardy et al., 1995). The transient 
expression of TM-4 tropomyosin exclusively in cardiac tissues strongly implies that it 
plays a role in cardiac development in the axolotl. Here, we describe the possible role of 
ATmC-3 in the ventricle of normal hearts and the effect of treatment with antisense 
isoform-specific oligonucleotides. 
 
 
2.2 METHODS 
 
2.2a Whole heart bioassay   
Wild type axolotl embryos were obtained from matings between animals from a colony at 
SUNY Upstate Medical University or the Indiana University axolotl (salamander) colony. 
Animals were maintained in aquaria in 50% Holfreter‟s solution (29 mM NaCl, 0.45 mM 
CaCl2, 0.33 mM KCl, 0.1 mM MgSO4, and 4.76 mM NaHCO3) and fed commercial 
salmon pellets as recommended by Indiana University.  
 
Embryos from stages 37–39 (staging system of Bordzilovskaya et al., (1989)) were 
mechanically released from their jelly coats with watchmaker forceps (number 5) and 
washed 4 times in filter-sterilized Steinberg‟s buffered salt solution [58 mM NaCl, 0.67 
mM KCl, 0.9 mM CaCl2, 0.2 mM MgSO4, 4.6 mM HEPES (pH 7.4), containing 1% 
GIBCO BRL
®
 Antibiotic/Antimycotic (100 units/ml penicillin G sodium salt, 0.1 g/ml 
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streptomycin sulfate, 0.25 μg/ml amphotericin B)]. Embryos were then anesthetized with 
MS-222 (Tricaine methanesulfonate). Hearts were extirpated with heat-sterilized forceps, 
sharpened tungsten needles and hair loops, as needed, under a dissecting microscope and 
placed into 100 μl of Steinberg‟s solution without antibiotics for transfection. 
Approximately 50 hearts were collected for each sample. 
 
2.2b Transfection  
Sense and antisense oligonucleotides were designed for ATmC-1 and ATmC-3 
tropomyosin isoforms. The ATmC-1 antisense chimeric oligonucleotide was  
 
A*G*G  *ACT  CCG  AGT  ACT  TGT  C*C*A  *C. 
 
The ATmC-3 exon 2 antisense and sense chimeric oligonucleotides were  
 
5‟-T*A*C  TAG  CTC  GTC   CTC  AAG  C*T*G    C-3‟ and 
 
5‟-fG*C*A  GCT  TGA  GGA  CGA  GCT  A*G*T  *A-3‟ respectively,  
 
where *N represents a phosphorothioate-blocked nucleotide and 
f
G represents a guanine 
tagged with fluorescein at the 5‟ end (IDT, Inc.).. The sense oligodeoxynucleotide was 
tagged with fluorescein (FS-ODN) as a positive control and to confirm localization within 
the myocytes.  
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The cationic liposome solution, LIPOFECTIN Reagent (Gibco-BRL) was mixed with 
Steinberg‟s solution for 30-45 minutes at 0.28 mg/ml. Then, 10 μl of oligonucleotide (final 
concentration of 0.1 μM) was added for 15 minutes. Drops of lipofectin solution (5 µl) 
were placed on Parafilm lined 60 mm Petri dishes that were previously exposed to 
ultraviolet light. The hearts were transferred with 5 µl of Steinsberg‟s solution into the 
lipofectin drops to make a total volume of 10 μl and to give the appropriate concentrations. 
The hearts were visually monitored for beating on a daily basis using a dissecting 
microscope. All these procedures were carried out at room temperature. During the culture 
period the hearts were also examined for introduction of FS-ODN and for myofibril 
formation with the confocal microscope at 4, 24, 48, 72, 96, and 120 hours. These hearts 
were examined live or fixed with 2% paraformaldehyde for 1 hour. For double staining to 
visualise nuclei, 1 mg/ml Hoechst dye was placed on randomly selected hearts for 10 
minutes. At the end of the culture period all of the hearts were washed several times in 
Steinberg‟s solution and treated for confocal microscopy (see below). 
 
2.2c Confocal microscopy 
Normal hearts processed for fluorescent staining were processed by a method adapted from 
Bell et al. (1987) which permits the fixation and permeabilization simultaneously using 
dithiobis (succinimidyl) propionate (DTSP, Pierce Biochemical, Inc.). Briefly, hearts were 
placed in 1 mM DTSP (cross-linking fixative reagent) dissolved with 1% 
dimethylsulfoxide (DMSO) in Steinberg‟s solution for 15 min. Thereafter, further 
permeabilization occurred in 0.5% Nonidet
®
 P-40 in Steinberg‟s solution for 15 minutes. 
The reaction was quenched by two 10-minute washes in 0.1 M glycine. Hearts were then 
incubated in monoclonal anti-tropomyosin primary antibody (CH1 (Lin et al., 1985)) 
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diluted to 1:30 in Steinberg‟s solution for one hour at room temperature. Nonspecific 
background was blocked with 0.1 mg/ml bovine serum albumen (BSA) or non-fat dry milk 
by 3 washes of 10 minutes each. Hearts were then transferred to a rabbit anti-mouse 
lissamine rhodamine secondary antibody (Jackson Immunoresearch, West Grove Pa) at a 
1:50 dilution was added for 30 minutes. The hearts were rinsed several times in BSA in 
Steinberg‟s solution and post-fixed in 2% paraformaldehyde overnight. The fixation was 
quenched by 0.1 M glycine for 30 minutes and then placed in Steinberg‟s solution.  
 
The hearts were mounted on slides in Biorad Fluorogard antifade reagent. Three layers of 
fingernail polish were used to support the glass coverslips to and to act as spacers to 
prevent crushing of the whole hearts. Coverslips were sealed using nail polish, and the 
specimens were viewed on a Biorad MRC-1024ES confocal laser scanning microscope. 
Black and gain levels were set using normal hearts stained with CH1 and then all samples 
were examined under identical conditions. A 24-section (0.5-μm/section) Z-series (optical 
sections) was made for each sample, and the Lasersharp system software was employed to 
display the image on the monitor. Digital image processing was performed with Adobe 
Photoshop
®
 5.0 software and printed with a Kodak
® 
8600 thermal dye printer. 
 
2.2d Total RNA extraction  
Total RNA was extracted from the transfected heart tissues using a Qiagen mini-RNA 
extraction kit. The total RNA was treated with RNAse-free DNAse (Gibco BRL) for 15 
minutes at room temperature, then phenol:chloroform extracted and precipitated with 
ethanol at -70°C for 1 hour or overnight at -20°C. RNA purity and concentration was 
estimated on a Pharmacia Biotech GeneQuant II RNA/DNA calculator. 
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2.2e RT-PCR analyses 
Reverse transcriptase polymerase chain reaction was used to evaluate the expression of 
transcripts ATmC-2 and ATmC-3 in the transfected embryonic heart RNA. Each first 
strand cDNA synthesis reaction was completed with 1.0 µl total RNA using Gibco BRL 
SuperScript
TM 
II Reverse Tanscriptase with Oligo(dT)12-18 primer. The reaction mix 
contained 1 µg of total RNA (~50 stage 37-39 embryonic hearts), 1 µg Oligo(dT)12-18 
primer, and dH2O to 12 µl, which was incubated at 70°C for 10 minutes then placed on ice. 
Subsequently, 7 µl of a reaction mix [per reaction: 2 µl 10X PCR buffer, 2 µl 25 mM 
MgCl2, 1 µl dNTP stock (10 µM each of dATP, dCTP, dGTP, and dTTP), and 2 µl 0.1 M 
DTT] was added to the RNA-primer mixture and incubated at 42°C for 5 minutes. Then 1 
µl (200 units) of SuperScript
TM 
II Reverse Transcriptase was added to the reaction and 
incubation for 50 minutes at 42°C. This was followed by a 15 minute incubation at 70°C to 
terminate the reaction, after which the samples were placed on ice. RNase H was added to 
each tube and incubated at 37°C before amplification of the target cDNA. 2 µl of the first 
strand synthesis reaction was subsequently used for amplification in a 100 µl PCR 
reaction. Primer-pairs used were TMC3(+) (sense strand ATmC-3, exon 5) with     
TMBS(–)2 (antisense strand ATmC-3, 3‟ UTR region) and TM+9 with TMend(–) which 
are specific for full length cloning of ATmC-2. Polymerase chain reaction was performed 
with a PE 9600 thermocycler using AmpliTaq DNA polymerase (Perkin-Elmer). The 
program used to amplify the target cDNA was:  
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(1) 2 minutes at 50°C,  
 
(2) 15 minutes at 70°C,  
 
(3) 2 cycles –  
a. Denaturing for 1 minute at 94°C 
b. Annealing for 30 seconds at 53°C 
c. Extension for 30 seconds at 68°C 
 
(4) 7 cycles –  
a. Denaturing for 10 seconds at 95°C 
b. Annealing for 10 seconds at 55°C 
c. Extension for 10 seconds at 72°C 
 
(5) 35 cycles –  
a. Denaturing for 10 seconds at 90°C 
b. Annealing for 10 seconds at 60°C 
c. Extension for 10 seconds at 72°C 
 
(6) Hold at 72°C 
 
The PCR products were electrophoresed on 1-1.5% agarose gel. 
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2.3 RESULTS 
 
Normal embryonic axolotl hearts, from stages 37-39, were treated with sense and antisense 
oligonucleotides for ATmC-1 and ATmC-3 tropomyosin isoforms using cationic 
liposomes. Normal control hearts had widespread branching myofibrils when stained with 
tropomyosin specific CH1 antibody (Figure 2-1a) or other contractile protein antibodies. 
Furthermore, double staining of the nuclei with Hoechst dye at 5 days clearly showed co-
localization of the fluorescein and nuclear staining (Figure 2-2). Fluorescein-tagged sense 
oligonucleotides provided a clear indicator of transfection efficiency. Analysis of the 
fluorescein and Hoechst staining showed up to 90% efficiency of oligonucleotide delivered 
to the nucleus. 
 
2.3a Liposome-mediated delivery of tropomyosin oligonucleotides 
At 5 days after transfection of sense oligonucleotide, myofibrils were present in the heart 
and the fluorescein-labelled oligonucleotide was detected in the nuclei (Figure 2-1b). 
Before 5 days, the fluorescein was detected in the cytoplasm. Transfection of antisense 
ATmC-1 into whole hearts primarily disrupted the conus region (an area which later 
becomes the outflow chamber from the ventricle), but not the ventricle. At 3 days, the 
fluorescein-tagged oligonucleotide was within the heart, but not all localized to the nuclei 
(Figure 2-1c). Transfection with antisense ATmC-3 revealed a decrease in tropomyosin 
protein in the ventricle, but not the conus (Figure 2-1d). Tropomyosin was reduced about 
the same amount in each section. Myofibril organization was significantly disrupted in 
these antisense-transfected hearts.  
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2.3b Effect of oligonucleotides on heart function of whole heart organ cultures 
Transfection of normal hearts with sense ATmC-3 chimeric oligonucleotide retained their 
ability to contract at an average of 14 beats per minute. All 8 hearts continued to beat for 5 
days after which they were fixed (Figure 2-3). However, beating was disrupted in the 
hearts transfected with antisense ATmC-3 transcript. Out of these 12 hearts contractions 
stopped completely in 8, and the average beats per minute of the remaining 4 hearts was 
half of those transfected with the sense oligonucleotide at 7 beats per minute (see Figure 2-
3). Antisense oligonucleotide transfection effectively replicated the phenotype of the 
cardiac mutant (c/c) hearts in this animal model (Starr et al., 1989), with a reduction of 
tropomyosin expression, a subsequent disruption of organized myofibrils, and a lack of 
beating. 
 
2.3c RT-PCR of transfected hearts 
RT-PCR of whole hearts transfected with antisense ATmC-3 showed decreased ATmC-3 
transcript. In contrast, transfection of sense ATmC-3 did not comparatively decrease the 
ATmC-3 transcript. Also in the antisense ATmC-3-transfected hearts, RT-PCR for the 
isoform ATmC-2 transcript did not demonstrate a decrease in the ATmC-2 transcript, as 
might be expected (see Spinner et al., (2002) for further details).  
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2.4 DISCUSSION 
 
Tropomyosin forms an alpha-helical coiled coil dimer in a head to tail arrangement and is 
closely associated with actin and troponin subunits (Ebashi, 1980). Hence, the lack of 
organised myofibrils may be caused by an error in the tropomyosin protein. This was 
demonstrated by the use of antisense oligonucleotides, where the blockade of tropomyosin 
transcript caused disordered myofibrillogenesis. It was noted that the antisense ATmC-1 
oligonucleotide disrupted the myofibrils of the future outflow tract (conus) and not the 
ventricle; whereas the opposite was true for antisense ATmC-3 oligonucleotide – only the 
myofibrils of the ventricles were in disarray. RT-PCR confirmed the decrease of ATmC-3 
transcript in those hearts transfected with antisense ATmC-3 oligodeoxynucleotides, hence 
the efficacy of cationic liposome-mediated transfection. 
 
The effect of tropomyosin antisense oligonucleotides is like that seen in the naturally 
occurring mutation that affects the development and function of the myocardium in the 
Mexican axolotl. Mutant embryos survive for a short period of time without establishing 
normal circulation. Their hearts do not beat and have been found to show a disruption of 
the myofibril organization (Lemanski, 1973). These cardiac (c/c) lethal mutants are 
characterised by a severe reduction in tropomyosin (as confirmed by biochemical studies 
(Moore & Lemanski, 1982; Starr et al., 1989)) and a lack of organised myofibrils 
(morphologically observed (LaFrance & Lemanski, 1995)). Although the mutants have 
near normal levels of actin, they are found in amorphous collections instead of as thin 
filaments as in the wild types. Liposome mediated introduction of tropomyosin protein in 
living mutant whole hearts have resulted in the formation of thin filamentous actin as well 
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as organised sarcomeric myofibrils (Zajdel et al., 2000). It thus appears that tropomyosin is 
necessary for the stabilisation of thin actin filaments. 
 
Transfection of oligonucleotides with LIPOFECTIN Reagent provided a method to 
examine function of a specific protein in an intact organ. Intercellular communications and 
mechanical load were maintained in these transfected hearts, which was critical because of 
the complex branching of myofibrils among the myocytes and the complex 
communications inherent in heart muscle. Staining with fluorescein-tagged sense 
oligonucleotide and Hoechst staining of the nuclei demonstrated delivery of the 
oligonucleotide to the nucleus in the majority of the cardiomyocytes. A disruption of 
structure and function in whole hearts was demonstrated after transfection of antisense 
oligonucleotides. Cationic transfection used in this manner could provide varied and 
interesting „knock-out‟ models to study the importance of particular proteins as illustrated 
in this study. It has been found that ATmC-3 is important in myofibril organisation as well 
as the functional beating of the heart. 
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Figure 2-1. Confocal micrographs of normal, sense and antisense 
transfected hearts. 
 
Scale bar = 5µm 
 
Figure 2-1a - Stereo anaglyph of a normal heart (12-μm thickness) stained with 
tropomyosin antibody. Branching myofibrils can be observed throughout the field.  
Note: Stereo anaglyphs are best viewed with red/green glasses.  
 
Figure 2-1b - Compressed Z series of a heart transfected with fluorescein-tagged ATmC-3 
sense oligonucleotide (green) and stained with tropomyosin antibody (red). This 
micrograph is composed of two optical sections (1-μm total thickness) to best show the 
nuclei.  
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Figure 2-1. Confocal micrographs of normal, sense and antisense 
transfected hearts. 
 
Scale bar = 50µm 
 
Figure 2-1c - Conus (12-μm total thickness) transfected with ATmC-1 fluorescein-tagged 
antisense oligonucleotide (green) and stained with tropomyosin antibody (red). 
 
Figure 2-1d - Heart (12-μm total thickness) transfected with ATmC-3 antisense oligo-
nucleotide and stained with tropomyosin antibody (red). 
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Figure 2-2. Localisation of transfected oligonucleotides 
 
 
Scale bar = 100µm 
 
Hearts were stained with Hoechst (blue – Figure 2-2a) 5 days after they were transfected 
with fluorescein-tagged sense ATmC-3 (green – Figure 2-2b).  
 
  
 I. The Role of Tropomyosin in Cardiac Myofibrillogenesis 
 
76 
 
 
Figure 2-3. Effect of antisense ATmC-3 on heart beat 
 
 
Heart beats are the average of 11 hearts for control, 8 hearts for sense, and 12 hearts for 
antisense oligonucleotides. 
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Published in 2004 in Biochemical and Biophysical Research Communications 320; 1291-
1297.  
 
 
CHAPTER THREE 
 
EXPRESSION OF A NOVEL CARDIAC-SPECIFIC 
TROPOMYOSIN ISOFORM IN HUMANS 
 
 
 
 
 
3.0 ABSTRACT  
 
Tropomyosins are a family of actin binding proteins encoded by a group of highly 
conserved genes. Humans have four tropomyosin-encoding genes: TPM1, TPM2, TPM3, 
and TPM4, each of which is known to generate multiple isoforms by alternative splicing, 
promoters, and 3′ end processing. TPM1 is the most versatile and encodes a variety of 
tissue specific isoforms. The TPM1 isoform specific to striated muscle, designated TPM1α, 
consists of 10 exons: 1a, 2b, 3, 4, 5, 6b, 7, 8, and 9a/b. In this study, using RT-PCR with 
adult and fetal human RNAs, we present evidence for the expression of a novel isoform of 
the TPM1 gene that is specifically expressed in cardiac tissues. The new isoform is 
designated TPM1κ and contains exon 2a instead of 2b. Ectopic expression of human 
GFP.TPM1κ fusion protein can promote myofibrillogenesis in cardiac mutant axolotl 
hearts that are lacking in tropomyosin. 
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3.1 INTRODUCTION 
Vertebrate tropomyosins (TMs) are a family of actin binding proteins encoded by a group 
of highly conserved genes that likely evolved as a result of gene duplication over the 
evolutionary periods. In humans, there are four tropomyosin-encoding genes: TPM1 
(located on chromosome 15q22), TPM2 (chromosome 9p13), TPM3 (chromosome 
1q21.2), and TPM4 (chromosome 19p13.1) (Perry, 2001; Martson & Redwood, 2003; 
Lees-Miller & Helfman, 1991; Wieczorek et al., 1988; Nadal-Ginard, 1990). Each gene is 
known to generate multiple isoforms via alternative splicing, alternative promoters, and 
different 3‟ end processing (Wieczorek et al., 1988; Nadal-Ginard, 1990). Of the four, 
TPM1 is the most versatile and encodes a variety of tissue specific isoforms via alternative 
splicing and/or the use of two promoters; the transcripts encode proteins of either 248 or 
284 amino acids in length. Tropomyosins may be divided into three categories: striated 
muscle TMs, smooth muscle TMs, and cytoplasmic TMs. The striated muscle isoforms are 
a component of the thin filaments of myofibrils, the contractile apparatus of striated muscle 
tissues. The TPM1 isoform specific to striated muscle consists of 10 exons: 1a, 2b, 3, 4, 5, 
6b, 7, 8, and 9a/b and is designated TPM1α (Figure 3-1) (Wieczorek et al., 1988; Nadal-
Ginard, 1990). The smooth muscle specific isoform of the TPM1 gene is designated 
TPM1β and consists of exons: 1a, 2a, 3, 4, 5, 6b, 7, 8, and 9c/d (Wieczorek et al., 1988; 
Nadal-Ginard, 1990).  
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This study presents evidence for expression of a novel isoform of the TPM1 gene that is 
expressed in the cardiac tissue of humans and contains “smooth muscle type” exon 2a. The 
hearts of cardiac mutant Mexican axolotls are an ideal system for studying 
myofibrillogenesis in vitro because they are deficient in tropomyosin protein (Zajdel et al., 
1998; Zajdel et al., 2002; Zajdel et al., 2003). As a result, these hearts do not have 
organized myofibrils (the contractile apparatus of cardiac muscle) and therefore do not 
beat. One can promote myofibrillogenesis by ectopic expression of tropomyosin. For 
example, when murine TPM1α is expressed in organ cultured mutant hearts, organized 
myofibrils are formed. We were interested to know whether TPM1α and TPM1κ from 
human have the ability to promote myofibrillogenesis in mutant axolotl hearts. 
 
 
 
3.2 MATERIALS AND METHODS 
 
3.2a Total human RNA 
Human total RNA was procured from a number of commercially available RNA banks; 
adult heart and skeletal RNA (Clontech), fetal heart and skeletal >6 weeks old 
(Stratagene), fetal heart and skeletal = 6 weeks (Genotech), and adult left ventricle, left 
atrium, right ventricle, and right atrium (Ambion).  
 
3.2b Reverse transcriptase polymerase chain reaction  
Reverse transcriptase polymerase chain reaction (RT-PCR) with RNA from adult and fetal 
sources was carried out with gene and isoform specific oligonucleotides (as outlined in 
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Figure 3-1) to determine the expression pattern of TPM1κ and TPM1α, following our 
standard protocol (Zajdel et al., 2002). Using 2 µg of total RNA, first strand synthesis of 
cDNA was done using Superscript II with oligo(dT) priming following the manufacturer‟s 
protocol (Invitrogen). PCR was carried out in an Applied Biosystems 9700 thermal cycler. 
Subsequent to PCR amplification and gel electrophoresis, Southern blot analysis was 
performed with isoform specific oligonucleotides as previously described (Zajdel et al., 
2002). The oligonucleotides used in this study are as follows:  
 
P1(+): 5′-TCG  AAT  TCA  TGG  ACG  CCA  TCA  AGA-3′  
and  
P2(–): 5′-ATG  TCG  ACC  TTA  TAT  GGA  AGT  CAT  ATC  G-3′  
 
which are common to both TPM1α and TPM1κ. Primer P1 contains an EcoRI restriction 
site and P2 contains a SalI site to facilitate directed ligation into the pEGFP expression 
vector.  
 
P3(+): 5′- TGT  CAC  TGC  AAA  AGA  AAC  TC-3′  
and detector oligonucleotide  
D1(+): 5′-AAG  ATG  AAC  TGG  ACA  AAT  AC-3′  
are specific to exon 2b of TPM1α.  
P4(+): 5′-TCG  AGG  AGG  ACA  TCG  CGG  CC-3′ 
and detector  
D2(+): 5′-GAA  GTT  GCT  GCG  GGT   GTC  GG-3′  
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are specific to exon 2a of TPM1κ. As a control, RT-PCR was performed for the human 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) house-keeping gene with gene 
specific primer-pair  
 
(+): 5′-GTT  TAC  ATG  TTC  CAA  TAT  GAT  TCC  AC-3′  
and 
(–): 5′-TCA  TAT  TTG  GCA  GGT  TTT  TCT  AGA  C-3′.  
 
3.2c DNA sequencing.  
DNA sequencing was performed at Cornell University DNA Sequencing Facility in Ithaca, 
NY.  
 
3.2d Preparation of pEGFP.HumTPM1α and pEGFP.HumTPM1κ expression 
constructs. Using our published strategy (Zajdel et al., 2003), we amplified either TPM1α 
or TPM1κ T/A cloned cDNA using primer-pair P1(+) and P2(–), which contains the 
restriction sites EcoRI and SalI, respectively, for ligation into the pEGFP expression vector 
(Clontech). Subsequent to restriction enzyme digestion and purification, T4 DNA ligase 
was used to insert each fragment into pEGFP. The ligation mix was then transformed into 
INVα F′ competent Escherichia coli cells (Invitrogen) and grown on LB plates in the 
presence of kanamycin selection (50 µg/ml). Colony hybridization using nitrocellulose 
membranes was carried out with isoform specific oligonucleotides end-labelled with 
32
P. 
Positive colonies were selected and DNA extracted for confirmation of insertion by 
sequencing. The GFP expression is driven by a CMV promoter with the tropomyosin 
isoform linked in frame to carboxy terminal end of the GFP.  
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3.2e Transfection of embryonic axolotl hearts  
Normal and mutant axolotl embryos were obtained from the Indiana University Axolotl 
Colony. Stage 37–39 embryos were washed in Steinberg‟s solution (58mM NaCl, 0.67mM 
KCl, 0.9mM CaCl2, 0.2mM MgSO4, and 4.6mM Hepes [pH 7.4], containing 1% Invitrogen 
antibiotic/antimycotic [100 U/ml penicillin G, 0.1 g/ml streptomycin sulfate, and 0.25 µg/ 
ml amphotericin B] and filter sterilized). Hearts were dissected out of MS-222 (tricaine 
methanesulfonate) anesthetized embryos using fine-tip forceps and placed into Steinberg‟s 
solution. Transfection of dissected hearts was facilitated by Lipofectin reagent 
(Invitrogen). Steinberg‟s solution and Lipofectin were mixed 1:1 and allowed to incubate 
at room temperature for 30–45 min. Plasmid DNA at a concentration of 5 µg (either 
pEGFP.HumTPM1α or pEGFP.HumTPM1κ) was then added to the Lipofectin/Steinberg‟s 
mix and incubated for another 15 min. The hearts were then transferred into the 
transfection solution, incubated for 48 h at 19°C, transferred to fresh Steinberg‟s, and 
incubated for another 72 h.  
 
3.2f Confocal microscopy  
Subsequent to incubation in the transfection media, embryonic axolotl hearts (normal and 
mutant) were processed for fluorescent staining using a process adapted from Zajdel et al. 
(1998). Hearts were placed in 1 mM DTSP dissolved in 1% DMSO in Steinberg‟s for 15 
min to mildly fix and permeabilize. The hearts were further permeabilized in 0.5% NP-40 
in Steinberg‟s for 10 min, and then quenched in two 10 min washes in 0.1 M glycine. 
Monoclonal anti-tropomyosin (CH1) at a concentration of 1:30 in Steinberg‟s or 
polyclonal anti-GFP at 1:100 was used for immunohistochemical staining of embryonic 
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hearts. Hearts were incubated in antibody solution overnight. Non-specific background 
binding was blocked with 0.1 mg/ml BSA by three 10 min washes. Secondary antibodies, 
lissamine rhodamine (red) anti-mouse and FITC (green) anti-rabbit at a 1:50 dilution in 
Steinberg‟s, were used for secondary staining. The hearts were rinsed in BSA in 
Steinberg‟s and fixed in 2% paraformaldehyde for ~2 h. The fixation was quenched using 
0.1 M glycine for 30 min and then placed in Steinberg‟s. Hearts were mounted on slides 
using Fluorogard antifade reagent (Bio-Rad) and viewed on an MRC-1024ES confocal 
laser scanning microscope at 20x. A multiple section Z-series was taken for each heart and 
visualized using Lasersharp system software.  
 
 
 
3.3 RESULTS 
Total human heart RNA obtained commercially. TPM1α and TPM1κ cDNA was amplified 
using PCR via the strategy depicted in Figure 3-1. The PCR product for each was then 
cloned into a T/A cloning vector (Invitrogen) and filter hybridization was carried out with 
isoform specific detector oligonucleotides to identify the positive clones, i.e., D1 for 
TPM1α and D2 for TPM1κ (Figure 3-1). DNA was extracted from the positive colonies 
and nucleotide sequence of each of the clones was determined. Figure 3-2 depicts the 
nucleotide sequence of the coding region of the TPM1κ isoform.  
Using RT-PCR, we determined the expression pattern of TPM1α and TPM1κ in skeletal 
muscle and cardiac tissues from humans at various stages of development. The results 
presented in Figure 3-4A show that the full coding sequence of TPM1α and TPM1κ (~860 
nucleotides long) can be amplified by “generic” primer pair P1(+)/P2(–). Southern 
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hybridization with the TPM1α specific probe D1 shows that TPM1α is expressed in all 
tissues (Figure 3-4B). However, TPM1α expression in adult (lane 2) and fetal skeletal 
muscles (lanes 4 and 6) is lower relative to its expression in cardiac tissues (adult heart, 
lane 1; and fetal cardiac tissues (lanes 3 and 5)). The most intriguing observation is that 
TPM1κ is expressed only in cardiac muscle tissues (adult, lane 1; and fetal, lanes 3 and 5, 
in Figure 3-4C) and not in skeletal muscles (adult, lane 2; and fetal, lanes 4 and 6). For 
normalization, we performed RT-PCR of human housekeeping gene, GAPDH (Figure 3-
4D).  
In order to confirm the cardiac specificity of TPM1κ, we performed RT-PCR using 
isoform specific primer pair P4(+) and P2(–) (Figure 3-5A). Additionally, we carried out 
Southern hybridization with isoform specific detector oligonucleotides (D1 for TPM1α and 
D2 for TPM1κ). The results presented in Figure 3-5B show that the primer-pair used does 
not amplify TPM1α since none was detected by D1. Figure 3-5C indicates that TPM1κ is 
expressed only in cardiac tissues (adult, lane 1; and fetal, lanes 3 and 5) but not in skeletal 
muscles (adult, lane 2; and fetal, lanes 4 and 6) when probed by D2. Ethidium staining of 
the RT-PCR amplification of human GAPDH is shown in Figure 3-5D. Expression of 
TPM1α can be seen in both cardiac and skeletal muscles tissues when amplified using 
isoform specific primers P3(+) and P2(–) (Figures 3-6A and B). The Southern 
hybridization in Figure 3-6C shows the specificity of the TPM1α primer pair since no 
TPM1κ can be detected by D2.  
RNA from an adult individual‟s left ventricle, left atrium, right ventricle, and right atrium 
was used for RT-PCR to see if there was any variability in expression of either TPM1κ or a 
between heart segments. As can be seen in the Southern hybridization data in Figures 3-7B 
and C, the expression of both isoforms is present across the four hearts segments analysed. 
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Two expression constructs with human TPM1α and TPM1κ, designated as 
pEGFP.HumTPM1α and pEGFP.HumTPM1κ were created to differentiate between the 
two isoforms of tropomyosin. Confocal microscopy was used to show that both 
GFP.HumTPM1α (Figures 3-8C and D) and GFP.HumTPM1κ (Figures 3-8E and F) could 
be incorporated into organized myofibrils in both normal and mutant axolotl heart. The 
proteins were observed by staining with both anti-GFP antibody (green) and CH1 anti-
tropomyosin antibody (red) that recognizes both TPM1α and TPM1κ, with yellow 
indicating areas of co-localization.  
  
 
3.4 DISCUSSION 
This is the first report of a cardiac specific tropomyosin isoform that is an alternative splice 
product of the TPM1 gene. The new isoform is designated as TPM1κ (to signify the 10th 
and newest isoform) and contains exons 1a, 2a (instead of 2b as in TPM1α), 3, 4, 5, 6b, 7, 
8, and 9a/b (Figure 3-1). From human heart RNA, Denz (of Denz et al. (2004)) identified, 
cloned, and sequenced the cDNA of TPM1κ and using RT-PCR determined the expression 
pattern of both striated muscle isoforms TPM1α and TPM1κ in striated muscle tissues of 
humans during development. Expression patterns of both isoforms have also been 
determined in different segments of human heart (i.e., left ventricle, left atrium, right 
ventricle, and right atrium). In addition, ectopic expression of GFP.Hum-TPM1α or 
GFP.HumTPM1κ fusion protein can promote myofibrillogenesis in mutant axolotl hearts, 
which are practically devoid of tropomyosin protein and therefore lack organized 
myofibrils (Lemanski, 1973; Zajdel et al., 1998). Thus if we can understand the processes 
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of myofibrillogenesis in the axolotl then we can easily extrapolate the findings to help 
elucidate the mechanisms involved in human cardiac diseases. 
This study has demonstrated the expression of a novel tropomyosin isoform of the human 
TPM1 gene, TPM1κ. An alignment of the nucleotide sequence of both the TPM1α form 
and the TPM1κ form shows them to be exactly the same, with the exception of exon 2 
(Figure 3-1). TPM1α contains exons that are specific to striated muscle, including exon 2b, 
whereas TPM1κ contains exon 2a, an exon normally associated with smooth muscle type 
isoform (TPM1β) from the TPM1 gene. The sequences for TPM1α and TPM1κ have been 
submitted to GenBank (Accession Nos. Y640415 and AY640414, respectively). 
Interestingly, exon 2 sequences of TM isoforms from various vertebrate species illustrates 
the highly conserved nature of both exon 2a, found in TPM1κ; and exon 2b, found in 
TPM1α (Figure 3-3). 
It is known that the striated muscle isoform of the TPM1 gene is primarily involved in 
cardiac muscle contractility and that the striated muscle isoform of the TPM3 gene (a.k.a. 
TM-30 or α-slow tropomyosin) is primarily involved in the contractile activity of skeletal 
muscles in humans. This would account for the reduced amount of TPM1 expression in 
skeletal muscle versus cardiac tissues. The use of specific detector oligonucleotides during 
Southern hybridization, namely D1 and D2 for TPM1α  and TPM1κ, respectively, strongly 
suggest that the splicing event(s) for generating TPM1κ is specific for cardiac tissues in 
humans.  
 
Currently, the theory of segmental heart development is gaining popularity. According to 
this theory, different segments of vertebrate hearts come from different heart fields 
(Markwald et al., 1996). This theory is supported by the differential gene expression 
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(transcription factors in particular) in different heart segments (Lyons, 1996). For example, 
in mice the dHAND gene is expressed in the left ventricle and the eHAND gene is 
expressed in the right (Srivastava, 1997). The splice factor(s) responsible for generating 
TPM1κ from the TPM1 gene in humans is/are specific to cardiac tissues. Hence we were 
interested in finding out whether there was a differential expression pattern of TPM1κ or 
TPM1α within the four chambers of the human heart. Expression of both isoforms was 
found in all four chambers and so there was no evidence of variable gene expression of 
TPM1α and TPM1κ in the human heart (Figure 3-7).  
Unfortunately, one of the difficulties in the field of tropomyosin research is the 
unavailability of isoform specific antibodies. CH1 anti-tropomyosin antibody recognizes 
both TPM1α and TPM1κ. This problem has been overcome by the creation of GFP fusion 
proteins for each of the two isoforms from the Mexican axolotl that have the ability to form 
myofibrils in axolotl hearts (Zajdel et al., 2002).  
Confocal microscopy images (Figure 3-8) suggest that the human and axolotl proteins are 
interchangeable. Striated myofibrils form in the mutant axolotl heart using either axolotls 
tropomyosin specific constructs GFP.ATmC-1 and GFP.ATmC-2 (Zajdel et al., 2002) or 
these human tropomyosin constructs GFP.HumTMP1α and GFP.HumTPM1κ. However, 
the expression pattern of TPM1κ in humans is quite different from that seen in Ambystoma 
mexicanum (Mexican axolotl) where TPM1κ is expressed both in skeletal muscle and 
cardiac tissues (Luque et al., 1997) and the relative expression of TPM1κ to TPM1α is 
higher in axolotl heart than in human heart (Zajdel et al., 2002). In chickens, both TPM1α 
and TPM1κ are expressed in embryonic heart but neither is expressed in adult heart (Zajdel 
et al., 2003). In addition, TPM1α but not TPM1κ is expressed in skeletal muscles from 
both adult and embryonic birds. The cardiac specific nature of TPM1κ in chickens, as well 
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as the role it may play developmentally, makes this newly found human TPM1κ isoform 
an interesting focal point when considering how mutations in tropomyosin leading to 
various heritable cardiomyopathies may function.  
 
Mutant axolotl hearts can be used for studying the structural/functional relationship of 
human tropomyosin proteins. Several missense mutations in the TPM1 gene have been 
implicated in familial hypertrophic cardiomyopathy (FHC) and dilated cardiomyopathy 
(DCM) (Marston & Redwood, 2003; Muthuchamy et al., 1999; Bottinelli et al., 1997). 
Two of them have been found in exon 5 (D175N (Asp175Asn) and E180G (Glu180Gly) 
(Thierfelder et al., 1994; Prabhakar et al,. 2001)), the putative troponin-T binding region 
that have been conserved during evolution. These two mutations appear to cause partial 
unwinding of the tropomyosin coiled-coil by alteration of surface charge in the troponin T 
binding regions (Golitsina et al., 1997). When studies have been done on human 
cardiomyopathies, generally only the striated muscle isoform, TPM1α is considered. 
However, the novel isoform TPM1κ also shares the latter two mutations since exon 5 is 
common to both. If it is found that TPM1κ also plays a role in cardiac myofibril formation 
in humans, one should consider that this novel isoform might also play an important role in 
the pathogenesis of human cardiomyopathies as well.  
Given the cardiac specific nature of TPM1κ as well as the FHC and DCM missense 
mutation found to be associated with the TPM1 gene, it would be logical to consider this 
novel splice variant as a new research avenue for discovering the mechanisms human 
cardiac dysfunction.  
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Figure 3-1. Strategy for PCR amplification of TPM1α and TPM1κ and the splicing 
pattern for each. 
 
 
 
On the left is the known splicing of TPM1α with exon 2b and on the right is the novel 
TPM1κ splicing pattern with exon 2a, typically found in smooth muscle type TMs. The 
location of the specific oligonucleotides used for amplification and detection is shown 
along with the size of fragment observed after gel electrophoresis (sequences of each 
oligonucleotide can be found in Materials and methods). 
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Figure 3-2. Nucleotide and amino acid sequence of human TPM1κ  
 
 
The sequence shares 100% homology with human TPM1α except at exon 2 (base pair 
115–248). (Accession No. AY640414). 
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Figure 3-3. Amino acid sequence alignment of TPM1κ and TPM1α from a variety 
of vertebrates.  
 
 
Hu, human; Ch, chicken; Ax, axolotl; and Ra, rat. 
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Figure 3-4. Identification of a cardiac specific novel isoform of TPM1.  
 
 
PCR amplification of both TPM1α and TPM1κ using „„generic” primer pair P1(+)/P2(–) 
followed by Southern hybridization with isoform specific detector oligonucleotides. RNA 
from: lane 1, adult heart; lane 2, adult skeletal muscle; lane 3, fetal heart >6 weeks old; 
lane 4, fetal skeletal muscle >6 weeks old; lane 5, fetal heart = 6 weeks old; lane 6, fetal 
skeletal muscle = 6 weeks old; and lane 7, primer control. (A) Ethidium staining of PCR 
amplification using P1(+) and P2(–) primer pair. (B) Southern hybridization using D1 
probe specific to exon 2b of TPM1α shows this isoform to be present each tissue. (C) 
Southern hybridization using D2 probe specific to exon 2a of TPM1κ. This novel isoform 
is expressed only the cardiac tissues: lanes 1, 3, and 5. (D) Ethidium staining of human 
GAPDH as a loading control. 
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Figure 3-5. TPM1κ is found only in cardiac tissues by PCR amplification with exon 
2a specific primer. 
 
RNA from; lane 1, adult heart; lane 2, adult skeletal muscle; lane 3, fetal heart >6 weeks 
old; lane 4, fetal skeletal muscle >6 weeks old; lane 5, fetal heart = 6 weeks old; lane 6, 
fetal skeletal muscle = 6 weeks old; and lane 7, primer control. Marker: top, 1353, 1078, 
872, and 603 bp. (A) Ethidium staining of PCR amplification using P4(+) and P2(–) primer 
pair. Strong staining is seen in both fetal heart lanes with weaker staining in adult heart. 
Lane 6 skeletal muscle shows staining which appears to be non-specific amplification since 
no hybridization is seen in B or C. (B) No Southern hybridization is seen using D1 probe 
specific to TPM1α. (C) Southern hybridization using D2 specific probe to TPM1κ 
confirms the presence of this isoform in adult heart, albeit with weaker expression than the 
fetal heart tissues. This could suggest a possible down-regulation of TPM1κ or isoform 
switching during development, however further analysis is required. (D) Ethidium staining 
of human GAPDH. 
 I. The Role of Tropomyosin in Cardiac Myofibrillogenesis 
 
94 
 
Figure 3-6. TPM1α is found in both cardiac and skeletal muscle tissues using PCR 
amplification with exon 2b specific primer. 
 
 
RNA from: lane 1, adult heart; lane 2, adult skeletal muscle; lane 3, fetal heart >6 weeks 
old; lane 4, fetal skeletal muscle >6 weeks old; lane 5, fetal heart = 6 weeks old; lane 6, 
fetal skeletal muscle = 6 weeks old; and lane 7, primer control. Marker: top, 1353, 1078, 
872, and 603 bp. (A) Ethidium staining of PCR amplified products using P3(+) and P2(–) 
primer pair. Strong staining is observed across all tissues. (B) Southern hybridization with 
D1 probe specific to TPM1α shows expression in all lanes. (C) No hybridization is seen 
when probed with D2 probe specific to TPM1κ. (D) Ethidium staining of human GAPDH.  
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Figure 3-7. Expression of both TPM1α and TPM1κ is consistent across four adult 
heart segments analysed. 
 
 
 
RNA from adult: lane 1, left ventricle; lane 2, left atrium; lane 3, right ventricle; lane 4, 
right atrium; lane 5, primer control. (A) Ethidium staining of PCR amplification using 
P1(+) and P2(–) primer pair. (B) Southern hybridization with D1 probe specific to TPM1α 
and (C) D2 specific to TPM1κ. No difference in expression is seen for either isoform. (D) 
Ethidium staining human GAPDH. 
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Figure 3-8 (A & B). Confocal microscopy of pEGFP.TPM1α and pEGFP. 
TPM1κ transfected hearts from both normal and cardiac mutant 
Mexican axolotl.  
 
Scale bar = 50µm 
Red: (CH1 anti-tropomyosin) recognizes both endogenous and GFP tagged tropomyosin; 
green: (anti-GFP) binds only to GFP tagged tropomyosin. 
 
Figure 3-8A - CH1 staining of a mutant axolotl heart shows lack of tropomyosin. A small 
amount of background staining is observed. The mutant control serves to establish the 
levels of detection for the subsequent images. 
 
Figure 3-8B - Normal CH1 stained heart shows intact myofibril structure of embryonic 
axolotl. Myofibrils can be seen as outlines of myocardial cells with some banding 
beginning to form in the upper region. 
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Figure 3-8 (C & D). Confocal microscopy of pEGFP.TPM1α and pEGFP. 
TPM1κ transfected hearts from both normal and cardiac mutant 
Mexican axolotl. 
 
Scale bar = 50µm 
 
Figure 3-8C - Mutant heart transfected with GFP.TPM1α and double labeled with CH1 
and anti-GFP. Myofibril formation indicates GFP.TPM1α ‟s ability to rescue the mutant 
heart phenotype. Upper region of heart shows strong expression and co-localization 
(yellow) of GFP.TPM1α with CH1 stained tropomyosin. Presence of yellow bands 
indicates incorporation of GFP.TPM1α into myofibrils.  
 
Figure 3-8D - Normal heart with GFP.TPM1α transfection. Double label staining shows 
prominent co-localization demonstrating human TPM1α ‟s compatibility with endogenous 
tropomyosin in the formation of myofibrils. 
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Figure 3-8 (E & F). Confocal microscopy of pEGFP.TPM1α and pEGFP. 
TPM1κ transfected hearts from both normal and cardiac mutant 
Mexican axolotl. 
 
Scale bar = 100µm 
Figure 3-8E - Mutant heart transfected with novel isoform GFP.TPM1κ which is also 
capable of rescuing the mutant heart, as seen by myofibril formation and incorporation of 
fusion protein (orange/yellow bands).  
 
Figure 3-8F - Normal heart with GFP. TPM1κ. Double label staining is similar to the 
pattern seen with TPM1α. Yellow/orange banding shows incorporation and co-localization 
GFP.TPM1κ with endogenous tropomyosin that indicates the inter-changeability of the 
two. Note. Co-localization of CH1 (red) and GFP (green) staining is observed throughout 
the heart, however, when the images are merged together the red staining can appear more 
predominant in regions of less GFP.TPM1 expression. Also, the accessibility of antibodies 
to certain heart regions may be limited, causing the co-localization appearance to range 
from yellow to red-orange.  
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Published in 2005 in Journal of Cellular Biochemistry. 95: 840-848. 
  
 
CHAPTER FOUR 
 
ANTI-SENSE-MEDIATED INHIBITION OF EXPRESSION OF THE 
NOVEL STRIATED TROPOMYOSIN ISOFORM, TPM1, DISRUPTS 
MYOFIBRIL ORGANISATION IN EMBRYONIC AXOLOTL HEARTS. 
 
 
4.0 ABSTRACT  
Striated muscle tropomyosin (TM) is described as containing ten exons; 1a, 2b, 3, 4, 5, 6b, 
7, 8, and 9a/b. Exon 9a/b has critical troponin binding domains and is found in striated 
muscle isoforms. This team have recently discovered a smooth (exon 2a)/striated (exons 
9a/b) isoform expressed in amphibian, avian, and mammalian hearts, designated as an 
isoform of the TPM1 gene (TPM1κ).TPM1κ expression was blocked in whole embryonic 
axolotl heart by transfection of exon-specific anti-sense oligonucleotide. Reverse 
transcriptase polymerase chain reaction (RT-PCR) confirmed lower transcript expression 
of TPM1κ and in vitro analysis confirmed the specificity of the TPM1κ anti-sense 
oligonucleotide. Altered expression of the novel TM isoform disrupted myofibril structure 
and function in embryonic hearts.  
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4.1 INTRODUCTION 
 
Tropomyosin (TM) is an actin binding two stranded α-helical coiled-coil protein found in 
every living cell. Diverse expression of TM isoforms in muscle and non-muscle cells is 
achieved through alternative splicing (Nadal-Ginard, 1990; Lees-Miller & Helfman, 1991; 
Pittenger et al., 1994). This occurs in a tissue specific pattern (for example, brain 
(Vrhovski et al., 2003); fibroblast and epithelial (Percival et al., 2000); Golgi apparatus 
(Heimann et al., 1999) and developmentally regulated (Hook et al., 2004; Clayton & 
Johnson, 1998) . The splicing pattern for each isoform serves to adapt TM to a specific role 
in a given cell. For instance, skeletal muscle tropomyosin, in association with the troponin 
complex, regulates the actin-myosin interaction that results in calcium dependent 
contraction in vertebrate striated muscle. These muscle isoforms have 284 amino acid 
residues and a highly conserved N-terminal region. Within the cytoskeleton, the non-
muscle tropomyosin is involved in stabilising the actin filaments. These tropomyosin 
isoforms are generally smaller than striated muscle tropomyosin and tend to vary in their 
N-terminal region. However, the mechanism by which the presence or absence of a certain 
exon in TM makes it more suited to a specific function is still unclear. By inhibiting the 
expression of TM isoforms containing a specific exon, it is possible to determine if 
knockdown of an isoform is of functional significance.  
 
Recent technological advances allowed for the discovery of many unknown isoforms of 
TM in heart (Cooley and Bergstrom, 2001). Most of these isoforms fall into previous 
categories for TM. Four TM genes have been characterized in vertebrates: α-TM (TPM1), 
β-TM (TPM2), γ-TM (TPM3), and -TM (TPM4) including localization to their human 
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chromosomes (Laing et al., 1995; Perry, 2001; Martson and Redwood, 2003). A 
predominant striated muscle isoform is composed of exons 1a, 2b, 3, 4, 5, 6b, 7, 8, 9a/b 
from the TPM1 gene (Nadal-Ginard, 1990; Lees-Miller & Helfman, 1991; Pittenger et al., 
1994). Exon 9a/b (amino acids 258-284 at the carboxyl end of the molecule) is particularly 
important for the function of the striated muscle tropomyosin isoforms (Mak & Smillie, 
1981; Luque et al., 1997) as it contains the Troponin-T-binding domain. The smooth 
muscle specific isoform of the TPM1 gene is designated TPM1β and consists of exons: 1a, 
2a, 3, 4, 5, 6b, 7, 8, and 9c/d (see Table 4-I).  
 
An isoform of TM that bridges the two descriptive categories has been described (Zajdel et 
al., 2000; 2002). This novel TM contains a smooth muscle exon 2a as well as striated 
muscle type exon 9a/9b is expressed primarily in heart tissues of amphibian, avian, and 
mammalian species. This TM has been designated as TPM1κ to signify the 10th isoform to 
be discovered as an alternative splice product of the TPM1 gene. No specific antibody that 
is distinct for all exons is currently available to examine the protein expression of this 
isoform but expression of a GFP-TM construct and incorporation into myofibrils is now 
possible (Zajdel et al., 2002). Since we have found the TPM1κ isoform to be present in 
cardiac tissues of various species and because it is capable of incorporation into myofibrils, 
we set out to determine its importance by inhibiting its expression in vivo.  
 
The use of anti-sense oligonucleotide mediated inhibition of mRNA expression has proven 
useful in determining what role a particular protein may play in cellular functions. The 
present study uses an exon 2a-specific antisense oligonucleotide to block expression of the 
TPM1κ isoform in whole embryonic axolotl hearts to see what effect knocked-down 
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expression of this isoform may have. Whole hearts were preferred for this work because 
they are amenable to transfection procedures and maintain intercellular connections and 
signalling pathways.  
 
 
4.2 MATERIALS AND METHODS 
 
4.2a Embryo care 
Axolotl embryos were obtained from the Indiana University axolotl colony and the axolotl 
colony at SUNY Upstate Medical University. Animals were maintained in aquaria in 50% 
Holfreter‟s solution (29 mM NaCl, 0.45 mM CaCl2, 0.33 mM KCl, 0.1 mM MgSO4, and 
4.76 mM NaHCO3) and fed commercial salmon pellets. The embryos were staged 
according to the standard staging system (Bordzilovskaya et al., 1989).  
 
4.2b Preparation of exon-specific oligonucleotides 
Sense and anti-sense oligonucleotides were designed for exon 2 of the axolotl TPM1κ TM 
isoform. Axolotl TPM1α and TPM4α isoforms were used as controls to theTPM1κ 
isoform. The TPMα isoform is the predominant isoform found in axolotl skeletal muscle, 
while the TPM4α (ATmC-3) isoform is the predominant TM isoform in embryonic axolotl 
hearts (Spinner et al., 2002). TPM1α and TPM1κ nucleotide sequences used for this 
experiment were the following: 
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TPM1αsense,   5′-AGT ACT CGG AGT CCT TGA-3′; 
 
TPM1α anti-sense, 5′- A*G*G*A CTC CGA GTA CTT GTC *C*A*A-3′. 
 
TPM1κ sense,  5′-fG*C*A*C ACT GCT GAC GAG AAA *G*C*C*-3′,  
 
where *N represents a phosphorothioate blocked nucleotide and fG represents G tagged 
with fluorescein (FITC) at the 50-end (IDT, Inc.).  
 
TPM1κ anti-sense, 5′-G*C*G*G CTT TCT CGT CAG CAG TG*T*G*C-3′; 
 
4.2c Cationic liposome mediated transfection in whole hearts 
Transfection of oligonucleotides and cDNA was performed according to previously 
published methods (Zajdel et al., 1998). Stage 38 normal embryos were anesthetized and 
then hearts were dissected free with watchmaker‟s forceps and placed into Steinberg‟s 
solution. Four microliters of sense and anti-sense oligonucleotides (10 mM) were placed 
into 20 ml of lipofectin and 20 ml of Steinberg‟s solution. All hearts were beating 
immediately after dissection. The transfection solution was prepared and applied in a 
single blind method for the initial experiments examining beating (so that the person 
counting the heartbeats was not aware of which samples were control or treated). 
Transfected whole hearts were maintained in culture for 5 days. 
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4.2d RT-PCR and Southern blot hybridization 
RT-PCR with oligo dT priming was performed to evaluate the expression of TPM1κ, 
TPM1α, and TPM4α isoforms using our previously published protocol (Zajdel et al., 
2000). The strategy for RT-PCR amplification of TPM1αand TPM1κ simultaneously with 
the same primer-pair and subsequent detection using isoform-specific detector 
oligonucleotide is presented in Figure 4-1. The sequence of PCR primers used are as 
follows:  
 
TPM1κ and TPM1α:   (+) 5′-ATG GAC GCC ATC AAG AAG AAG-3′; and  
(common to both isoforms):  (–) 5′-ACG CTC CTG AGC ACG ATC CA-3′; 
 
TPM4α:    (+) 5′-CCG CTC CCT GAC ACC GGT TCC CG-3′ and  
(–) 5′-GCT CTC CCT CCA GAA TAA CAA GTT-3′.  
 
Southern blot hybridization was carried out using with (
32
P)-labelled isoform specific 
detector oligonucleotides, the sequence of which are as follows:  
TPM1κ:    5′- AGG GTG CTG GAT GAA CTG CAC AA-3′; 
 
TPM1α:    5′-AGT ACT CGG AGT CCT TGA-3′; and  
 
TPM4α:    5′-TGG CGC GCG GAC GGG GTG TTG CT-3′. 
 
 I. The Role of Tropomyosin in Cardiac Myofibrillogenesis 
 
105 
 
4.2e Confocal microscopy 
Whole mount immunostaining and confocal microscopy were performed according to the 
laboratory‟s published procedures (Zajdel et al., 1998). Monoclonal antibody, CH1 
(obtained from Developmental Hybridoma Bank, Johns Hopkins University) was used for 
the immunodetection of TM (Lin et al., 1985) with Lissamine Rhodamine anti-mouse used 
as a secondary antibody. FITC tagged oligonucleotides could be visualized without 
immunodetection. Specimens were viewed on a BioRad MRC 1024ES confocal laser 
system mounted on a Nikon Eclipse E600 microscope. Control hearts and treated hearts 
were examined using identical confocal settings. A simultaneous or sequential (double 
staining) Z-series was made for each.  
 
4.2f In vitro analysis of the isoform specificity for sense- and anti-sense 
oligonucleotides 
Total RNA (5 µg) from axolotl heart was annealed with 10 pmoles of isoform specific 
sense or anti-sense oligonucleotide at 65°C for 5 min, after which the annealed mixture 
was chilled on ice. One microliter of RNase Inhibitor was added to the annealed mixture 
with 1 µl of RT-buffer, and 1 µl of RNase H (Invitrogen superscript First Strand Synthesis 
Kit).The mixture was incubated at 37°C for 20 min followed by denaturation at 70°C for 
10 min to inactivate the enzyme. The 10-µl reaction was then chilled. RT reaction was 
performed using 5 µl of the above reaction mix in a total volume of 20 µl following 
Invitrogen‟s standard oligo dT protocol. Finally, PCR amplification was carried out with 2 
µl of the RT product using isoform specific primer-pairs followed by the Southern blot 
analysis with (
32
P)-labelled  isoform specific detector oligonucleotides. 
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4.3 RESULTS 
 
4.3a Specificity of TPM1κ anti-sense oligonucleotide in vitro 
The specificity of the TPM1κ anti-sense oligonucleotide was examined in vitro (Figure 4-
3), using the strategy outlined in Figure 4-2. TPM4α probe was used as a control. TPM4α 
has a striated muscle exon 2b compared to smooth muscle type exon 2a in TPM1κ. Sense 
and antisense expression was relatively equal for the TPM4α probe. TPM1κ expression 
was reduced for TPM1κ antisense oligonucleotide with the TPM1κ probe. The sense 
oligonucleotide did not reduce expression as seen with the TPM1κ probe. 
 
4.3b Anti-sense TPM1κ and anti-sense TPM1α specificity in vitro 
Three isoforms of TM have currently been identified in embryonic axolotl heart. 
TPM1αand TPM1κ are derived from the same TPM1 (α-TM) gene (Zajdel et al., 2000) 
while TPM4α is from a TM-4 type gene (Luque et al., 1994; Spinner et al., 2002). Figure 
4-4 illustrates the expression of these three isoforms in anti-sense TPM1κ- and TPM1α-
treated heart RNA. Lane 1 shows that expression of TPM1αor TPM4α was not reduced 
with the use of the anti-sense TPM1κ oligonucleotide for each probe, respectively. The use 
of the TPM1κ probe clearly demonstrates reduced expression of this isoform with anti-
sense TPM1κ oligonucleotide treatment. Likewise, TPM1αanti-sense oligonucleotide 
treatment reduced expression of TPM1αas indicated by that probe. TPM1αand TPM4α 
expression was not reduced with antisense TPM1κ oligonucleotide.  
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4.3c Sense and anti-sense TPM1κ specific oligonucleotide in vivo 
TPM1κ exon 2 specific oligonucleotides were transfected into whole normal hearts. Whole 
hearts were used to maintain intercellular pathways and connections. After 5 days, the 
expression of mRNA was examined by TPM1κ and TPM4α probes. TPM4α, a TM-4 type 
TM is the predominant TM found in these embryonic hearts and this probe was used as a 
control. Figure 4-5 demonstrates a reduction in TPM1κ expression in TPM1κ exon 2 anti-
sense-treated hearts. Expression was not decreased in the sense treated normal whole 
hearts. TPM4α expression was unaffected in TPM1κ sense or anti-sense oligonucleotide-
treated normal hearts.  
 
4.3d Confocal laser scanning microscopy of TPM1κ sense- and anti-sense-treated 
whole hearts 
Confocal laser scanning microscopy was used to examine the thickness of the whole 
normal hearts. Normal hearts transfected with antisense TPM1κ oligonucleotides (Figure 
4-6a) demonstrated a disruption of myofibril organization with few sarcomeric myofibrils 
compared to normal hearts transfected with FITC-tagged TPM1κ sense oligonucleotides 
that showed no disruption in myofibrils (red) (Figure 4-6b). The presence of the sense 
oligonucleotide was confirmed by FITC detection (green) localized to the nucleus of the 
myocytes.  
 
4.3e Contractions in TPM1κ anti-sense oligonucleotide treated hearts 
Synchronous contractions of the whole hearts were monitored during the course of the 
experiments in a single blind method (Table 4-II). The normal control hearts and 
oligonucleotide treated hearts were not descriptively labelled so that they were examined 
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blindly. Normal and TMP1κ whole hearts were used as a control and had no reduction in 
beating with contractions continuing for the full 5 days in 11 of 11 in both categories. 
Contractions were disrupted in the experimental hearts during the course of the 
experiments. At 4 and 5 days of treatment, 3 of 11 hearts were not beating, which 
coincides with the reduction in TPM1κ RNA expression. There appeared to be a partial 
recovery or compensation of the TPM1κ anti-sense treated hearts at day 2 and 3, but by 
day 4 and 5, the number of beating hearts was again reduced. The heart rate of the hearts 
still beating was reduced compared to the normal controls. Even during this period of 
possible recovery, the heart rate of the beating hearts averaged below the control hearts.  
 
 
4.4 DISCUSSION 
 
The predominant TM isoform expressed in striated muscle has been considered to be 
TPM1α expressed by the TPM1 gene (Lees-Miller and Helfman, 1991). TPM1α consists of 
exons 1a, 2b, 3, 4, 5, 6b, 7, 8, and 9a/b, typical of striated muscles. This team have cloned 
and sequenced cDNAs for three striated muscle isoforms of TM from axolotl hearts. These 
isoforms are designated as TPM1α, TPM1κ, and TPM4α. Of these, TPM1κ is the novel 
isoform, which unlike TPM1α contains smooth muscle type exon 2a (in place of exon 2b). 
We believe TPM1α and TPM1κ are alternatively spliced products of the TPM1 gene. This 
novel splicing is not unique to the Mexican axolotl. We have cloned and sequenced the 
TPM1 isoform, TPM1κ, from avian as well as mammalian species, including human 
(Luque et al., 1997; Zajdel et al., 2003; Denz et al., 2004).  
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The cardiac mutant axolotl heart has specific advantages for determining the 
structural/functional relationships of TM because mutant hearts are deficient in the 
sarcomeric TM protein (Lemanski, 1979; Lemanski et al., 1996; Zajdel et al., 1998). 
Unfortunately, a lack of isoform specific antibodies limits the study of which TM isoform 
is essential for the formation of myofibrils in vivo or, whether various combinations of the 
three isoforms play a crucial role in forming myofibrils as well as affecting the contractility 
of cardiac muscle in vivo. In addition, gene knock-out technology is not well established in 
amphibian systems, and even if it was it would not be possible to knockout a single 
isoform at this present time. Furthermore, it is difficult to utilize a transgenic mouse model, 
since α-TM (TPM1) knock-out has been found to be embryonic lethal (Rethinasamy et al., 
1998). In any case, knockout technology cannot be used to eliminate exon 2a as it is a 
component of both, the novel isoform, TPM1κ, and TPM1β, a smooth muscle isoform, as 
shown in Table 4-1. Therefore, since exon 2a is required for another essential TM isoform, 
TPM1β, simply knocking out this exon will not provide the information as to whether 
TPM1κ is essential for cardiac contractility and cardiogenesis. 
 
This issue has been addressed by inhibiting the expression of TPM1κ using an exon 2a 
specific anti-sense oligonucleotide. The specificity of this oligonucleotide was determined 
in vitro (Figures 4-3 and 4-4). Annealing of the antisense oligonucleotide specific for exon 
2a to total heart RNA and subsequent RNase H treatment allowed the degradation of 
TPM1κ mRNA (in the RNA-DNA hybrid) but not TPM1α or TPM4α (see Figure 4-2). On 
the other hand, the exon 2a specific sense oligonucleotide did not have any effect. 
Additionally, transfection of the exon 2a anti-sense oligonucleotide into normal axolotl 
hearts in organ culture reduced the concentration of TPM1κ transcripts but not 
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TPM4α,which has already been reported to play an essential role in the cardiac 
contractility in axolotl (Figure 4-4) (Spinner et al., 2002). On the contrary, anti-sense 
TPM1α was previously found to have an insignificant effect on the myofibril formation in 
axolotl heart in culture (Zajdel et al., 2000). 
 
The TPM1κ specific anti-sense oligonucleotide, but not its sense counterpart, decreased 
cardiac contractility (Table 4-II). At 24 h post treatment with TPM1κ anti-sense (day 1), 
the number of hearts beating (3/12) was significantly lower than either the control or 
TPM1κ sense treated hearts (11/11). By day 2 and 3, the number of anti-sense treated 
hearts beating increased, but not to the level seen in the controls nor the same rate (25 and 
28 beats/min, respectively, compared to 38 beats/min for the controls). At day 4 and 5 
post-treatment with TPM1κ anti-sense, the number of beating hearts was again reduced to 
levels seen at day 1 (3/11 for both) as well and the rate of beating for those 3 hearts (12 and 
11 beats/min, respectively). The rate of contraction and number of beating hearts stayed 
consistent in the control and TPM1κ sense treated hearts. The partial recovery seen in the 
anti-sense treated hearts could indicate partial compensation for the TPM1κ reduction, 
possibly through upregulation of another TM isoform, but that was ultimately insufficient 
to maintain proper contraction. After 5 days, some of the hearts restarted beating possibly 
suggesting the ability to overcome the anti-sense inhibition.  
 
The anti-sense oligonucleotide specific for TPM1κ caused disorganization of the 
myofibrils in normal axolotl heart (Figure 4-6a). In contrast, the FITC labelled sense 
oligonucleotide, although it can be detected within the myocardium of transfected axolotl 
heart, did not affect the existing myofibrils or cardiac contractility (Figure 4-6b and Table 
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4-2). Hence, it is tempting to conclude that TPM1κ plays a critical role in the contractility 
as well as myofibrillogenesis of axolotl hearts. Our results do not permit us to conclude 
that the TPM1κ specific anti-sense oligonucleotide that has been used in this study does 
not affect other important isoforms, such as TPM1β, because exon 2a is also a part of this 
isoform. However, the smooth muscle isoform is not known to play any significant role in 
cardiac contractility or cardiac myofibrillogenesis. 
 
Another important question that remains is how does TPM1κ affect the process of 
myofibril formation in striated muscles, and especially in cardiac muscle? There is 
evidence of TPM1κ being cardiac specific in human (Denz et al., 2004), chicken (Zajdel et 
al., 2003), and rat (unpublished results). The mechanism for formation of a mature 
myofibril in cardiac muscles may follow the three-step process of myofibrillogenesis 
proposed by Rhee et al. (1994). According to this model, the formation of mature 
myofibrils is mediated by the initial deposition of pre-myofibrils in close association with 
the cell surface. Pre-myofibrils then give rise to nascent myofibrils that subsequently help 
to form mature myofibrils. Each of these stages is associated with specific sarcomeric 
protein markers; for example, non-muscle myosin IIB is present in pre-myofibrils but is 
replaced by myosin in nascent myofibrils. The costameric proteins, talin and vinculin, first 
appear in mature myofibrils. The pre-myofibril model of myofibrillogenesis also appears to 
be applicable to myofibrillogenesis in skeletal muscle cells (Rhee et al., 1994; 
Rethinasamy et al., 1998).  
 
It is important to understand whether TPM1α and TPM1κ play the same role in myofibril 
formation in cardiac tissues in a competitive manner. Or, do both isoforms take part in the 
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process of myofibrillogenesis in a very specific manner where each of them may play a 
critical role at different stages of myofibril formation? Again, such is the case with non-
muscle myosin IIB, which is essential in pre-myofibril formation and then is replaced by 
the muscle specific myosin. At present, this team are planning to evaluate the progression 
of myofibrillogenesis in axolotl heart where one can control the process of cardiogenesis 
by regulating the environmental temperature. Differential epitope tagging of various TM 
isoforms will facilitate the identification and localization of the ectopically expressed TM 
protein molecules on sarcomeres using epitope specific antibodies and subsequent confocal 
microscopy and/or immunoelectron microscopy. 
 
To summarise, in vitro analysis was used to confirm the critical specificity of the 
oligonucleotide compared to other TM isoforms. Reverse transcriptase polymerase chain 
reaction (RT-PCR) demonstrated decreased TPM1κ expression in embryonic hearts and 
confocal scanning microscopy showed disruption of myofibril organization and an 
associated decrease in contractility. 
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Figure 4-1. Strategy for amplification of TPM1α and TPM1κ by RT-PCR using the 
same primer-pair and the location of isoform specific detector oligonucleotides for 
Southern hybridization. 
 
 
 
 
 (# indicates number.) 
P2 
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Figure 4-2. Scheme for testing the in vitro specificity of sense and anti-sense 
oligonucleotides 
 
 
 
RNA-DNA hybrids are treated with Ribonuclease H (RNase H), a non-specific 
endonuclease, which degrades the RNA, but not the DNA nor unhybridised RNA.   
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Figure 4-3. RT-PCR showing specificity of TPM1κ anti-sense oligonucleotide in 
vitro. 
 
 
TPM1κ sense (lane 1) and anti-sense (lane 2) treated axolotl heart RNA. Primer control 
lane was blank (not included). The Southern hybridization of PCR products amplified with 
either TPM4α or TPM1κ specific primer pairs and probed with isoform specific 
oligonucletides is shown. TPM4α normally found in axolotl embryonic hearts was used as 
the control. The amount of TPM1κ transcripts was drastically reduced in the anti-sense 
treated RNA lane demonstrating the specificity of the TPM1κ anti-sense oligonucleotide 
compared to another predominant cardiac isoform, TPM4α. 
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Figure 4-4. Anti-sense TPM1κ and anti-sense TPM1α specificity in vitro. 
 
Lane 1, Anti-sense TPM1κ treated RNA with TPM1α, TPM1κ, and TPM4α axolotl 
tropomyosin probes. Lane 2, Antisense TPM1α treated RNA with TPM1α, TPM1κ, and 
TPM4α axolotl tropomyosin probes. Lane 3, Primer control. Shown is the Southern 
hybridization of PCR products amplified with either TPM1α/TPM1κ or TPM4α specific 
primers and probed with isoform specific oligonucleotides. TPM1κ expression was 
reduced with TPM1κ anti-sense treatment and TPM1α expression was reduced with 
TPM1α anti-sense treatment. TPM4α was unaffected by either anti-sense oligonucleotide 
and was again used as a control. This demonstrates the specificity of the TPM1κ anti-sense 
oligonucleotide compared to another TM isoform (TPM1α) from the same gene. 
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Figure 4-5. Effect of TPM1κ sense and anti-sense oligonucleotides on transcript 
levels in vivo. 
 
 
TPM1κ anti-sense (lane 1) and sense (lane 2) treated whole axolotl heart. TPM4α probe 
was used as a control. Lane 3, Primer control. TPM1κ mRNA expression was reduced in 
whole normal hearts transfected with TPM1κ antisense oligonucleotide. The expression 
ofTPM1κ was not affected when the hearts were transfected with the sense 
oligonucleotide. The expression of TPM4α was again unaffected by transfection of either 
oligonucleotide. 
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Figure 4-6 - Myofibril organization and entry of FITC-tagged oligonucleotide into 
cells of whole hearts.  
 
Scale bar = 50µm 
 
Confocal z-series images of stage 
38 embryonic axolotl hearts 
transfected with either TPM1κ 
anti-sense or sense 
oligonucleotides. Immuno-
detection of sarcomeric 
tropomyosin using CH1 
monoclonal antibody is shown in 
red. (a) TPM1κ anti-sense 
transfection disrupted the 
myofibril organization in normal 
axolotl heart compared to TPM1κ 
sense transfection. Very little 
organized structure is seen when 
examined by the tropomyosin 
staining. The secondary antibody 
is contained within amorphous 
areas in the cells. In (a) the cells 
are identifiable by black circular 
areas surrounded by staining. The amorphous staining can be seen at the periphery of the 
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black circular areas or at the cell membrane. Since this is a three dimensional projection, 
not all the cells and surrounding staining is the plane of focus. (b) Shows that the TPM1κ 
sense oligonucleotides did not affect the structure. Since no effect on myofibril structure 
with TPM1κ sense was observed, we tagged the oligonucleotide with FITC (green) to 
verify its presence and found it to be within the myocytes (panel b). Double staining of the 
nucleus (green) and the myofibrils at the periphery of the cells (red) can be seen. The green 
staining is ovoid in shape and primarily located at the centre of the cells (Zajdel et al., 
2000). Cells can be identified by the consistent myofibril linear and circular staining below 
the membrane, by the black non-staining area below the myofibril staining, and the green 
nuclear staining in the middle of the cells. This figure shows that TPM1κ plays a critical 
role in maintaining the myofibrillar structure in embryonic axolotl hearts. Note: panel (a) is 
at 60x to show the lack of myofibril structure at a higher resolution while panel (b) is at 
20x to show the clear structure in conjunction with presence of the FITC tagged sense 
oligonucleotide 
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Table 4-1. Nomenclature of various isoforms of TPM1 referred to in his 
study 
 
 
 
 
 
 
TPM1      
isoforms 
Isoforms of tropomyosin 
currently known as 
Exon                
composition 
TPM1α Striated muscle 1a, 2b, 3, 4, 5, 6b, 7,8, 9a/b 
TPM1β Smooth muscle 1a, 2a, 3, 4, 5, 6b, 7,8,9d 
TPM1γ TM-2 fibroblast 1a, 2b, 3, 4, 5, 6b, 7, 8,9d 
TPM1 TM-3 fibroblast 1a, 2b, 3, 4, 5, 6a, 7, 8, 9d 
TPM1 TM-5a fibroblast 1b, 3, 4, 5, 6b, 7, 8, 9d 
TPM1κ Novel striated/cardiac muscle 1a, 2a, 3, 4, 5, 6b, 7, 8,9a/b 
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Table 4-2. Five day comparison of synchronous contractions in control, 
sense, and anti-sense treated whole hearts 
 
 
 
 
  
 Number of beating hearts (beats/min) 
Day Control Sense TPM1κ Anti-sense TPM1κ 
1 11/11 (17) 11/11 (15) 3/12 (13) 
2 10/11 (30) 11/11 (38) 9/12 (25) 
3 11/11 (36) 11/11 (38) 9/11 (28) 
4 10/11 (36) 11/11 (38) 3/11 (12) 
5 11/11 (37) 11/11 (32) 3/11 (11) 
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Published in 2005 in Cardiovascular Toxicology 5; 1-8.  
  
 
CHAPTER FIVE 
 
CARDIAC MYOFIBRIL FORMATION IS NOT AFFECTED BY 
MODIFICATION OF BOTH N- & C-TERMINI OF  
SARCOMERIC TROPOMYOSIN 
 
 
 
 
 
 
5.0 ABSTRACT  
 
 
Although the role of tropomyosin is well defined in striated muscle, the precise mechanism 
of how tropomyosin functions is still unclear. It has been shown that extension of either N- 
or C- terminus ends of sarcomeric tropomyosin do not affect cardiac myofibrillogenesis, 
but it is not known whether simultaneous extension of both ends affects the process. In 
order to study the structural/functional relationships of sarcomeric tropomyosin, we have 
chosen the cardiac mutant Ambystoma mexicanum because the heart is deficient in 
sarcomeric tropomyosin. In this study, we have made an expression construct, 
pEGFP.TPM4α.E-L-FLAG that upon transfection into normal and mutant axolotl hearts in 
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organ culture, expresses GFP.TPM4α.E- L-FLAG fusion protein in which both the N- and 
C- termini of TPM4α are being extended. TPM4α is one of the three tropomyosins 
expressed in normal axolotl hearts. Both confocal and electron microscopic analyses show 
that this modified sarcomeric tropomyosin can form organized myofibrils in axolotl hearts.  
 
 
 
5.1 INTRODUCTION 
 
 
In vertebrate striated muscle, the thin filament, responsible for mediating Ca
2+
 control of 
contraction and relaxation, consists largely of actin, tropomyosin (TM), and the troponin 
(Tn) complex (Tn-I, Tn-C and Tn-T). Tropomyosin is an alpha-helical, coiled-coil protein 
that binds end-to-end along the actin filament of seven actin monomers. It functions with 
the troponin complex to regulate actin-myosin interactions, which are dependent on Ca
2+
 
(Perry, 2001; Lees-Miller & Helfman, 1991; Zot et al., 1986). The ends of tropomyosin are 
required for binding with actin and also for the cooperative regulation of actin filaments by 
other proteins like myosin, troponin-T (Palm et al., 2003). Although the role of TM is well 
defined in striated muscles, the precise mechanism of how TM functions is still unclear. 
This is partly due to the complexity of the isoform diversity of different myofibrillar 
proteins including TM and also due to the incomplete knowledge of structural/functional 
relationships. There are four TM genes (TPM1, TPM2, TPM3, and TPM4), which exhibit a 
very high degree of conservation in species ranging from Drosophila to human (Lees-
Miller & Helfman, 1991; Perry, 2001). 
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Amphibians have been widely used to study the process of induction, specification, and 
determination of embryonic tissue. This is especially true for urodeles, including the 
Mexican axolotl (Ambystoma mexicanum). Ambystoma is facultative neotenous and 
provides a valuable model to study development of the heart because it carries a lethal 
mutation (gene c) which affects only heart muscle. This cardiac mutation of the axolotl is a 
lethal recessive causing the embryo to die about a fortnight post hatching. The mutants 
have abnormal cardiomyogenesis. Morphological studies have shown that the myocardium 
lacks organized myofibrils, having instead large collections of amorphous material, but 
retains normal electrophysiological properties (Lemanski, 1973; 1979; Zhang et al., 2004). 
As a result, the embryos die due to a lack of a functional circulation. The mutant axolotl 
heart provides a unique system for studying the intricate process of cardiac development 
and also examining the specific functional role of each TM isoform in this process. This is 
because the protein level of TM is profoundly diminished in c/c mutant hearts resulting in 
an absence of organized myofibrils and inability to beat (Lemanski, 1973; 1979). ). Most 
importantly, the mutant hearts can be rescued in situ by supplying exogenous TM protein 
or TM cDNA in an expression construct under the control of an appropriate promoter 
(Zajdel et al., 1998; 2000; 2002). In addition, mutant hearts can be rescued by an RNA that 
is unrelated to tropomyosin. It is not known how this RNA modulates the expression of 
tropomyosin and its subsequent organization into de novo myofilaments in rescued mutant 
hearts (Lemanski et al., 1996; Zhang et al., 2003). Extensive molecular characterization of 
the various isoforms of TM expressed in the Mexican axolotl has been carried out, and so 
far three isoforms have been identified in cardiac tissues. These isoforms are designated as 
TPM1, TPM1κ and TPM4. (Luque et al., 1997; Spinner et al., 2002) (Table 1).  
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The aim of the present study was to understand the structural specificity of the end-to-end 
association of tropomyosin to form cardiac myofibrils in situ. For this purpose we have 
prepared an expression construct containing sarcomeric tropomyosin TPM4 that has been 
modified at both N- and C- termini by fusing green fluorescent protein (GFP) at the N-
terminal end and L-E-FLAG (a 10-mer peptide) (Metzger et al., 2003) at the C-terminal 
end. The expression construct containing the double-tagged TPM4 was transfected into 
mutant axolotl heart, which is practically devoid of sarcomeric tropomyosin protein. The 
ectopic expression of the GFP.TPM4.E-L-FLAG promotes myofibrillogenesis in mutant 
hearts as determined by confocal as well as scanning electron microscopic analyses. 
 
 
 
5.2 MATERIALS AND METHODS 
 
 
5.2a pEGFP.TPM4α.E-L-FLAG expression construct   
 
TPM4α cDNA was PCR amplified with  
P1(+) (5‟-GGA ATT CAT GGA GGC CAT CAA GAA-3‟) and  
P2(–) (5‟-GGG AGC TCT AAG GAA GTC ATA TCG TT-3‟) primer pair.   
 
At the 5‟-end of the P1 primer an EcoRI site was inserted followed by the TPM4α 
sequences starting from ATG. At the 5‟-end of the P2(–) primer, a SacI site was inserted 
followed by the TPM4α sequences prior to the stop codon. In other words, we excluded the 
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stop codon so that any epitope such as FLAG can be added at the 3‟-end contiguously. The 
PCR-amplified DNA was digested with SacI enzyme followed by the ligation with T4 
ligase to the FLAG cassette that was made by annealing two oligonucleotides  
 
L1 (5‟-CGA TTA TAA AGA TGA TGA TGA TAA ATA AG-3‟) and  
L2 (5‟-TCG ACT TAT TTA TCA TCA TCA TCT TTA TAA TCG AGC T-3‟). 
 
The ligation mix was digested with EcoRI and SalI and was subsequently ligated to the 
pEGFP vector digested with the same enzymes (i.e., EcoRI and SalI). The ligation mix was 
then used for transforming Escherichia coli (Invitrogen) following the protocol supplied by 
the manufacturer.  Positive clones containing TPM4α.E-L-FLAG were picked up after 
filter hybridization with [
32
P]-labeled L2 oligonucleotide. DNA was isolated from the 
positive clones and the nucleotide sequence was determined for verification.  
 
 
5.2b Embryo care and whole heart organ culture  
Normal and mutant axolotl embryos were obtained from matings between heterozygous 
(+/c x +/c) animals from the Indiana University axolotl colony and the axolotl colony at 
SUNY Upstate Medical University.  Animals were maintained in aquaria in 50% 
Holtfreter‟s solution (29 mM NaCl, 0.45 mM CaCl2, 0.33 mM KCl, 0.1mM MgSO4, and 
4.76 mM NaHCO3) and fed commercial salmon pellets. The embryos were staged 
according to the standard staging system (Bordzilovskaya et al., 1989). Removal of normal 
and mutant hearts was performed on stages 35–39 embryos via dissection of anesthetized 
animals following our published protocol (Lemanski, 1973; 1979; Lemanski et al., 1996; 
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Zajdel, et al., 1998; 2000; 2002; Zhang et al., 2003; 2004). Embryos at „heartbeat‟ stage 
34/35 (when beating starts) were removed from their jelly coats, washed several times and 
identified as normal or mutant based upon whether they had beating hearts. The culture 
medium was modified Steinberg‟s solution, (58 mM NaCl, 0.67 mM KCl, 0.9 mM CaCl2, 
0.2 mM MgSO4, 4.6 mM HEPES, pH 7.4) with 1% antibiotic/antimycotic (Gibco: 1000 
units penicillin, 1 mg streptomycin, and 2.5 µg amphotericin B/liter) that was filter 
sterilized using 0.22 µm filter units before use. Using watchmaker forceps, non-beating 
mutant hearts and beating normal hearts were extirpated and placed individually in 10 µL 
drops of Steinberg‟s solution in a sterile 60 mm Petri dish lined with parafilm. Culture 
dishes were placed in a humid chamber, oxygenated regularly and kept at 18
 
degrees C for 
the duration of the culture period. The heart explants were checked periodically under a 
dissecting microscope. 
 
 
5.2c Transfection procedure 
Hearts were transfected via Lipofectin reagent (Invitrogen) using a standard procedure 
(Zajdel, et al., 1998; 2000; 2002). Lipofectin reagent was mixed with Steinberg‟s solution 
for 30–45 minutes room temperature at 0.28 mg/mL. Approximately 5 µg of 
pEGFP.TPM4α.E-L-FLAG expression vector was added to the mix and allowed to 
incubate 15 minutes. The hearts were placed into 10 µL of transfection solution, incubated 
at 17°C, and monitored for beating daily. At 2 days post transfection, the hearts were 
transferred into fresh Steinberg‟s solution and incubated for an additional 3 days. Hearts 
were then fixed with 2% paraformaldehyde for 1 hour for confocal analysis.     
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5.2d Confocal microscopy 
Whole mount immunostaining and confocal microscopy were performed. Monoclonal 
tropomyosin antibody (Lin et al., 1985) was obtained from the Developmental Studies 
Hybridoma Bank. Anti-GFP mono/polyclonal antibodies (Clontech) and polyclonal anti-
FLAG antibody (Sigma) were used to detect GFP and/or FLAG tagged tropomyosin 
proteins. Anti-rabbit rhodamine red secondary antibody and anti-mouse/anti-rabbit FITC 
(Jackson Immunohistochemicals) secondary antibodies at a dilution of 1:50 were used for 
detection of primary antibodies. Whole hearts were mounted onto slides in BioRad 
Fluorogard antifade reagent. Specimens were viewed on a BioRad MRC 1024ES confocal 
laser system mounted on a Nikon Eclipse E600 microscope. Control hearts and treated 
hearts were examined using identical confocal settings. A simultaneous or sequential 
(double staining) Z-series was made for each. Digital image processing was performed 
using LaserPics (BioRad). 
 
5.2e Electron microscopy 
Normal and mutant transfected hearts were fixed for 1 hour at room temperature in in 
glutaraldehyde-formaldehyde and picric acid, buffered to pH 7.4 with 0.1M phosphate 
buffer. Hearts were post-fixed with 1% osmium tetroxide in the same buffer for 40 
minutes, dehydrated in a series of ethanol solutions, and embedded in Epon or Araldite. 
Sections of 50-90 nm were cut, stained with uranyl actetate and lead citrate, and viewed in 
a JEOL 100CX II electron microscope at an acceleration voltage of 80 kv (Lemanski et al., 
1996).    
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5.3 RESULTS 
 
The strategy for creating the TPM4α fusion protein construct in pEGFP (Clontech) is 
presented in Figure 5-1. The expression construct was transfected into normal or mutant 
axolotl hearts using lipofectamine following the method of Zajdel et al. (1998; 2000; 
2002). Five days post transfection, the hearts were stained with CH1 monoclonal antibody, 
which is specific for sarcomeric tropomyosin. Figure 5-2a represents a normal heart 
stained with CH1, which shows organized myofibrils.  In contrast, the control mutant heart 
does not have organized myofibrils and also is deficient in tropomyosin protein (Figure 5-
2b), However, upon transfection myofibril formation can is observed (Figure 5-2c).  
 
The normal and mutant hearts were transfected with the same expression construct and 
after 5 days post transfection were stained with anti-GFP (monoclonal) and anti-FLAG 
(polyclonal) antibodies. Figure 5-3a depicts the normal heart stained with anti-GFP 
antibodies. The results suggest that GFP has been incorporated into organized myofibrils. 
Also, staining with anti-FLAG antibody shows incorporation of the FLAG epitope in 
organized myofibrils (Figure 5-3b). When these figures were superimposed onto one 
another, the GFP and FLAG signals were found to be co-localized in the normal heart 
(Figure 5-3c).  
 
In mutant heart transfected with the pEGFP.TPM4α.E-L-FLAG expression construct anti-
FLAG and anti-GFP antibody staining showed evidence of tropomyosin TMP4α fusion 
protein expression, followed by the formation of well-ordered myofibrils (Figures 5-4b and 
5-4c respectively). This is confirmed by ultra-structure images of the normal, mutant and 
transfected mutant embryonic hearts in Figure 5-5.  
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5.4 DISCUSSION 
 
The fusion protein construct, pEGFP.TPM4α.E-L-FLAG, showed the expression and 
subsequent incorporation of tropomyosin-4α into well-organized myofibrils, in both the 
normal and mutant embryonic axolotl hearts (Figures 5-3 and 5-4). The superimposed 
image (Figure 5-3c) demonstrated the co-localization of GFP and FLAG, strongly 
suggesting that GFP.TPM4α.E-L-FLAG is expressed in myocardium and is subsequently 
incorporated into organized myofibrils. The ectopically expressed TPM4α appears to have 
had a rescuing effect upon the mutant heart by encouraging the development of myofibrils 
which are lacking in cardiac lethal mutants (Figures 5-4 and 5-5). This effect of TMP4α 
(also known as ATmC-3) upon myofibrillar formation has been noted before (Spinner et 
al., 2002). However, the current study is the first where this tropomyosin protein has been 
demonstrated to function „normally‟ even though the N- and C-termini have been 
modified.   
 
Tropomyosin, approximately 70 kDa, is a dimeric actin binding protein that can be 
homodimeric (TPM1/TPM1 or, TPM2/TPM2) or heterodimeric (TPM1/TPM2), with 
heterodimerization thermodynamically favoured (Gimona et al., 1995). It is of interest to 
ask whether ectopically expressed GFP.TPM4α.E-L-FLAG fusion protein itself can form 
dimers and then become incorporated into organized myofibrils? Alternatively, does this 
fusion protein form heterodimers with an endogenous sarcomeric tropomyosin in normal 
cardiomyocytes? Furthermore, is the heterodimer then incorporated into organized 
myofibrils? The results presented in Figure 5-2c suggest that the fusion protein, which is 
ectopically expressed in mutant heart lacking endogenous tropomyosin, can form 
homodimers. However, it could be argued that transfection of mutant hearts with the 
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expression construct could somehow induce the expression of another endogenous 
tropomyosin that is recognized by CH1 monoclonal antibody against tropomyosin, or that 
promotion of myofibril formation in mutant hearts takes place with tropomyosin that has 
been generated after the cleaving off of one or both fused epitopes from the fusion protein.  
 
In order to show that the tropomyosin seen is the fusion protein itself, the post-transfected 
mutant hearts were stained with either anti-FLAG (Figure 5-4b) or anti-GFP antibodies 
(Figure 5-4c). The results presented in Figure 5-4 strongly suggest that indeed the 
GFP.TPM4α.E-L.FLAG fusion protein is expressed and subsequently incorporated into 
organized myofibrils in mutant hearts, which are deficient in tropomyosin protein. Hence, 
it is tempting to conclude that GFP.TPM4α.E-L-FLAG fusion protein is capable of 
forming homodimers in mutant heart tissue and the homodimer can thus be incorporated 
into organized myofibrils in mutant axolotl hearts. This is an important consideration from 
a biomedical point of view. Various missense mutations in tropomyosin and also in other 
myofibrillar proteins have been implicated in Familial Hypertrophic Cardiomyopathies in 
humans (FHC) (Bottinelli et al., 1998; Muthuchamy et al., 1999; Marston & Redwood, 
2003).  
 
FHC is a subset of Hypertrophic Cardiomyopathy (HCM), the most common cause of 
sudden death in young adults. It is a genetic disease with an autosomal dominant mode of 
inheritance with a few exceptions (Maron et al., 1996). In FHC, one of the two alleles of 
the TPM1 gene is mutated. So the question is whether the FHC phenotype is due to the 
incorporation of a homodimer of two mutant tropomyosin molecules or a heterodimer of a 
mutant and a wild-type of tropomyosin. This is particularly important for Asp175Asn or 
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Glu180Gly FHC mutations in tropomyosin since the 170-180 region in tropomyosin is the 
putative troponin binding region. Hence, it is still an open question whether the 
homodimers of Asp175Asn mutant tropomyosin can support the organization of myofibrils 
in vivo. Mutant axolotl hearts with tropomyosin deficiency present an ideal system for 
studying this question since only the ectopically expressed protein (tagged or untagged) is 
available for myofibril formation.    
 
To substantiate the above confocal results at an ultra-structural level, transmission electron 
microscopy was carried out with normal, mutant, and transfected mutant hearts for 
confirmation of the formation of organized myofibrils in mutant hearts transfected with 
pEGFP.TPM4α.E-L-FLAG expression construct. Consistent with published observations 
(Lees-Miller & Helfman, 1991; Lemanski, 1973), no organized myofibrils were seen in 
mutant hearts (Figure 5-5B) when compared to normal. On the contrary, organized 
myofibrils are evident in mutant hearts transfected with pEGFP.TPM4α.E-L-FLAG 
(Figure 5-5C). 
 
The N- and C- terminal ends of tropomyosin, required for high actin affinity, are encoded 
by alternatively expressed exons. The ends overlap to form continuous cables of 
tropomyosin along both sides of the actin filament, enabling co-operative interactions 
(McLachlan & Stewart 1975). Expression studies with a double fusion protein of 
sarcomeric tropomyosin in mutant axolotl suggest that the extension of both N- and C-
terminal ends of the sarcomeric protein does not affect the formation of continuous cables 
along the actin filament. In addition, it also does not seem to affect the co-operative 
interaction of tropomyosin with other sarcomeric proteins, especially actin, as indicated by 
its incorporation into regular repeating myofibrils.  
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Table 5-1. Nomenclature used for Tropomyosin isoforms in this chapter. 
 
 
ATmC-1: Axolotl Tropomyosin Cardiac–1 (Zhang et al., 2003); ATmC-2: Axolotl Tropomyosin Cardiac–2 (Zajdel et al., 2002; Zhang et al., 2003); 
ATmC-3: Axolotl  Tropomyosin Cardiac –3 (Luque et al., 1997). 
 
Nomenclature of 
various isoforms of 
tropomyosin 
referred to 
The gene encoding 
the isoforms: new 
nomenclature 
(old nomenclature) 
Isoforms of 
tropomyosin currently 
known as 
Exon composition 
Nomenclature 
used in 
previous 
publications 
on axolotl 
TPM1 TPM1(-TM) Striated muscle 1a, 2b, 3, 4, 5, 6b, 7, 8, 9a/b ATmC-1/-Tm-1 
TPM1 TPM1(-TM) Smooth muscle 1a, 2a, 3, 4, 5, 6b, 7, 8, 9d Sm -Tm 
TPM1 TPM1(-TM) TM-2 fibroblast 1a, 2b, 3, 4, 5, 6b, 7, 8, 9d  
TPM1 TPM1(-TM) TM-3 fibroblast 1a, 2b, 3, 4, 5, 6a, 7, 8, 9d  
TPM1 TPM1(-TM) TM-5a fibroblast 1b, 3, 4, 5, 6b, 7, 8, 9d  
TPM1 TPM1(-TM) Novel striated/cardiac 1a, 2a, 3, 4, 5, 6b, 7, 8, 9a/b ATmC-2/-Tm-2 
TPM2 TPM2 (-TM) Striated/Skeletal muscle 1a, 2b, 3, 4, 5, 6b, 7, 8, 9a/b  
TPM TPM3(hTMnm) Skeletal Muscle 1a, 2b, 3, 4, 5, 6b, 7, 8, 9a/b  
TPM TPM4 (TM4) StrTM4 1a, 2b, 3, 4, 5, 6b, 7, 8, 9a/b ATmC-3/Str.TM-4 
TPM4 TPM4 (TM4) 
Non-muscle TM4 in 
amphibians and avian species. 
1b, 3, 4, 5, 6, 7, 8, 9?  
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Figure 5-1. The strategy for making pEGFP.TPM4α.E-L-FLAG 
expression construct.  
 
 
The details of the strategy have been described under Materials and Methods. The expression of the fusion 
protein GFP.TPM4α.FLAG is driven by cytomegalovirus promoter, which is an integral part of the pEGFP 
vector (Clontech).  
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Figure 5-2. Confocal micrographs of embryonic stage 39 hearts.   
 
CH1 anti-tropomyosin staining shows well 
organized sarcomeric myofibrils in the normal 
heart (Figure 5-2a), which are absent in the 
mutant heart of the same stage (Figure 5-2b). 
However, mutant heart transfected with the 
expression construct pEGFP.TPM4α.E-L-
FLAG that expresses fusion protein shows 
abundant sarcomeric tropomyosin throughout 
the heart. The expressed fusion protein is well 
organized.  
 
(a) Normal heart stained with CH1. 
(b) Mutant heart stained with CH1. 
(c) Transfected mutant heart stained with 
CH1. 
 
Our recent calcium spike experiments suggest 
that the wild-type and mutant hearts remain 
alive and have the normal electrophysiological 
properties after the entire lipofection process 
(Zhang et al., 2004). 
 
Scale bar = 50µm 
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Figure 5-3. Confocal micrograph of stage 39 normal transfected hearts 
stained with anti-GFP and anti-FLAG antibodies.   
 
The results show that GFP.TPM4α.FLAG fusion 
protein is expressed and subsequently incorporated 
into organized myofibrils in normal (and mutant 
hearts (see Figure 5-4)). 
 
(a) Staining with anti-GFP. 
 
 
 
 
(b) Staining with anti-FLAG. 
 
 
 
 
 
(c) Co-localization of anti-GFP and anti-FLAG 
antibodies.  
Scale bar = 100µm 
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Figure 5-4. Confocal micrograph of stage 39 mutant transfected hearts 
with pEGFP.TPM4α.E-L-FLAG 
constructs and stained with anti-GFP 
and anti-FLAG antibodies.  
The results show that the fusion protein was 
expressed and subsequently organized in mutant 
axolotl hearts. 
(a) Control mutant heart stained with anti-FLAG 
antibodies. 
 
 
 
(b) Transfected mutant heart stained with anti-
FLAG antibodies. 
 
 
 
 
(c) Transfected mutant hearts stained with anti-
GFP antibodies.  
Scale bar = 50µm 
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Figure 5-5. Transmission electron micrograph of portions of normal, mutant, and 
pEGFP.TMP4α.E-L-FLAG transfected mutant hearts of embryonic stage 39. 
 
(a) The normal heart shows 
well-differentiated myofibrils where 
Z-lines and I-bands can be identified 
(arrows). 
 
 
 
(b)  The mutant heart lacks 
myofibrils, but contains amorphous 
collections with dense bodies. 
 
 
(c) Transfected mutant heart 
shows reduced amount of 
amorphous collections and organized 
myofibrils with identified Z-lines 
(arrows). 
Scale bar = 25µm 
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CHAPTER SIX  
 
INTRODUCTION AND GENERAL METHODOLOGY 
 
 
6.0 ABSTRACT 
 
Part II of this thesis falls into two sections; (i) the distribution of the preganglionic vagal 
neurones in the medulla (Chapter 7), and (ii) the study of cardiorespiratory control in 
axolotls (Chapter 8). In Chapter 7, Fluoro-Gold, a retrograde neural-tracer was used to 
locate the vagal neurones in the neotenous, metamorphosing and metamorphosed axolotls. 
Neotenous axolotls only had one group of cells that were all located in the dorsal motor 
nucleus of the vagus (DMV). In the metamorphosing and metamorphosed there appeared 
to be a transition of cells from the DMV to a new ventrolateral position over the 
metamorphic course. It was hypothesised that this relocation could relate to the evolution 
of heart rate variability, and that this region may be equivalent to a primitive form of an 
area called the nucleus ambiguus found in higher organisms. Thus, in Chapter 8, the 
cardiac and ventilatory behaviour of neotenous and metamorphosed axolotls was 
examined, along with pharmacological intervention. Atropine, a cholinergic muscarinic 
antagonist, raised the heart rate in both neotenous and metamorphosed axolotls, indicating 
the presence of some vagal tone. The β-adrenergic antagonist propranolol caused a 
decrease in heart rate, indicating the presence of sympathetic control. Ventilation rates in 
the neotenous generally followed that of the heart rate. However the metamorphosed form 
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showed a series of bradycardia-tachycardia oscillations immediately post ventilation, 
which may be indicative of respiratory sinus arrhythmia (RSA).   
 
 
6.1 INTRODUCTION 
 
The axolotl, Ambystoma mexicanum, is an intriguing animal in which to study the changes 
associated with the transition from primarily aquatic to aerial modes of respiration. The 
neotenous axolotl is perennibranchiate having external gill structures of three stalks (rami) 
on each side of the head, each consisting of fern-like filaments (fimbriae) plus internal gills 
located on paired branchial arches, plus poorly develop lungs, so respiratory gas exchange 
is predominantly carried out with the surrounding water (Duellman & Trueb, 1986). It is 
generally thought that the fimbriae, where the main role is to increase surface area for gas 
exchange, are longer (~8 mm) and more elaborately branched in healthy adult individuals 
that are found in stagnant waters, where oxygen levels may be relatively low. The opposite 
is true for axolotls that are in well aerated waters; they have much smaller gill filaments 
(Jones, P. pers. comm.; Malvin & Heisler, 1988). Some axolotls at University of 
Birmingham that were kept in well aerated water had filaments that were a mere 1 mm in 
length. Of course the genetic makeup of the animal would too determine the overall length 
of the gill filaments. The lungs in the neotenous forms are rudimentary and are unlikely to 
play a major role in respiratory gas exchange, although these animals do come up to the 
surface periodically and buccal pump (gulp air from the surface). These periodic inflations 
may play a part in buoyancy control (Porter, 1972). The skin, as in all amphibians, is also 
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likely to be involved in some cutaneous respiration, with CO2 excretion being more 
important than oxygen uptake (Feder & Burggren, 1985). 
 
After metamorphosis the gills are resorbed and the lungs grow and are actively ventilated 
so that they now play the major role in respiratory gas exchange. The neotenous axolotl 
lungs are a pair of simple membranous sacs with simple alveoli. However, post 
metamorphosis, several anatomical alterations are observed within the lung to 
accommodate the new mode of ventilation. Coleman & Hessler (1997) found (1) lung 
volume increased to 5.309 x 10
-2
 cm
3
, more than three times that of neotenous form, (2) 
lung wall thickness (~50 µm) reduced by approximately one-third (as the surface area of 
the lumen increased), (3) there was approximately 12% increase in the length of the lung, 
and (4) many new small blood vessels vascularised the metamorphosed lung. All these 
changes are related with increasing the effectiveness of oxygen and carbon dioxide gas 
exchange associated with lung-dependent respiration. Associated with these morphological 
changes in the respiratory organs are marked changes in the associated cardiovascular 
(CV) system, with the branchial arches supplying the gills regressed and replaced by 
internal and external carotid arteries (Kolesová et al., 2007). It can be anticipated that there 
will be changes in the control of physiological function associated with these 
morphological changes that would be reflected in changes in the central nervous system. 
Preliminary studies have indeed indicated evidence of some neuroanatomical changes 
associated with the switch to air breathing at metamorphosis (Ihmied, 1989; Taylor et al., 
2001).   
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Neuroanatomically, when looking at the vagal preganglionic neurones (VPN) in the 
medulla oblongata of a variety of species, there appeared to be a phylogenetic trend 
towards a progressive increase in the proportion of these neurones in a ventrolateral 
location outside of the dorsal vagal motonucleus (DVN) (Taylor, 1993). However, recent 
studies have revealed variation within groups, possibly related to the proportional 
relationship between central and peripheral control of cardiorespiratory interactions (CRI) 
(Taylor et al., 2010). Elasmobranch fishes have around 10% of these neurons in a ventral 
lateral location and this seems to be associated with central interactions between 
respiratory and cardiac control centres. Other fish have less than 2% of VPN outside the 
DVN and; CRI seems to be determined predominantly by peripheral feedback loops. Some 
amphibians (e.g. Xenopus) have from 20-30% of VPN outside the DVN while others (e.g. 
Rana) have all of their VPN in the DVN. The functional correlations of these differences 
are the subject of present investigations (E. W. Taylor and others, unpublished 
observations). Reptiles have varying numbers of VPN outside of the DVN, though RSA 
was recorded from rattlesnakes, Crotalus (Campbell et al., 2006). There is sparse 
information on birds but in the duck, Anas while only 2% of VPN are outside the DVN 
30% of cardiac VPN (CVPN) are so placed, implying that 2 locations for CVPN may be of 
functional importance. In mammals generally more than 50% of VPN are outside the DVN 
and up to 80% of CVPN may be located in the nucleus ambiguous, an area ventro-lateral to 
the DVN (Bennett et al., 1981; Taylor et al., 1999). 
 
Interestingly, it has been found that some neurones migrate from the medial position 
(DVN) to a more ventrolateral position during brain stem development in human embryos 
and foetuses (Brown, 1990; Windle (1933) in Bennett et al., 1981). Generally, it seems that 
II. Neuroanatomy and Physiology of Cardiorespiratory Control  
 
144 
 
as the number of PVN in the ventrolateral region increases so does the animal‟s reliance on 
lung ventilation. Therefore, this ventrolateral location may be involved in the ontogeny and 
evolution of lung breathing (and/or its control). 
 
Before its innervation, the heart has myogenic rhythmicity, with the sinoatrial node being 
the pacemaker. Pacemaker cells spontaneously depolarise driving the rest of the 
myocardium to contract during systole, thereby determining heart rate. The depolarisation 
is thought to be caused by spontaneous Ca
2+
 release by the sinoatrial node cells. These 
cells have intracellular Ca
2+
 stores beneath the cell plasma membrane and Ca
2+
 is released 
in a cyclic way (Bogdanov et al., 2001; Vinogradova et al., 2002).  Localised events cause 
cyclic Ca
2+
 release during diastolic depolarisation (Lakatta et al., 2003). The cyclic Ca
2+
 
variations appear to control the rate of action potentials, hence contributing to the final 
heart rate (Maltsev et al., 2004). The diastolic depolarisation is driven by the activation of 
the hyperpolarisation-activated inward current, known as the funny or pacemaker current 
(If) (Bucchi et al., 2007; Verkerk et al., 2009). Hyperpolarisation causes the f-channels to 
open and carry the inward current, thereby generating the diastolic depolarisation. This 
eventually leads to the threshold for Ca
2+
 channel activation and action potential firing. 
Studies suggest that spontaneous sarcoplasmic reticulum Ca
2+
 release may too be involved 
in sinus rhythm generation (Lakatta & DiFrancesco, 2009; Maltsev & Lakatta, 2009; Hata 
et al., 1996).  
 
The sympathetic limb of the autonomic centre increases heart rate and force of cardiac 
contraction via adrenaline binding on adrenoceptors of cardiac cells. This action is 
facilitated by the release of noradrenaline from the sympathetic fibres. When the β-
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adrenergic receptors of the sinoatrial node cells are thus stimulated, there is an increase in 
the frequency and amplitude of spontaneous Ca
2+
 release in the subcellular space 
(Vinogradova et al., 2002). It is thought that β-adrenoceptor stimulation increases cyclic 
adenosine monophosphate (cAMP) levels which activate ion channels that increase entry 
of Ca
2+
 into the myogenic cells from the extracellular fluid (Baruscotti et al., 2005).  
 
The cardiac vagal axons from the nucleus ambiguus (part of the parasympathetic limb) 
have a cardioinhibitory affect by release of the neurotransmitter acetylcholine which acts 
directly on cardiac M2-muscarinic cholinoceptors and slowing pacemaker cell activity in 
the SA-node of the heart. Parasympathetic signals activated through these receptors cause 
an outward current of potassium which contributes to the bradycardia. Vagal tone is the 
normal bradycardic effect on the heart rate by the vagus nerve (the tenth cranial nerve) 
which contains the parasympathetic fibres. Thus an increase in vagal discharge, and or a 
decrease in sympathetic signals would cause bradycardia, and tachycardia would result 
from an increase in sympathetic discharge and/or a decrease in parasympathetic discharge. 
 
Since the respiratory and CV systems supply oxygen to the tissues and are responsible for 
removal of metabolically produced CO2, it is important that these systems are functionally 
linked and work in harmony to deal with increasing and decreasing metabolic demands. 
Baroreceptors located in the carotid sinus and the aorta detect arterial pressure and cause 
modulation of the CV system appropriately; and chemoreceptors located in the carotid and 
aortic bodies detect circulatory changes in pH, partial pressure of CO2 and partial pressure 
of O2, which act on the respiratory system to promote homeostasis (Daly & Jones, 1998).  
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Intriguingly, in many vertebrates the heart demonstrates beat-to-beat fluctuations, known 
as heart rate variability, which seems to be generated by fluctuations in the degree of vagal 
control (vagal tone) (McDonald (1980) in Taylor, 1994; Taylor et al., 1999). 
Mechanoreceptors and chemoreceptors contribute to heart rate variability via the 
cardiorespiratory centre which then alters heart rate and blood pressure to maintain 
circulatory homeostasis. Humans show a slight increase in heart rate upon inspiration and a 
corresponding decrease during expiration, a phenomenon called RSA (Hyndman et al., 
1971).  
 
RSA is the main contributor to HRV in human adults. The origin of RSA has been 
attributed to three main areas:– (i) volume receptors - increased diastolic filling during 
inspiration stimulates the right heart atrial volume receptors resulting in a reflex increase in 
heart rate, known as the Bainbridge reflex (Bainbridge, 1920); (ii) lung expansion 
receptors - inspirational lung expansion activates the pulmonary-cardiac reflex (Hering, 
1895; Anrep et al., 1936b); or is triggered by central mechanisms (Anrep et al., 1936b). 
The general accepted consensus is that all three are involved in producing RSA with 
integration within the brain stem of the autonomic control of the heart (Yasuma & Hayano, 
2004).  
 
Lung expansion detectors, heart volume receptors and central mechanisms appear to 
contribute to this RSA via the vagus nerve which emanates from the cardiac vagal 
motorneurons in the brainstem and innervates the SA node (Anrep et al., 1936a & b; 
Bainbridge, 1920; Jordan & Spyer In: Taylor, 1987). During the respiratory cycle, decrease 
in vagal nerve activity during inspiration and increase during expiration, causes the heart 
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rate to rise and fall respectively. In vagotomised animals or animals that have cholinergic 
antagonists, RSA is eradicated (Samaan, 1935; Anrep et al., 1936b; Hamlin et al., 1966; 
Coker et al., 1984). Therefore it appears that there are mechanism(s) which interrupt vagal 
discharge during the breathing cycle, thereby producing HRV. An important contributor is 
the respiratory modulation of the baroreceptor reflex (Piepoli et al., 1997). Normally when 
baroreceptors are stimulated during inspiration they would have an excitatory effect on 
vagal cardio-motorneurons which would cause a fall in heart rate. However, this is not 
observed as the afferent input from the baroreceptor is gated prior to the cardio-
motorneurons during inspiration, thus causing an increase in HR (Melcher, 1980; Keyl et 
al., 2000). Vagal inhibition is also mediated by a mechanism that involves lung stretch 
receptors which are stimulated lung inflation (Taha et al., 1995). The lung stretch receptors 
also inhibit vagal discharge by acting on the brainstem and it is the afferent input from 
these receptors that cause the gating of the baroreceptor reflex (Jordan & Spyer, 1986). 
Changes in blood gas composition, detected by chemoreceptors, effect central respiratory 
drive, and increase RSA (Shykoff et al., 1991). Therefore vagal discharge is inhibited 
directly and indirectly by inspiratory neurons (Spyer, 1989).  
 
It can be seen that both peripheral and central mechanisms contribute to the generation of 
RSA, but crucially the generation is centrally integrated within the brainstem and the vagal 
innervation of the heart. Measurements of this respiratory related HR oscillation may 
provide an indication of autonomic function and integrity of the medulla oblongata, so it 
could be used to measure parasympathetic control, though this is contentious in humans 
(Katona & Felix, 1975; Hayano et al., 1991; Grossman and Taylor, 2006).   
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In animal models heart and ventilation rates can be measured electrophysiologically to 
examine heart rate variability, hence parasympathetic control. The axolotl is an apt animal 
model to study the ontogeny of heart rate variability and related neural changes as it 
predominantly uses its gills when in the larval form, and upon metamorphosis, becomes a 
committed lung breather. The central nervous system is likely to undergo essential 
modifications in association with lung, and possibly heart, innervation and gill 
degeneration. Another advantage of using the axolotl is that it is neotenic (reaching sexual 
maturity whilst in its larval form) and, thus, large enough for valuable neuroanatomical and 
physiological examinations from larval to induced metamorphic life stages.  
 
Thus the axolotl is an excellent animal model to use to determine if there is a direct 
correlation between the onset of heart rate variability and the ventrolateral migration of 
PVN. Measurement of heart rates and ventilation rates, along with collection of hind brain 
tissues of neotenous, metamorphosing and metamorphosed axolotls may yield a greater 
understanding of the functional roles of the migration pattern of VPN and their relationship 
with cardio-respiratory control. 
 
 
6.2 AIMS AND OBJECTIVES 
 
The aim of the experimental studies in Part II of the present thesis sought to investigate the 
hypothesis that relocation of VPN relates to the onset of heart rate variability (HRV) in the 
committed lung breathing axolotl. It was thought that the relocation may cause 
physiological changes in heart rate which could be evidence for autonomic change. 
II. Neuroanatomy and Physiology of Cardiorespiratory Control  
 
149 
 
Therefore the objectives of Part II were:  
 
 To induce metamorphosis in axolotls (present Chapter). This would permit the 
observation of progressive developmental changes that occur from a larval, aquatic 
axolotl to the metamorphosed, lung breathing form.  
 
 To examine the neuroanatomy of VPN in the medulla oblongata in the neotenous, 
metamorphosing and metamorphosed forms (Chapter 7). This was novel on 
metamorphosing axolotls, and, although one study already looked at VPN‟s in the 
neotenous and metamorphosed forms (Ihmied, 1989), it was interesting to compare 
findings, especially since this study used the newer technique of fluorescent 
retrograde tracing by intraperitoneal injection.  
 
 To record heart and ventilation rates in the neotenous and metamorphosed axolotls 
and then, with drug intervention, to determine if there is evidence of HRV, 
especially in the latter forms. Drug intervention would determine the level of 
cholinergic and adrenergic effect upon the heart and ventilation rates (Chapter 8).  
 
 
6.3 MATERIALS AND METHODS  
 
6.3a Axolotls 
The experimental animals were bred from the resident colony at University of 
Birmingham, maintained in a holding room with water and air temperature at 15 ± 2.0 °C 
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and 20.0 ± 2.0°C respectively, with an alternating 12:12-h light cycle. Neotenous axolotls 
(A. mexicanum) were kept in shallow plastic tanks (60 x 35 x 20 cm (lwh)) containing 50% 
Holtfreter‟s solution (100% solution per litre: NaCl, 3.5 g; KCl, 0.05 g; CaCl2, 0.1 g; 
NaHCO3, 0.2 g;  MgSO4
.
7H2O, 0.2 g) diluted in dechlorinated tap water (Asashima et al., 
1989). This solution acts to prevent infection (www.ambystoma.org/AGSC/) and increase 
hardness of water, which axolotls prefer (www.axolotl.org/requirements.htm#hardness). 
They were fed with beef or lamb heart three times per week. Axolotls used were of either 
gender, aged 17 months, with a mean (±SE) weight of 72.2 ± 2.8 g.  
 
6.3b Induction of metamorphosis 
Axolotls remain neotenous as they do not release thyronine hormone from the thyroid 
gland. This results in a block in the thyroxin pathway and thus failure to metamorphose 
naturally (Norris & Platt, 1973; Taurog, 1974). However, metamorphosis can be 
experimentally induced using triiodo-L-thyronine (T3) or thyroxine (T4) (Norris & Platt, 
1973; Taurog, 1974). Axolotls may be immersed in a T3 or T4 solution (Volk et al., 1998; 
Maake et al., 1999; Brown, 1997; Rosenkilde & Ussing, 1996). Rosenkilde recommends 
using a dosage between 20-40 nM of T3, initially dissolved in 0.6% sodium carbonate 
(pers. comm.), but Brown (1997) routinely used 30 nM of T4 as it was found to be 
remarkably non-toxic. Metamorphosis may also be induced by intramuscular or 
intraperitoneal injection of T3 or T4 (Prahlad & DeLanney 1965; Gahlenbeck & Bartels, 
1970; Crawford & Vincenti, 1998; De Groeff et al., 2000; Gaur et al., 2001).  
 
The above methods were initially tried and resulted in a very poor success rate. After 
seeking advice from the David Mortimer, the resident vet of Biomedical Science Unit, 
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University of Birmingham, and the Home Office, I was permitted to try variations of the 
published methods, so that the University could have a working protocol for the induction 
of metamorphosis in axolotls as specific, useful information in this area was lacking. This 
was thought to be especially pertinent as it would prevent the repetitions of metamorphic 
failures by future researchers and hence reduce mortality rates. Therefore the preferred 
procedure used in this study was a modification from those that are already published.  
 
Axolotls were injected intramuscularly with T3 at a concentration of 1.9 µg per gram body 
weight. Around 7 days post induction the holding tanks were gently tilted up at one end so 
as to provide a „beaching‟ area and some large drain pipes were cut in half and placed into 
the tanks to provide shelter/cover as the axolotls preferred to be under cover (Figure 6-1). 
Gravel (≤ 1.5cm diameter) was taken out as a couple of axolotls were found to have 
ingested them following a post mortem examination to establish the cause of death. At this 
time they refused to take food. For optimum hygiene the water was changed daily to 
prevent contamination of shedding skin (Figure 6-2) by microbes. Most axolotls started to 
come out of the water on days 9-11 post induction, although some took much longer (see 
Figure 6-3). Around 14 days post induction some axolotls showed signs of „rebound‟ effect 
- where the moulting appeared to be incomplete, thus leaving layers of dead cells on the 
skin surface (see Figure 6-4). The rebound effect is thought to be due to insufficient or lack 
of thyroid hormone after induction of metamorphosis. To remedy this, the axolotl was 
immersed in a weak solution of T3 (20 nM) as advised by Rosenkilde & Dube (pers. 
comm.). However, the axolotl was always provided with an „island‟ by placement of 
appropriately sized rocks or slabs. The immersion solution strength was gradually reduced 
from 20 nM to 5 nM over a 6 week period. Rosenkilde suggested that incompletely 
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metamorphosed individuals, having unsloughed skin, can be kept in a 6 nM solution of the 
hormone, which was sufficient to ensure moulting of the skin and the onset of feeding 
(pers. comm.). From 30 ± 5 days the axolotls were fully metamorphosed and were feeding 
(see Figures 6-5(C) & (D)). The reducing weight of all the axolotls was recorded 
throughout the metamorphic process. 
 
6.3c Experimental stages 
The developmental stages used in the neuroanatomical and studies were neotenous, 
metamorphosing (mid-metamorphic) and metamorphosed. For electrophysiological 
recordings only neotenous and metamorphosed were used. Neotenous axolotls were the 
normal larval, sexually mature forms; mid-metamorphic stage was determined by those 
having just gill stubs left and a preference for being out of the water (Figures 6-5(A) & 
(B)); and metamorphosed stage was determined as those individuals that had fully 
metamorphosed and were readily taking food (Figures 6-5(C) & (D)). 
 
6.3d Outcome 
Due to the problems initially encountered with induction of metamorphosis there was a 
shortage of time and lack of sufficient number of animal availability. Each axolotl can take 
over a month to fully metamorphose. As a consequence, only one animal of each stage was 
used as an example to show the changes that are involved in the VPN neuroanatomy. 
Nevertheless, selection pressure for anatomical structures that are important in survival 
would be very similar within species and so with the axolotls, each developmental stage is 
bound to be highly representative.   
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Figure 6-1. Axolotl habitat setup during metamorphic induction. The tank was lifted so 
that the water would be available only at one end. The slope was gradual so that the 
axolotl could walk out with ease. Cut drain pipes provided cover and the sponge, 
moss and rocks provided different substrates for the axolotl to sit on.  
 
 
 
Figure 6-2. Shedding sheets of skin in the tank during metamorphosis. White strip is 4 
cm long. 
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Figure 6-3. Transition from aquatic to aerial habit. Axolotl coming out of the water for 
the first time on day 9 (A), day 10 (B). On day 13 this axolotl (C) only had some gill 
atrophy and came out of the water for the first time on day 21 (D) post induction. 
Strip of paper is 4 cm long. 
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Figure 6-4. Rebound effect. (A) Axolotl 26 days post induction showing some signs of 
„rebound‟ effect of insufficient hormone. There is a layer of dead cells in the skin 
(arrowheads). (B) Five days after immersion in 20nM hormone solution the skin is 
shiny and smooth, the normal appearance of amphibian skin. Strip of white paper is 
4cm long.  
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Figure 6-5. Aerial metamorphic changes. (A) Two axolotls that are at mid-
metamorphosing stage as indicated by the presence of gill stubs and the preference of 
being out of the water throughout the day. Photograph was taken 14 days post 
induction of metamorphosis. The white strip is 4 cm long. (B) Another mid-
metamorphic stage (see gills), although induction took place 29 days ago. (C) 
Photograph of an almost fully metamorphosed axolotl taking food (beef heart) on 
day 32 post induction. (D) A fully metamorphosed axolotl. Photograph taken on day 
40 post induction. 
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CHAPTER SEVEN 
 
NEUROANATOMY OF VAGAL PREGANGLIONIC NEURONES IN THE  
NEOTENOUS, METAMORPHOSING AND METAMORPHOSED 
AXOLOTL, AMBYSTOMA MEXICANUM.  
 
 
A RETROGRADE STUDY USING FLUORESCENT 
FLUOROGOLD TRACER 
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7.0 INTRODUCTION 
 
This chapter was the study of the neuroanatomical changes that may be associated with the 
transition from gill breathing (neotenous) to obligate lung breathing (metamorphosed) in 
the Mexican axolotls, Ambystoma mexicanum. The dorsal nucleus of the vagus nerve 
(DVN) is located in the medulla oblongata (Chapter 1). The medulla oblongata is known to 
contain centres that deal with autonomic, involuntary functions. For instance, the 
respiratory centre regulates breathing depth and rate by chemosensors, and the cardiac 
centre regulates heart rate through sympathetic and parasympathetic inputs. The nA is in 
the medulla located in a ventral lateral position in mammals and is thought to interact with 
the DVN in regulating cardiorespiratory functions. Indeed it is thought be involved in the 
onset of RSA in humans ((Hou et al., 2009; Taylor, 1994). Activity in these ventrolateral 
vagal motoneurons varies with mode of respiration in fish and mammals. Generally, as 
detailed in Chapters 1 and 6, there appears to be a phylogenetic trend towards an increase 
in the proportion of VPN in the ventrolateral location outside of the DVN (Taylor et al., 
1999) that appears to be associated with increase in reliance of lung breathing. However, 
some variation is sees in the actual proportion found in this ventrolateral area (Taylor et 
al., 2010). Therefore this ventrolateral group may be involved in the transition to lung 
breathing, and it may be a primitive equivalent of the mammalian nA.  
 
VPN in the brain stem of axolotls were labelled with a fluorescent neural tracer. The 
fluorochrome, Fluoro-Gold (FG) (Fluorochrome, Inc., Sigma-Aldrich), whose active agent 
is hydroxystilbamidine methanesulfonate, (Wessendorf, 1991) is a monosynaptic 
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retrograde axonal tracer (Schmued & Fallon, 1986). It has been found to label VPN when 
introduced into an animal by intraperitoneal injection (Leong & Ling, 1990; Cheng et al., 
1997; Cheng & Powley 1999; 2000; Akhavan et al., 2006), since it specifically labels 
preganglionic autonomic and motor neurons in the brain stem. FG does not cross the 
blood-brain barrier and so it only labels the central neurons with peripheral axons. This 
means that no interneurons are labelled in the brain nor spinal cord (Persson & Havton, 
2009). FG appears to be taken up by the peripheral termini during post-synaptic reuptake 
of neurotransmitter (Ambalavanar & Morris, 1989), and is localised within the cell bodies 
and proximal dendrites of labelled neurones (Schmued et al., 1989). More specifically, 
fluorogold is found to accumulate within intracellular lysosomes (Wessendorf, 1991; 
Persson & Havton, 2009) and it also binds to the A–T-rich regions of DNA (Festy & 
Daune, 1973; Festy et al., 1975). When a fluorochrome molecule absorbs light radiation it 
becomes electronically excited and then returns to its original state by emitting radiation at 
almost always a longer wavelength than the excitation wavelength. Using optical filter 
systems the emitted wavelength can be selected by blocking out all other wavelengths. The 
fluorochrome is then seen as bright objects against a black background. FG is excited by 
UV light at <330 nm and <390 nm and has peak emission at <450 nm and <600 nm. The 
effectiveness of the use of FG to label vagal neurons has been demonstrated by Powley et 
al. (1987) and so it was decided to use this retrograde label in the present study owing to 
its simple administration. 
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7.1 AIMS AND OBJECTIVES 
 
The aim of this chapter was to re-examine the findings of the appearance of a ventral 
lateral group of VPN in metamorphosed axolotls (Ihmied, 1989). Unlike the previous 
study, this was done with using a minimally invasive technique of using an intraperitoneal 
injection of a retrograde fluorescent tracer, Fluoro-Gold (FG) that is known to trace vagal 
motoneurons. In the previous study the researcher used HRP which involves finding, 
exposing and then crushing the nerves which is likely to introduce more errors than this, 
more refined, method. In addition, the previous study did not study the VPN in mid-
metamorphosing axolotls, so this was novel.  
 
This chapter links with the hypothesis that the ventrolateral relocation of VPN relates to 
the onset of HRV in the obligate lung breather. Therefore, the first aim of Part II of the 
thesis was to establish that there are neuroanatomical changes in the DVN and surrounding 
areas pre-, during, and post-metamorphosis.  
 
Therefore the objectives this Chapter were:  
 To examine the neuroanatomy of VPN in the medulla oblongata in the neotenous, 
metamorphosing and metamorphosed forms. This was achieved by collecting the 
medulla oblongata‟s at the appropriate stages and processing them for frozen 
sectioning. The sections were viewed using a fluorescence microscope to make cell 
counts rostral and caudal of obex, where the DVN is known to be located.    
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7.2 METHODS 
 
For retrograde labelling of VPN fluorogold was dissolved in distilled water to give 3 
mg/ml concentration according to established protocols (Cheng et al., 1997; 1999; 2000) 
and kept at 4°C until use and re-use after mixing. The axolotls (A. mexicanum) were held 
in position and a volume of 3.3 µl per gram axolotl weight of the concentrate was 
administered (since Cheng et al. (1999) used 1 ml per 300g rat) intraperitoneally. The 
angle of the needle was perpendicular to the skin surface and the needle was held in 
position for a few seconds after administration of the fluorogold. When the needle was 
drawn out gentle pressure was applied to the injection site to prevent leaking. The axolotls 
were then returned to their developmental stage specific habitat and treated normally for 
10-12 days before collection of neotenous, metamorphosing and metamorphosed stages. 
The animals behaved completely normally after the FG injection. 
 
7.2a Perfusion system 
After the required survival time the axolotls were deeply anaesthetised with 0.2% solution 
of buffered (NaHCO3) tricaine methane sulphonate (MS222) and transferred to an 
operating dish. Note that the metamorphosing and metamorphosed axolotls were placed in 
a small plastic chamber (volume 500 ml) with their head raised out of the anaesthetic 
solution to prevent possible drowning (Figure 7-0(A)). The axolotls remained in some 
MS222 solution whilst perfusion took place. An incision was made in the chest area to 
reveal the sacral plates which were carefully pinned back to expose the chest cavity. The 
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pericardial membrane was cut open to expose the beating heart. A polyethylene tubing 
(PE10 Intramedic) cannula was gently placed into the truncus arteriosus by puncturing 
obliquely as shown in Figure 7-0(B). The animals were then perfused with frog saline 
(firstly each chemical was made to a [1M] and then the following volumes were used to 
make up to 1L with distilled water; NaCl, 115 ml; KCl, 3.2 ml; NaHCO3, 2.4 ml; CaCl2, 
2.7 ml) containing 0.3% heparin for approximately 30 minutes to flush out the red blood 
cells and then, once the perfusate was running clear, the fixative was perfused through the 
animal (10% neutral buffered formaldehyde, Surgipath, Europe) for 1 hour (see Figure 7-
0(C)). 
 
The brain and some of the spinal cord was dissected out carefully (Figure 7-0.1(A)) and 
post fixed for up to 8 hours at 4°C in 20-30 ml of the same fixative used for perfusion, with 
a change of solution half way. The sample was washed with buffer and placed in 10% 
sucrose phosphate buffer (to cryoprotect) at 4°C overnight with one change during this 
time. The following day the portion of interest (Figure 7-0.1(B)) was transferred to 
embedding media (OCT), with orientation noted on the foil box container, and then gently 
lowered into liquid nitrogen. The sample was stored at –70°C until ready for sectioning. 
 
7.2b Sectioning and mounting 
 
Sections were cut at a thickness of 20 µm using a –20°C cryostat with a fixed, regularly 
sharpened blade, mounted onto Superfrost glass slides (Surgipath) and were left at room 
temperature to air dry overnight. The flowing day the slides were placed in phosphate 
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buffered saline for 10-15 mins to wash out the embedding media and then dehydrated 
through a graduated series of alcohols (ethanol) (30%, 50%, 70%, 95%, 2 x 100%) for 2 
mins each and finally cleared in xylene twice for 5 mins each. The slides were dried in air 
briefly, then mounted with Fluoromount (BDH) and coverslipped. These were left over 
night at room temp in the dark.  
 
The sections were viewed using a photomicroscope with ultraviolet epi-illumination at a 
wavelength of 365 nm that caused labelled cells to fluoresce, emitting light at a wavelength 
of 420 nm. Digital images of the fluorescing cells were captured using an image analysing 
system (Quips Pathvision package, Apple Mac). Once the obex was located, cell body 
counts were made using sections that were 60 µm apart, both in a caudal and rostral 
direction from the obex.   
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Figure 7-0 (A) Mid-metamorphic stage axolotl being anaesthetised in MS222. A pile 
of absorbent towels act as a head rest to ensure airways are out of the solution and so 
prevent possible drowning. There is sufficient anaesthetic traversing the relatively 
permeable amphibian skin to induce sleep, although this took longer in 
metamorphosing and metamorphosed axolotls than in the neotenous. (B) 
Cannulation of the truncus arteriosus. The end of the cannula was cut obliquely 
and 4-5 mm was eased into the vessel in a rostral direction and then held in place by 
suturing. A small incision was made in the auricle to allow the blood and perfusate to 
flow out. Note that the ventricle is deplete of red blood cells due to perfusion and the 
thickness of the ventricular tissue is relatively thin, hence the „white‟ appearance.  
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Figure 7-0 (C) Arrangement of the perfusion system.   
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Figure 7-0.1 (A) Dorsal surface of the axolotl (A. mexicanum) brain. The choroid 
plexus of the fourth ventricle has been removed 
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Figure 7-0.1 (B) Section of brain embedded for neuroanatomical studies. 
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7.3 RESULTS  
 
The medulla oblongata of neotenous, metamorphosing and metamorphosed axolotls was 
processed, sectioned and viewed as described in the methods. When view the obex was 
located first and then the sections used for cell counts were 60 µm apart (every third 
section as they were 20 µm thick). Counts were made in both a rostral and caudal direction 
relative to the obex. VPN cell bodies that were labelled with the FG retrograde tracer were 
counted using and fluorescence microscope. The total number of VPN‟s found in the 
dorsal medial area (where the DVN would be) were: 
Neotenous (n=1)  647 
Metamorphosing (n=1)  633 
Metamorphosed (n=1)  488 
In the neotenous axolotl the vagal preganglionic neurones (VPN) spanned an area from 1.5 
mm caudal to obex, to just over 4mm rostrally. That‟s a span of 5.5 mm. The majority of 
the VPN were distributed around obex to 3 mm rostral, but the largest group was found at 
around 4 mm rostral from obex (Figure 7-1(A)). The metamorphosing axolotl had slightly 
less VPN in the medial region, but still showed a concentrated area at 4mm rostral of obex. 
There were more cells in 1-2 mm rostral to obex range in comparison to the neotenous 
(Figure 7-1(B)). The metamorphosed axolotl had the least number of VPN in this region, 
but the distribution was essentially very similar to that of the metamorphosing (Figure 7-
1(C)). The number of VPN in the ventrolateral area for each type of axolotl was:  
Neotenous  0 
Metamorphosing 97 
Metamorphosed 109 
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In the ventrolateral zone there were no VPN in the neotenous axolotl, and around a 
hundred in both metamorphosing and metamorphosed. The VPN in these axolotls were 
generally distributed around 2.0 – 3.5 mm rostrally from obex (Figure 7-1(D) and (E)). In 
addition to these fluorogold stained cells the mid-metamorphic axolotl had 40 VPN in an 
area that was intermediate between the medial and lateral regions of the hind brain (Figure 
7-1(F)). 
 
Total number of VPN in the medulla were:  
Medial:- 
Rostral of Obex 
Neotenous: 583   Metamorphosing: 563     Metamorphosed: 415 
Caudal of Obex 
Neotenous: 64    Metamorphosing: 54      Metamorphosed: 74 
Total medial 
Neotenous:  647 Metamorphosing: 617 Metamorphosed: 489 
 
Lateral:- 
Rostral of Obex 
Neotenous: 0      Metamorphosing: 83      Metamorphosed: 89 
Caudal of Obex 
Neotenous: 0      Metamorphosing: 14        Metamorphosed: 20 
Total lateral 
Neotenous:  0  Metamorphosing: 97 Metamorphosed: 109 
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The topographical organisation of the VPN in the hind brains of neotenous, 
metamorphosing and metamorphosed axolotl was graphed in Figure 7-2.  
 
Digital microscopic images of the VPN in the specific regions graphed in Figure 7-2 were 
taken. Figures 7-3.0 to 7-3.6 show some of the fluorescing cells in the neotenous axolotl. 
Discrete fluorescing groups were observed in the dorsal medial region. There were mainly 
undifferentiated neurones in the central grey area that appeared as spherical bodies. More 
mature cells, as recognised by having dendrites, were closer to the periventricular area, (the 
area adjacent to the white matter) than the fourth ventricle (see Figure 7-3.1 for example). 
The VPN images of the metamorphosing axolotl are shown in Figures 7-4.0 to 7-4.7. The 
hind brain sections appear to show a lateral group forming and some migrating cells 
(Figures 7-4.1, 7-4.2 and 7-4.4). Some were found in an area between the medial and 
lateral groups (Figures 7-4.4, 7-4.5 and 7-4.7). Figures 7-5.0 to 7-5.8 show the VPN of the 
metamorphosed hind brain. The cell bodies in this axolotl were relatively large in 
comparison to the neotenous sections (for example, Figure 7-5.2). VPN had migrated into 
the white matter creating at a new ventrolateral location in the metamorphosed axolotls 
(Figures 7-5.3 – 7-5.5, and 7-5.8).  
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7.4 DISCUSSION 
 
The preganglionic vagal neurones (VPN) in the neotenous medulla oblongata were round, 
quite small at 15 – 20 µm diameter and apparently undifferentiated (Figures 7-3.0 – 7-3.6).  
As fluorogold causes the cell bodies of VPN and particularly their nuclei (Festy & Daune, 
1973; Festy et al., 1975) to fluoresce brightly, but does not label other features of the 
neurons, such as distant axons and dendrites (Schmued et al., 1989), this may reflect 
limitations on the labelling of cell structures by the neural tracer. However, it could also 
indicate that the neurons are relatively undifferentiated in the neotenous brain. This is not 
that surprising as they are neotenic, hence, large, although sexually mature, tadpoles.  
 
The metamorphosed brain had more differentiated cells (Figures 7-5.0 – 7-5.8) and, as can 
be seen, they tended to be much larger, at around 40 µm diameter, than those in the 
neotenous. The VPN in the metamorphosed medulla also appeared to be differentiated, 
having definable proximal dendrites and axons and the classic stellate shape (Figures 7-5.5 
and 7-5.8, for example).  
 
The neotenous axolotls had distinct clusters of VPN as seen in the digital micrographs. The 
metamorphosing and metamorphosed sections showed VPN clustered in the dorsal vagal 
motonucleus (DVN) region, in a ventrolateral position and some in the area between the 
two. Intriguingly, the metamorphosed and the metamorphosing axolotls had some 
migrating cells which were described as such owing to their torpedo-like morphology 
(Figure 7-5.1). These migrating cells were orientated in a ventro-lateral position, 
suggesting that they were relocating to that position. The cells in the intermediate location 
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may suggest migration. Although in the mammalian brain stem there are VPN in the 
reticular formation, between the DVN and nA (Ranson et al., 1993). However, if they were 
transitioning from the grey matter area (near the fourth ventricle or the periventricular 
area) then their presence in the intermediate zone would be logical. Indeed, others have 
found evidence of VPN migrating from DVN to a ventrolateral position during brain 
development in humans (Brown, 1990) and cats (Windle (1933) in Bennett et al., 1981). 
Curiously the metamorphosing axolotl in Figure 7-4.3 had cells that appeared to be 
dividing. Fluorogold is known to stain intracellular lysosome in intact cells (Wessendorf, 
1991; Persson & Havton, 2009) and also bind to DNA (Festy & Daune, 1973; Festy et al., 
1975). The staining in the micrograph is strongest at opposite poles of the enlarged VPN, 
suggesting imminent cytokinesis. However, the use of a mitotic marker would be required 
to definitively know if the neuronal blast cells seen in the central grey just migrate to the 
periventricular (and eventually the white matter) or if the migrate and then also divide. 
 
The number of cells in the medial region of neotenous, metamorphosing and 
metamorphosed axolotl hind brains gradually decreased in number, whereas those in the 
lateral region progressively increased in number. This, along with the digital images, 
strongly suggests cells are migrating from a dorsal-medial region to a ventrolateral area. 
The total number of cells found in the metamorphosed axolotl was 597, of which 109 were 
located in the ventrolateral area (the rest in the DVN). Consequently, 18% of all VPN were 
in the new ventrolateral position. This figure is slightly higher than one already published 
of 14% for axolotls (Ihmied, 1989). However, this author used the horseradish peroxidase 
(HRP), a retrograde intra-axonal neural tracer, which requires manual nerve damage for the 
tracer to be taken up. Damaged axons could theoretically take less HRP up as they could 
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be crushed too much, or the HRP may not be taken up due to insufficient number of 
damaged axons. Hence, this would potentially result in some variability. There would be 
more reliability with using the fluorescent retrograde tracer Fluorogold as it labels all VPN 
without the need for any damage to the nerves nor invasive surgery on the animal. Thus 
fluorogold labelling, via injection after which the animals can be left to behave normally 
for at least a week, is a much better option for tracing VPN.  
 
In the periventricular area of both the metamorphosing and the metamorphosed axolotl 
there was clear evidence of differentiating cells that were totally absent in the neotenous. 
Therefore, during the transition from gill to lung breathing, the brain does appear to 
undergo changes in the DVN and surrounding regions. It is known that the DVN and 
surrounding area, in particular the ventrolateral area, is involved in cardiorespiratory 
control and that in mammals the ventrolateral VPN cluster, designated the nucleus 
ambiguus (nA), contains predominantly cardiac VPN (Bennett et al., 1981; Taylor et al., 
1999). Hence the relocation of the DVN cells to a more ventrolateral area could suggest 
that the metamorphosed axolotls possess a primitive nA. The nA in humans generates 
rhythmic sinus arrhythmia, that is an increase in heart rate upon inspiration (Hyndman et 
al., 1971). This is caused by a temporary reduction in vagal tone which slows the heart 
(McDonald (1980) in Taylor, 1994; Taylor et al., 1999). It would be most interesting to 
find out if the metamorphosed axolotl displays heart rate variability too which could 
suggest that the migration of VPN to a ventrolateral position has a functional role in a 
committed lung breather.  Therefore, the ventrolateral VPN cluster may be involved in 
cardiorespiratory control. This was investigated in Chapter 8.  
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Figure 7-1. The distribution of cell bodies of vagal preganglionic neurones in the hind 
brain of the axolotl. Neurones were stained with Fluorogold. 
 
(A)   
(B)   
(C)   
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Figure 7-1. The distribution of cell bodies of vagal preganglionic neurones in the hind 
brain of the axolotl (continued). Neurones were stained with Fluorogold. 
 
(D)   
(E)   
(F)   
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Figure 7-2. (A) Diagram of the neotenous axolotl medulla oblongata. The 
topographical reconstruction of the whole vagus motor column as indicated by 
Fluorogold labelled cell body counts. Positions were determined by relative distance 
from the obex.  
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Figure 7-2. (B) Diagram of the metamorphosing axolotl medulla oblongata. The 
topographical reconstruction of the whole vagus motor column as indicated by 
Fluorogold labelled cell body counts. Positions were determined by relative distance 
from the obex.  
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Figure 7-2. (C) Diagram of the metamorphosed axolotl medulla oblongata. The 
topographical reconstruction of the whole vagus motor column as indicated by 
Fluorogold labelled cell body counts. Positions were determined by relative distance 
from the obex.  
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Figure 7-3.0 Neotenous axolotl medulla oblongata. Blue arrows correspond to the 
location of the Fluorogold images on the following pages.  
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Figure 7-3.1 Micrographs of transverse 20 µm sections of neotenous axolotl medulla 
oblongata showing a medial group of vagal preganglionic neurons labelled with 
fluorescent tracer Fluorogold.  
 
 
  
(a) – Grey matter to right of orange line; white matter to the left.  
Bar = 30 µm. FV = fourth ventricle.  
 
(b) – Image (a) at a higher magnification.  
Bar = 20 µm  
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Figure 7-3.2 Photomicrograph of transverse 20 µm sections of neotenous axolotl medulla 
oblongata showing a medial group of preganglionic motoneurones labelled with 
Fluorogold.  
 
 
Grey matter to right of orange line; white matter to the left.  
Bar = 30 µm. FV = fourth ventricle.  
 
  
FV  
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Figure 7-3.3 Micrograph of transverse 20 µm sections of neotenous axolotl hind brain 
showing a medial group of preganglionic neurons with fluorescent tracer Fluorogold.  
 
 
Grey matter to right of orange line; white matter to the left.  
Bar = 30 µm. FV = fourth ventricle.  
  
FV  
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Figure 7-3.4 Micrographs of transverse 20 µm sections of neotenous axolotl medulla 
showing a medial group of vagal preganglionic neurons with fluorescent tracer Fluorogold.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) – Grey matter to left of orange line; white matter to the right.  
Bar = 20 µm. FV = fourth ventricle.  
 
(b) – Image (a) at a higher magnification.  
Bar = 20 µm  
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Figure 7-3.5 Micrographs of transverse 20 µm sections of unmetamorphosed axolotl 
medulla showing vagal preganglionic motoneurones labelled with retrograde fluorescent 
tracer Fluorogold. 
 
 
 
(a) – Grey matter to left of orange line; white matter to the right.  
Bar = 30 µm. FV = fourth ventricle.  
 
(b) – Image (a) at a higher magnification.  
Bar = 10 µm  
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Figure 7-3.6 Micrograph of transverse 20 µm sections of neotenous axolotl medulla 
oblongata showing a medial group of preganglionic neurons labelled with fluorescent 
tracer Fluorogold.  
 
  
 
Grey matter to right of orange line; white matter to the left.  
Bar = 30 µm. FV = fourth ventricle.  
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Figure 7-4.0 Mid-metamorphosed axolotl medulla oblongata. Blue arrows correspond 
to the location of the Fluorogold images on the following pages.  
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Figure 7-4.1 Photomicrograph of transverse 20 µm sections of mid-metamorphosed 
axolotl medulla oblongata showing vagal preganglionic motoneurones labelled with 
fluorescent tracer Fluorogold.  
 
 
 
Section shows the shape of cell bodies that appear to be migrating to a ventrolateral 
location (L). The migrating cells are larger than those in the medial area. Grey 
matter is to the right of the orange line and white matter towards the left.  
Bar = 60 µm. L = lateral group. M = medial group. FV = fourth ventricle.  
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Figure 7-4.2 Micrograph of transverse 20 µm sections of mid-metamorphosed axolotl 
medulla showing preganglionic motoneurones labelled with retrograde fluorescent tracer 
Fluorogold.  
 
 
 
Section shows the shape of cell bodies that appear to be migrating to a ventrolateral 
location (L). The migrating cells and some in the medial area are larger than those 
found in the neotenous axolotl. Grey matter to the top of the orange line; white 
matter towards the bottom.  
 
Bar = 40 µm. L = lateral group. P = periventricular group. M= medial group. FV = 
fourth ventricle.  
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Figure 7-4.3 Micrograph of transverse 20 µm sections of mid-metamorphosed axolotl 
medulla oblongata showing vagal preganglionic motoneurones labelled with fluorescent 
tracer Fluorogold.  
 
 
 
A medial group of neurones showing some cells that are larger than those found in the grey 
matter of the neotenous axolotl (blue arrowheads). Some cells may be dividing as 
suggested by Fluorogold DNA staining which shows intensity at polar ends of the 
enlarged cells (white arrowheads). Grey matter to the top of the orange line; white 
matter towards the bottom.  
 
Bar = 30 µm. FV = fourth ventricle.  
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Figure 7-4.4 Micrograph of transverse 20 µm sections of mid-metamorphosed axolotl 
medulla showing preganglionic motoneurones labelled with fluorescent tracer Fluorogold. 
 
 
 
(a) – Large migrating neuron in the periventricular white matter area (blue arrowhead). 
There is a clump of cells which are larger than the rest in the medial area 
(parenthesis).  
Bar = 40 µm. FV = fourth ventricle.  
 
(b) – Image (a) at a higher magnification. Bar = 20 µm   
a   
b   
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FV  
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Figure 7-4.5 Micrograph of transverse 20 µm sections of mid-metamorphosed axolotl 
medulla oblongata showing vagal preganglionic motoneurones labelled with fluorescent 
tracer Fluorogold.  
 
 
A medial group of motoneurones that are larger than those found in the neotenous axolotl 
medial zone. One cell is just on the outside of the periventricular area which 
appears to be migrating towards the white matter (blue arrowhead). Grey matter 
above the orange line. 
 
Bar = 40 µm. FV = fourth ventricle.  
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Figure 7-4.6 Micrograph of transverse 20 µm sections of mid-metamorphosed axolotl 
medulla showing preganglionic motoneurones labelled with fluorescent tracer Fluorogold. 
 
 
 
(a) – A medial group of vagal preganglionic motoneurones. Some are large, unlike those 
found in the neotenous axolotl medulla.  
Bar = 70 µm. FV = fourth ventricle.  
 
(b) – Image (a) at a higher magnification. Primary dendrites are labelled with the tracer 
(blue arrowheads). Bar = 35 µm   
FV  
FV  
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Figure 7-4.7 Micrograph of transverse 20 µm sections of mid-metamorphosed axolotl 
medulla showing preganglionic motoneurones labelled with fluorescent tracer Fluorogold.  
 
 
(a) – On the border of the grey matter and periventricular white matter there is a medial 
group of neurones which appear to be differentiating owing to their large size and 
dendrites (parenthesis).  
Bar = 40 µm. FV = fourth ventricle. 
 
  
 
(b) – Image (a) at a higher magnification. Primary dendrites are labelled with the tracer 
(blue arrowheads) and the cell bodies are large (white arrowheads). Bar = 40 µm  
  
b   
a   
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Figure 7-5.0 Metamorphosed axolotl medulla oblongata. Blue arrows correspond to the 
location of the Fluorogold images on the following pages.  
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Figure 7-5.1 Micrograph of transverse 20 µm section of metamorphosed axolotl medulla 
oblongata showing vagal preganglionic motoneurones labelled with the fluorescent tracer, 
Fluorogold. 
 
 
Section showing a group of relatively enlarged cells in the medial area (M) and a migrating 
neuron with long dendrites (blue arrowhead) projecting ventrolaterally (L). Grey 
matter on the right of the orange line.  
 
Bar = 40 µm. FV = fourth ventricle.  
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Figure 7-5.2 Micrograph of transverse 20 µm section of metamorphosed axolotl medulla 
showing preganglionic neurones labelled with Fluorogold. 
 
 
A group of enlarged neurones within the medial area. Grey matter on the right of the 
orange line.  
 
Bar = 60 µm. FV = fourth ventricle.  
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Figure 7-5.3 Micrograph of transverse 20 µm section of metamorphosed axolotl hind brain 
showing preganglionic neurones labelled with Fluorogold. 
 
 
Image shows a group of enlarged migrating vagal preganglionic motoneurones within the 
lateral area (L). Grey matter on the top right of the orange line.  
 
Bar = 70 µm. M = medial. FV = fourth ventricle.  
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Figure 7-5.4 Micrograph of transverse 20 µm section of metamorphosed axolotl hind brain 
showing preganglionic neurones labelled with Fluorogold. 
 
 
 
Image shows a group of vagal preganglionic motoneurones in two distinct groups: the 
lateral group on the left of the orange line (L) and the medial group on the right of 
the orange line (M), part of the grey matter  
 
Bar = 30 µm.  
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Figure 7-5.5 Micrograph of transverse 20 µm section of metamorphosed axolotl medulla 
showing preganglionic neurones labelled with Fluorogold. 
 
 
(a) – Section showing a group of neurones in the medial area (M), a motoneurone that is 
relatively large (white arrowhead) in the periventricular area, and a vagal 
preganglionic neurone in the lateral area (L). Grey matter to left of orange line; 
white matter to the right.  
Bar = 60 µm. FV = fourth ventricle.  
 
(b) – Image (a) at a higher magnification, showing the migrating neurone (white 
arrowhead) and dendrites on other cells that are relatively large and appear to be 
migrating and / or projecting ventrolaterally. 
Bar = 30 µm  
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Figure 7-5.6 Micrograph of transverse 20 µm section of metamorphosed axolotl medulla 
showing preganglionic neurones labelled with Fluorogold. 
 
 
 
Image shows a group of medial motoneurones. In the vicinity of the periventricular area 
(P) there are a few neurones that are enlarged and appear to be migrating (white 
arrowheads). The grey matter is on the left hand side of the orange dotted line. 
 
Bar = 45 µm. FV = fourth ventricle. M = medial. L = lateral.  
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Figure 7-5.7 Micrograph of transverse 20 µm section of metamorphosed axolotl medulla 
showing preganglionic neurones labelled with Fluorogold. 
 
 
 
Section shows the medial group of neurons on both sides of the fourth ventricle. These 
cells are in the vicinity of the periventricular white matter.  
 
Bar = 60 µm. FV = fourth ventricle. M = medial. L = lateral.  
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Figure 7-5.8 Micrograph of transverse 20 µm section of metamorphosed axolotl medulla 
oblongata/upper spinal cord junction showing vagal preganglionic motoneurones labelled 
with the retrograde tracer, Fluorogold. 
 
 
 
Section shows neurons in the medial area that appear to be migrating laterally (white 
arrowheads). These migrating cells have clear primary dendrites (blue arrowheads). 
The relatively large, migrating cells are in the vicinity of the periventricular white 
matter. The contrast and brightness of the image has been set to allow visualisation 
of tissue morphology to aid orientation. 
 
Bar = 60 µm. M = medial. L = lateral.  
 
 
  
L  
M  
II. Neuroanatomy and Physiology of Cardiorespiratory Control  
 
204 
 
CHAPTER EIGHT 
 
CARDIORESPIRATORY PHYSIOLOGY OF THE  
NEOTENOUS AND METAMORPHOSED AXOLOTL, 
AMBYSTOMA MEXICANUM 
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8.0 INTRODUCTION  
This chapter was the study of the changes that may be associated with metamorphosis. The 
neotenous axolotl is a gill breather, but when it is induced to metamorphose by 
introduction thyroid hormone (Chapter 6), it becomes a committed lung breather. It is 
thought that after the axolotl has metamorphosed, the relocation of VPN to a more 
ventrolateral location of the DVN (Chapter 7) may be linked with the onset of HRV. 
Activity in subpopulations of cardiac vagal motoneurons vary with mode of respiration in 
fish and mammals. Therefore this new ventrolateral location may be a primitive equivalent 
of the nA region in the mammalian brain which is known to be involved in the onset of 
RSA in humans (Hou et al., 2009; Taylor, 1994). In humans, heart rate increases with 
inspiration and decreases when exhalation occurs. This is caused by inhibitory signals to 
the nA which prevents the vagal nerve from being stimulated. Normally the vagal nerve 
exerts an inhibitory effect on the heart rate by increasing parasympathetic input to heart, 
which decreases the rate of SA node firing. When expiration occurs the cells in the nA are 
activated which cause the heart rate to fall.  
 
The use of drugs to block either parasympathetic or sympathetic control can give an 
indication of the influence of these autonomic branches upon the heart. For instance, 
atropine, a competitive antagonist for the muscarinic acetylcholine receptor, will block 
parasympathetic vagal influence, whose normal effect is to slow heart rate. Propranolol is a 
non-selective beta blocker and so blocks the effects of the sympathetic system, whose 
actions are normally to increase heart rate. Thus the effect of drug intervention will provide 
clues to the extent of cholinergic and adrenergic control of the heart rate.  
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HRV can be seen on an ECG trace as the RR-intervals, of the PQRST wave (see diagram 
below), will be of different lengths and they would to be related to the ventilation cycle if 
there is cardio-respiratory coupling. Therefore, the relocation of VPN to a ventrolateral 
position may cause physiological changes in heart rate which could be evidence for 
autonomic change. 
P wave represents the wave of depolarisation that spreads from 
the SA node throughout the atria. This is followed by a brief 
isoelectric period which represents the time in which the impulse 
is travelling within the AV node and the bundle of His. The QRS 
complex represents ventricular depolarisation. The isoelectric 
period following the QRS is the time at which the entire ventricle 
is depolarised. The T wave represents ventricular repolarisation.  
 
8.1 AIMS AND OBJECTIVES 
The aim of this chapter was describe the cardiac and ventilatory changes associated with 
the transition from neotenous to metamorphosed axolotl (A. mexicanum).  This was 
achieved by inserting electrodes to record ECGs, and recording ventilation rates and 
patterns of the neotenous and metamorphosed axolotls. Parasympathetic and sympathetic 
blockade was used to show the relative influence of these on heart and ventilation rates. 
Therefore the objectives of Chapter 8 were:  
 To record heart and ventilation rates / patterns in the neotenous and metamorphosed 
axolotls and then to determine if there is evidence of HRV in the latter forms 
Chapter 8).  
 To investigate the relative control of the heart rate in the neotenous and the 
metamorphosed axolotls by the sympathetic and parasympathetic branches of the 
autonomic system by injecting propranolol and atropine, respectively.  
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8.2 METHODS 
The heart and ventilation rates were recorded for neotenous and metamorphosed axolotls. 
Firstly they were anaesthetised in 0.1% solution of buffered (NaHCO3) tricaine methane 
sulphonate (MS222) before being transferred to an operating table. To anaesthetise, 
metamorphosed axolotls were placed in a 500 ml plastic chamber with their heads raised 
above the anaesthetic solution as described in Chapter 7. The neotenous forms were left 
submerged in the solution. Throughout the surgical procedure the neotenous axolotls 
remained in contact with MS222 solution by way of gill irrigation, whereas the 
metamorphosed axolotls were laid in a shallow depth of the solution to facilitate dermal 
diffusion. In both cases this ensured the animals were under anaesthetic throughout the 
operation.  
 
8.2a Surgery 
Once the axolotls were fully anaesthetised, determined by loss of righting reflex, 2 
electrodes were inserted to read heart rate. These copper wire electrodes (0.5 mm) were 
made in advance: One end was soldered onto 1.5 mm
2
 silver plated crimp contacts (RS 
Components Ltd) and insulation at the tip of the other end was stripped away over 
approximately 2 mm to make a good contact surface to pick up the electrocardiogram 
(ECG) signal. The exposed end was inserted into the tip of a hypodermic needle (23G x 
1.25″) for 3-4 mm (stripped portion inclusive) then carefully folded back ensuring that the 
point of the needle was clear. Each hypodermic needle was then gently inserted 
subdermally into the chest area on the ventral side of the animal close to the axis of the 
forelimb. The electrode was twisted to make a loop around itself to prevent tugging and 
then sutured onto the skin securely. The needle was carefully pulled away, thus leaving the 
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implanted electrode in place. This was done for both the right and left sides of the chest 
(Figure 8-0(A)). The ECG electrodes were then wrapped over and either sutured into place 
on the dorsal side of the neotenous axolotl (Figure 8-0(B)) or taped in place in the case of 
the metamorphosed form (Figure 8-0(C)). Following surgery the neotenous axolotls were 
placed in small plastic chamber (volume 500ml) with a flow of dechlorinated aerated tap 
water and the metamorphosed in a shallow dish of water, ensuring airways were above the 
water line by placement of paper towels, until awake. All axolotls recovered within 2 hours 
of anaesthetisation and began normal swimming/walking and breathing movements. They 
were then transferred back to their appropriate habitat and allowed to recover from the 
anaesthetic for an hour before baseline ECG recordings were taken (mainly to check 
electrode conduction efficacy). Recovery was checked by eliciting an overt response to the 
animal to stretching its toes. Complete recovery over at least 24 hours was allowed before 
pharmacological intervention.  
 
8.2b Experimental protocol  
The following day the ECG leads were connected to record heart rates. The system 
employed was the Neurolog System 1401 (Digitimer) which had the AC NL105 amplifier 
and filters. The voltage fluctuations were pre-amplified by an Isleworth A101 Preamplifier. 
The Neurolog system was connected to a Viglen Genie PCI 4DX266 computer, and heart 
rate data was captured and displayed using either the processing Spike2 software (via 
CED1401 Intelligent Interface (Cambridge Electronics Design) hardware) or ChartLab 
software (ADInstruments), when using AD Instruments PowerLab system. Typically, raw 
data was sampled continuously at 100 Hertz for as long as possible when the animals were 
still to achieve clear ECG traces. The raw data was displayed continually in real time and 
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simultaneously stored to hard disk. Ventilation rates were visually observed over 20 
minute window frames during the ECG sampling period and were digitally marked onto 
the ECG trace by manually pressing a key on the keyboard. 
 
The heart rate is controlled by vagal cholinergic inhibitory signals and sympathetic 
adrenergic excitatory nerves. Inhibitory signals cause bradycardia, and excitatory signals 
cause tachycardia. Acetylcholine is the primary neurotransmitter of the vagus nerve, and 
atropine opposes the effect of acetylcholine by blocking the muscarinic cholinoceptors on 
the heart. Thus atropine was introduced via intraperitoneal injection (1 mg kg
-1
) to detect 
changes in heart rate. An hour later the axolotls were injected with propranolol (at 0.1 mg 
kg
-1), a catecholamine receptor antagonist. It acts by blocking the β-adrenergic receptors of 
the CV system, thereby abolishing the excitatory effect of the catecholamine 
noradrenaline. Heart and ventilation rate were measured before, at and after the injection of 
drugs, in both neotenous and metamorphosed axolotls. 
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Figure 8-0 Electrode placement. (A) ECG electrodes looped and sutured in place. The 
electrodes were secured by suturing on the dorsal ridge (B) or with insulation tape 
(C) depending on axolotl form. 
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8.3 RESULTS 
 
8.3a Neotenous axolotl 
The neotenous axolotls display rhythmic ventilation and surfacing behaviour. Ventilation 
was noted by gill twitching under the water surface and taking breaths at the surface before 
submerging again. Figure 8-1 shows the ECG picking up the buccopharyngeal movements 
of a neotenous axolotl at rest. The interval between surface breaths was 20.0 ± 2.5 min, 
thus there were 3 to 4 surface breaths taken per hour. The gill twitch frequency was, on 
average, 17 ± 7 beats per minute (bpm). In general it was observed that the rate and 
intensity of gill twitching gradually increased to culminate in a surface breath. This was 
followed by an immediate bout of slower gill twitches in the water followed by a period of 
slight gill twitch movements or complete stillness before a gradual increase in the rate and 
intensity of gill twitches, to commence the cycle again (for example, see Figure 8-4(C)). 
The heart and ventilation rates appear to be synchronous, and the heart rate did not show 
variability around a gill twitch (Figure 8-2), nor after a surface breath as the R-R intervals 
of the „PQRST‟ ECG wave remained the same (Figure 8-3). 
 
There was a marked increase in both heart and gill twitch rate post atropine injection. For 
example, the heart rate more than doubled, from 16 bpm (Figure 8-3(B)), to 54 bpm 
(Figure 8-4). The gill ventilation went up by 7 bpm to 18, as also shown in Figure 8-4. In 
all neotenous cases the effect of the atropine took place within 2 minutes of the injection as 
indicated by a rise in resting heart rate, reaching the maximum number of bpm in 18.75 ± 
2.39 mins (mean ±SE). An hour later the mean heart rate did not return to resting level of 
16 bpm, and was at 39 ± 2.93 beats min
-1
.  
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After one hour of being injected with atropine the axolotls were injected with propranolol. 
This resulted in an apparent decrease in heart rate and gill ventilation rate, when compared 
to atropine (Figure 8-5). After 1.5 to 2 hours heart rate returned to that of resting rate, but 
gill ventilation and air breaths varied from some demonstrating an increase in air breaths, 
some just an increase in gill ventilation and some showed no change in gill ventilation. 
However, the rhythm of a gradual beat frequency increase before an air breath, followed by 
a gradual decrease before increase, remained. Axolotls injected with saline did not display 
any changes in heart and ventilation rates. 
 
8.3b Metamorphosed axolotl 
The metamorphosed axolotl ventilation rate was recognised as a deeper breath intake by 
lowering of the buccal cavity lower and for a slightly longer period of time than when 
making regular buccal movements. These generally occurred at around 2 minute intervals 
(Figure 8-6). They displayed irregular heartbeats when compared with the neotenous 
forms. There were cyclic rhythms of bradycardia followed by tachycardia as indicated by 
the R-R interval (Figure 8-7).  
 
Atropine increased the heart rate and eliminated bradycardia. The maximum mean heart 
rate was achieved in 3.2 minutes  ± 0.58 (SE) after which it took 16.67 ± 2.58 minutes 
(mean ± SE) for heart rate to reach normal resting rate. Figure 8-8 shows the effects of 
atropine on the heart rate of a metamorphosed axolotl. 
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Propranolol reduced the heart rate over time. The first reduction occurred within 6.5 ± 0.5 
minutes post injection. The mean time (±SE) to reach heart rates lower than those recorded 
for resting rate was 28.4 ± 13.12 minutes and they remained at this level for at least an 
hour. Figure 8-9 show the effects of propranolol on the ECG trace of a metamorphosed 
axolotl.  
 
The effect of these drugs on ventilation was conflicting. Some axolotls displayed an 
increase in ventilation, whereas others displayed a reduction. Therefore there was not clear 
pattern with either of the drugs. The metamorphosed axolotl used in Figures 8-8 and 8-9 
demonstrated an initial reduction in ventilation rate from 30 to 18 and then an increase to 
48 ventilations per hour following atropine injection. Propranolol elicited an increase in 
ventilation rate, but this was not an immediate response. Metamorphosed axolotls 
displayed no changes in heart and ventilation rate when injected with saline. 
 
The same axolotl continued to display heart rate variability 8 days post-surgical 
implantation of electrodes. Ventilation resulted in immediate bradycardia, followed by 
tachycardia in an oscillatory fashion (Figure 8-10). 
 
8.3c Comparisons of neotenous and metamorphosed axolotls 
The heart rate for the neotenous was lower than that of the metamorphosed. The mean 
neotenous heart rate was 27.20 and metamorphosed was 34.47 bpm (Figure 8-11). The 
neotenous heart beats show an oscillatory pattern which was not as pronounced in the 
metamorphosed (Figure 8-12).  
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The neotenous and metamorphosed axolotls demonstrated the same response to atropine 
and propranolol but there were differences in the magnitude of the effects. After atropine 
injection the heart rate of the neotenous axolotl almost doubled, but for the metamorphosed 
there was only a third rise in heart rate. After propranolol both forms of axolotls reached a 
mean heart rate of 24.4 bpm (Figure 8-11). In both neotenous and metamorphosed groups 
the animals displayed no changes in heart and ventilation rates after being injected with 
saline. 
 
 
8.4 DISCUSSION 
 
Electrocardiograms (ECG) and ventilation rates were measured in the present study to test 
the hypothesis that the relocation (or migration (Windle, 1933)) of vagal preganglionic 
neurones (VPN) to a ventrolateral position may relate to the generation of heart rate 
variability in the metamorphosed axolotl, Ambystoma mexicanum. In Chapter 7 there was 
evidence of cells migrating to the ventrolateral location by the presence of torpedo / 
spindle shaped cells that have been associated with cell migration. These cells appeared to 
move from the dorsal vagal motor nucleus (DVN) (see Figures 7-4.2, 7-4.4, 7-4.5, 7-5.1, 7-
5.3, 7-5.5, 7-5.6 and 7-5.8 in Chapter 7). The ventrolateral location may be a primitive 
nucleus ambiguus (nA) counterpart seen in mammals, which is known to contain cardiac 
vagal-preganglionic neurons (CVPN). The CVPN in the nA appear to be involved in 
respiratory and cardiac rhythms, whereas those found in the DVN are not involved in the 
respiratory cycle (Taylor et al., 2010).  
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The neotenous axolotl demonstrated a ventilatory rhythm. After an air breath, the gills, 
once underwater again, would twitch very slightly (gill ventilation). After a while the 
intensity of gill ventilation gradually increased. This sometimes resulted in the axolotl, 
which is usually quite still in the water, to want to move around. After a few movements 
the neotenous axolotl would suddenly come up and take a gulp of air before quickly 
submerging again, thus starting the cycle over again (see Figure 8-4(C) for an example of 
the cycle, but note that this cycle is much faster than that normally occurring at rest and 
when there is no drug intervention). This would suggest the possibility of the presence of 
mechano- and or chemo-receptors on the gills. Unlike fish that actively vent their gills by 
swimming, and therefore, oxygenating them efficiently, the axolotl generally stays very 
still in the water. This may lead to a systemic increase of CO2 through metabolic activity, 
which could be detected by chemoreceptors and cause the gills to ventilate more forcefully 
via mechanoreceptors stimuli.  
 
Gill ventilation generally appeared to be synchronous with heart rate when gill twitching 
was observed, but the overall mean frequency of gill ventilation did not match heart rate 
due to a reduction in gill twitches post an air breath. Figure 8-2 shows evidence of cardio-
respiratory coupling. Note that when the period between two gill twitches increases so does 
the interval between the R-R spikes on the ECG. Therefore there appears to be some 
modulation of heart rate with ventilation, but there is clearly no evidence of heart rate 
variability with ventilation, where one would expect to see a regular pattern of tachycardia 
upon inspiration events (as seen in humans and known as respiratory sinus arrhythmia). 
The absence of heart rate variability with respiration is supported by preliminary power 
spectral analysis of beat-to-beat changes in resting heart rate (Figure 8-13) and the 
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tachogram (Figure 8-12(A)) of a neotenous axolotl. Both figures resemble those seen in 
traces from fish (Campbell, pers. comm.). The ventilation rate for this neotenous axolotl 
was around 14.2 seconds and the heart rate was around 19.5 beats min
-1
. This can produce 
aliasing and cause the power spectrum to show as a series of peaks as the spectrum folds in 
on itself (Campbell et al., 2004; Taylor et al., 2006)  
 
The ECG trace of a resting metamorphosed axolotl showed a significant increase in the 
heart rate compared to that of the neotenous (Figure 11). This was reflected in the shorter 
period between R-R intervals and there was generally more variation in the R-R intervals 
when compared with the neotenous forms. The tachogram of the metamorphosed axolotl in 
Figures 8-12(B)–(D) show a very different pattern to that of the neotenous which showed a 
regular oscillatory fish-like pattern. The metamorphosed heartbeats appear to drift in 
comparison, indicative of some long and short term cardiorespiratory control. Preliminary 
examination of the possibility of cardiorespiratory interaction was sought using power 
spectral analysis.  This showed a peaked at a frequency of 0.0079 Hz, a time domain of 
126.6 seconds. This matched the frequency of the ventilations of that animal, and indeed, 
this ventilation pattern of around 2 minutes was also observed in other metamorphic 
individuals (Figures 8-6(A) and (C)). Hence the metamorphosed axolotl does appear to 
show heart rate variability around ventilation, but not around buccal movements. 
Unfortunately, due lack of animal availability and shortage of time meant that only one 
metamorphosed axolotl was used for the spectral analysis. More metamorphosed axolotls 
would need to be used in the future to make a more convincing, and statistically significant 
argument.   
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Upon close inspection there was clear tachycardia and bradycardia with the 
metamorphosed axolotl ECG traces (Figures 8-7(A)-(D)). In Figures 8-7(B), 8-8(A) and 8-
10(A) and (B), the ECG trace showed that a ventilation event was followed by bradycardia, 
and then a tachycardia. So there was a lag before the tachycardia. This is also seen on the 
metamorphosed tachogram where the RR-intervals get further apart post ventilation and 
before tachycardia (Figure 8-12). In humans tachycardia results from inspiration causing 
stimulation of lung stretch receptors which results in a reduction in vagal tone, so perhaps 
this is the case with metamorphosed axolotls too. If it is, then perhaps the air that is taken 
in during a gulp remains in the buccopharyngeal cavity for a short while, causing the initial 
bradycardia (and lag in tachycardia), and then the some of the air is inspired (into the 
lungs), activating stretch receptors and reducing vagal tone as indicated by the first 
tachycardia after a ventilation event. To explain the less pronounced bradycardia and 
tachycardia that appear to occur in-between the 2 minute ventilation cycle (Figure 8-12), it 
can be suggested that, perhaps the air that is taken in during ventilation does not enter the 
circulatory system in one go. Maybe the metamorphosed axolotls are able to retain some of 
the ventilated air within the buccal cavity and release it into the respiratory system in a 
rhythmic fashion, thereby causing a rhythmic bradycardia and tachycardia as seen on the 
ECG.  
 
Interestingly, this rhythmic pattern may be remnant of gill twitches (i.e., anatomically 
derived from the same structures that produced gill twitches in the neotenous form) that 
cause modulated inspiration by, somehow controlled buccal movements in the 
metamorphosed axolotl. Regular buccal movements have been noted to play an olfactory 
role (see Wang et al., 1999), but it might be possible that the buccal cavity is also used to 
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not only hold the inspired air, but also to gradually allow it to enter the lungs in a rhythmic 
fashion, like the rhythmic cycle of gill twitching. (During metamorphosis, the gill twitches 
seen in the neotenous could be replaced with oscillatory buccal movements that produce 
the tachycardia and bradycardia (not the usual buccal movements that are normally seen – 
which occur at a much faster, regular rate); and the surface breaths that are displayed by 
the neotenous could be modified to the 2 minute ventilation rate seen in the 
metamorphosed. This could explain the cyclic bradycardia and tachycardia between the 
more obvious ventilations if it is assumed that the tachycardia is resulting from lung stretch 
receptors inhibitory effect on vagal tone. Of course there are likely to other stimuli that 
could cause inhalation per se, such as peripheral chemoreceptors in central vasculature and 
chemoreceptors in the brain. It is apparent that more research needs to take place in order 
to understand the cause of the less pronounced oscillatory cycles of bradycardia and 
tachycardia between the 2 minute ventilation events.  
 
Surface breath frequency in the resting neotenous axolotl is around 3.5 h
-1
. The ventilation 
rate in the metamorphosed axolotl is higher at around 30 h
-1
. A higher rate of ventilation 
would be expected in the metamorphosed as they do not possess gills and so cannot 
ventilate „passively‟ (when compared with surface breathing), by gill twitching nor moving 
around more in the water to „ram‟ ventilate, and their skin becomes more keratinised and 
so there is less diffusion of oxygen through the skin post metamorphosis. Furthermore, 
they have more musculature on their terrestrially adapted limbs and the heart muscle too 
appears to show an increase in trabeculation (Figure 8-14) as indicated by Farmer (1999). 
These changes would increase the metabolic demands placed upon the metamorphic 
axolotl and thus an increase in ventilation rate would seem appropriate. 
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The neotenous and metamorphosed axolotls responded by an increase in heart rate 
following muscarinic receptor blockade using atropine. This demonstrates that they both 
possessed inhibitory vagal signals on the heart. However the actual response between the 
two groups was quite different. Although both forms responded by showing an increase in 
heart rate within 2-3 minutes (Figure 8-4(A) and 8-8(B)), the neotenous axolotls heart rate 
continued to rise to twice the resting rate over a 20 minute period, but the metamorphosed 
heart rate only rose by around 30% of the resting heart rate and within the first 3-4 
minutes, much sooner than that seen in the neotenous form. Furthermore, the 
metamorphosed axolotls returned to their resting heart rates after 18 minutes whereas the 
neotenous form reached their maximum heart rate in around that time and they did not 
return to the normal resting rate even after an hour. This could suggest that vagal tone is 
not as effectively modulated in the neotenous axolotl as it is in the metamorphosed. 
Parasympathetic control appears to be quite diffuse, but dominant in the neotenous as it 
had a doubling of heart rate, whereas vagal tone in the metamorphosed appears to be more 
finely controlled owing to the return to homeostatic heart rate levels much quicker than 
that seen in the neotenous. It is tentative to suggest that perhaps this extra control comes 
from the ventrolateral cells, but, of course, the exact mechanisms would have to be 
examined further. 
 
In the case with propranolol, both axolotl forms showed a reduction in heart rate within 4-6 
minutes of being injected (Figures 8-5(A) and 8-9(A)). However, it took the 
metamorphosed axolotls only 30 minutes (mean value) to reach their lowest heart rate (the 
metamorphosed in Figure 8-9(B) took 9 minutes), whereas the neotenous forms took over 
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1.5 hours (Figure 8-5(B)). Furthermore, with this set of data, there wasn‟t a significant 
difference between normal and propranolised heart rates with the neotenous. This may 
indicate that their heart rate is predominantly modulated by cholinergic influence, and that 
adrenergic input is minor. The recovery of the neotenous and metamorphosed was 
comparable as they both had low heart rates for a long time post propranolol administration 
(almost 2 hours in the neotenous (Figure 8-5(B)) and at least 70 minutes in the case of the 
metamorphosed (Figure 8-9(F)). It is interesting to also note that when sympathetic control 
was blocked in both, the neotenous and metamorphosed axolotls, the heart rate was, on 
average, 24 bpm (Figure 8-11). This is likely to be the pacemaker rate of the heart since the 
atropine (injected an hour before) would block all vagal control and sympathetic control 
would have been blocked by propranolol; so only the intrinsic cardiac pacemaker rate 
would be acting on heart rate at this point.  
 
The gill ventilation rate in the neotenous increased with atropine but not at the same 
magnitude as heart rate; heart rate increased by almost 200%, but gill ventilation only 
increased by around 44% (Figures 8-2, 8-3(B) and 8-4(B)). This constraint in magnitude is 
likely due to the biomechanics of physically not being able to move the gills at a faster 
rate, and is also likely to be compensated by the axolotl demonstrating more air breaths to 
meet the demands of an increasing heart rate. However, the number of air breaths taken did 
not increase significantly, but interestingly, the axolotls did want to move around more, 
probably in an attempt to increase ventilation at the gill surface. When under hypoxic 
conditions the neotenous forms do show an increase in air breaths (McKenzie & Taylor, 
1996), but if there is sufficient oxygen in the water then they may be stimulated to want to 
move around more in order to „ram‟ ventilate when metabolic demands increase. Gill 
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ventilation reached maximum twitch rate at the same time as the maximum heart rate (20 
minutes) (Figure 8-4(B)) and with propranolol administration the gill twitch rate decreased 
with heart rate (Figure 8-5(B)). This is a clear demonstration of cardiorespiratory coupling. 
Moreover, since there is a bigger change in heart and ventilation rates post atropine than 
with propranolol, the neotenous axolotl‟s basic resting heart rate must be significantly 
dampened by acetylcholine from the tenth cranial nerve. They show a relatively high 
degree of vagal tone, and some excitatory sympathetic control by noradrenaline. 
 
The ventilation rate in the metamorphosed axolotl, as defined by a more forceful buccal 
depression (Wang et al., 1999) was at 2 minute intervals when resting. However the ECG 
did not always pick up the buccal movements (Figure 8-8(B)). This could be due to the 
axolotl taking particularly shallow ventilations or limitations in measuring device and so 
future studies should consider a more sensitive way of measuring ventilation. After 13 
minutes post atropine injection the heart rate and ventilation rate returned to normal 
(Figure 8-8(C)). However, after a further 9 minutes the ventilation rate went down to 18 h
-
1
, even though the heart rate was normal (Figure 8-8(D)). This followed by an increase in 
ventilation to 48 h
-1
 (but not in heart rate) after a further 8 minutes (Figure 8-8(E)). The 
increase in ventilation rate could be to compensate for the earlier reduction in ventilation. 
Interestingly, the axolotl appeared to yawn during the higher rate ventilation period. 
Yawning is known to be a reflex mechanism that is triggered by a drop in circulatory 
oxygen levels. At this time the return of bradycardia and tachycardia is observed, although 
it takes a further 9 minutes (40 minutes post atropine administration) for the ECG wave to 
return to normal, with longer bradycardia post a ventilation event (Figure 8-8(F)). Atropine 
abolished heart rate variability indicating that the variability is caused by the decrease in 
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vagal discharge (Figure 8-8(B)). The effect of atropine on ventilation was no longer 
observed after 50 minutes.  
 
Propranolol too had varied effects on ventilation in the metamorphosed axolotl. With heart 
rate there was an almost immediate decrease, falling to 22bpm after 9 minutes of injection 
(Figure 8-9(B) and remaining there for at least 68 minutes after (Figure 8-9(F)). However, 
ventilation did not follow this trend. Nine minutes after the injection there was the lowest 
fall in ventilation at 12 per hour. It can be seen that this coincides with the lowest heart rate 
recorded. So when sympathetic control is removed and thus heart rate falls, the first 
response is a drop in ventilation rate. But then, like that seen with atropine, there appears to 
be a compensatory mechanism that comes into play, causing an increase in ventilation, 
culminating in the maximum level of 30 per hour (the normal rate, when heart rate is 
normal with nor drug intervention), by 45 mins post propranolol injection (even though 
there is no change in heart rate) (Figures 8-9(C) and (D)). The β-adrenergic receptors 
obviously slow down the heart, but there must be peripheral or central chemoreceptors that 
possibly detect an increase in CO2 levels, due to slowing of the heart rate, that trigger the 
hyperventilation observed. Around 10 minutes later the ventilation drops again, to less than 
the normal rate (this might be due to the low heart rate) and continues to fall to 18 
ventilations per hour after over an hour post propranolol injection (Figures 8-9(E) and (F)). 
Therefore, taking into account the observations made with atropine and propranolol on the 
metamorphosed cardiorespiratory system, it can be seen that the ventilation and heart rates 
are not coupled like that seen in the neotenous axolotl.  
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In summary, the metamorphosed axolotls show evidence of heart rate variability and 
ventilation patterns that did not always couple with heart rate. This indicates that there 
must be more than one area of the central nervous system that controls in the internal 
homeostasis of gas exchange. It could be possible that the relocation of VPN to the 
ventrolateral position from the DVN (Chapter 7) help to co-ordinate respiration and heart 
rate more tightly. Modified cardiorespiratory control post metamorphosis is likely to 
include innervation changes in the lungs and heart too. In contrast, the cardiorespiratory 
system of the neotenous axolotl functions very much like that of a fish and show coupled 
cardiorespiratory interactions. 
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Figure 8-1. An example of the underwater buccal movements of a neotenous axolotl as picked up by ECG electrodes. A few were 
marked manually at the time of recording (dotted lines) to aid identification on the ECG trace. Labels „B‟ denote the buccal 
movements. (24h post-surgery.) 
 
            B           B  B      B           B             B B      B              B                  B                      B               B             B            
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Figure 8-2. The heart rate appears to be occurring around ventilation bouts. The tall spikes on the trace are the R spikes of the 
QPRST wave and the downward spikes are the ventilation gill twitches (V). There was no evidence of any variability in heart rate 
around the gill twitches. The average heart rate for this neotenous axolotl was 22 bpm, and the gill ventilation rate on this ECG trace 
was 14 bpms (28 in the 2 mins).  (24h post-surgery.) 
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Figure 8-3. Heart rate around an air gulp did not change, indicating there was no heart rate variability present in the neotenous 
axolotls. Figures (A) and (B) are two different neotenous axolotls. 
(A) Heart rate is 20 bpm before and after the surface breath (SB). (4 days post-surgery.) 
       SB 
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Figure 8-3. Heart rate around a surface breath did not change, indicating there was no heart rate variability present in the 
neotenous axolotls. Figures (A) and (B) are two different neotenous axolotls. 
 
(B) Heart rate was 16 bpm and gill twitch (V) rate was 11/min. (SB – surface breath.) (24h post-surgery.) 
 
         SB          V        V  V  V V   V   V  V    V     V   V  V  
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Figure 8-4. Changes in heart rate and gill ventilation rate post atropine injection in the neotenous axolotl. (24h post-surgery.) 
 
(A) This is the same axolotl as in Figure 3(B) where the heart rate was 16 bpm and gill ventilation (V) rate was 11/min. The heart rate is 
now 54 bpm and the gill ventilation rate is 18 per minute. Measurement was taken 15 minutes after atropine injection.  
                                   V                              V                                          V                                  V                                         V                                    V                                V 
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Figure 8-4. Changes in heart rate and gill ventilation rate post atropine injection in the neotenous axolotl. (24h post-surgery.) 
 
(B) This is the same axolotl as in Figure 2, 20 minutes after being injected with atropine. The heart rate has risen from 22 bpm to 58 bpm; 
ventilation (V) rate has increased by 6 to 18 per minute.  
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Figure 8-4. Changes in heart rate and gill ventilation rate post atropine injection in the neotenous axolotl. (24h post-surgery.) 
 
 (C) Same axolotl as in Figure 2 and Figure 4(B), 30 minutes after atropine injection. Note the frequency of gill twitching (V) increases just 
before the axolotl moves (M) to take an air breath (SB) from the surface, after which the it reduces. Also note that there is no heart 
rate variability around the air breath. Heart rate is 56 bpm and gill ventilation rate is 16 bpm. 
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Figure 8-5. Effect of propranolol upon heart rate and gill ventilation rate. This neotenous axolotl is the same one as in Figure 3(B) and 
Figure 4(A). (24h post-surgery.) 
 
(A) ECG trace 10 minutes after propranolol injection. Heart rate has reduced from 46 bpm just before propranolol injection (given one hour 
after atropine) to 30 bpm. The gill ventilation (V) rate is now 12 bpm. 
                      V                V           V         V 
 
  
II. Neuroanatomy and Physiology of Cardiorespiratory Control  
 
232 
 
Figure 8-5. Effect of propranolol upon heart rate and gill ventilation rate. This neotenous axolotl is the same one as in Figure 3(B) and 
Figure 4(A). (24h post-surgery.) 
 
(B) Heart rate returns to that at resting after almost 2 hours post propranolol injection. Heart rate is at 15 bpm; but the gill ventilation 
(dashed vertical lines) is still relatively high at 12 bpm. (SB – surface breath.) 
 
                                 SB 
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Figure 8-6. Ventilation rate in the metamorphosed axolotls was around 2 minute intervals.  
 
(A) The chart below shows there are 9 ventilations (V) in this 16 minute period. Note that there appears to be some evidence of variation in 
heart rate between the ventilations. This is indicated by a group of RR-intervals separated by a gap, suggestive of a longer RR-interval 
(highlighted in the oval). (1h post-surgery.) 
 
                             V                         V                          V                     V                               V                          V                     V                          V                           V 
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Figure 8-6. Ventilation rate in the metamorphosed axolotls was around 2 minute intervals.  
 
(B) A larger scale of the same animal ECG. There are 5 ventilations (V) in the 9 minute interval. (24h post-surgery.) 
 
             V                             V                                               V                                               V                                                     V 
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Figure 8-6. Ventilation rate in the metamorphosed axolotls was around 2 minute intervals. 
 
(C) Ventilation rate in another metamorphosed axolotl. There are 5 ventilations in the 9 minute period (~30/h). The ventilations are marked 
with „V‟ underneath the chart, from 54 minutes, 25 seconds onwards. The second trace was achieved by using the digital filter (band-
pass) solely to aid clearer visualisations of the ventilations. (24h post-surgery.) 
 
 
 
            V                    V                                V                                                   V                                                 V    
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Figure 8-7. Bradycardia and tachycardia in the metamorphosed axolotl. 
 
(A) This is the same animal as in Figure 6(A) & (B). Heart rate variability can be seen in the gross traces as white gaps amongst the black 
R-R spikes. The inverted colour section was magnified and the R-R intervals were digitally measured using ChartLab as shown. The 
time period between R-R intervals are recorded below the expanded trace (seconds). (1h post-surgery.)  
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Figure 8-7. Bradycardia and tachycardia in the metamorphosed axolotl. 
 
(B) An example of heart rate variability in another metamorphosed axolotl. There is clear variation between the two ventilations, marked 
underneath by „V‟. (9 days post-surgery.) 
 
                       V                 V 
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Figure 8-7. Bradycardia and tachycardia in the metamorphosed axolotl. 
 
(C) This is the same animal as in Figure 7(B), but 26 days post-surgery. The inverted colour section in the middle trace was magnified 
(bottom trace) to digitally measure the R-R intervals using ChartLab. The time period between R-R values are written underneath the 
bottom trace (seconds), starting with the furthest left of the two spikes. The upper trace is the raw ECG; the middle trace was digitally 
filtered (band-pass) for smoothing. (Discrepancies in exact electrode placement can produce double spikes as seen in this trace.)  
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Figure 8-8. The effect of atropine on the heart rate and ventilation rate of a metamorphosed axolotl. (24h post-surgery.) 
 
(A) Just prior to atropine administration. Bradycardia is followed by tachycardia. The axolotl ventilated (V) at approximately 2 minute 
intervals (30 hour
-1
). The heart rate before atropine was 27 bpm. Atropine was injected at 28 minutes, 50 seconds on this ECG trace.  
 
                                        V                          V                                     V                                           V                                   V  
 
  
II. Neuroanatomy and Physiology of Cardiorespiratory Control  
 
240 
 
Figure 8-8. The effect of atropine on the heart rate and ventilation rate of a metamorphosed axolotl. (24h post-surgery.) 
 
(B) Chart starts at 4 minutes post atropine injection and at this time the heart rate rose to 33 bpm. Heart rate variability (HRV) is apparent 
before 37 minutes on the chart scale, but is not afterwards. Ventilation could not be observed until 40.4 minutes, although the ECG 
trace may have picked one up at 34 minutes. The heart rate at 39 minutes was 30 bpm. 
 
                          ----------                          HRV                           ----------                          ----------               no HRV            ----------                    
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Figure 8-8. The effect of atropine on the heart rate and ventilation rate of a metamorphosed axolotl. (24h post-surgery.) 
 
(C) Chart starts at 13 minutes post atropine injection. The heart rate at 49 minutes (on chart scale) was 27 bpm. The ventilation rate (V) is 
still 30 per hour. There was some bradycardia and tachycardia, although it was not as pronounced as that seen before atropine (Figure 
8(A)).  
 
                                  V                                                                       V                           V                                                           V                                                               V    
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Figure 8-8. The effect of atropine on the heart rate and ventilation rate of a metamorphosed axolotl. (24h post-surgery.) 
 
D) Chart starts at 22 minutes post atropine injection. At the 1 hour mark of the chart, the heart rate was 28 bpm and the ventilation rate (V) 
in this trace is 18 per hour.  
                                 V                                                    V                                                                         V    
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Figure 8-8. The effect of atropine on the heart rate and ventilation rate of a metamorphosed axolotl. (24h post-surgery.) 
 
(E) Chart starts at 31 minutes post atropine injection. The heart rate was 28 bpm in this trace. The ventilation rate increased to 48 per hour, 
which includes one episode of gaping (G) that looked like yawning near 1h 9min on the scale. There were some very rapid buccal 
movements (RB) and are separate from ventilation (V). The chart shows there was some brady- and tachy-cardia. (M – movement.) 
 
                                                        V                                          V                                        M      V       RB                  RB   V   RB       V V     V    V                  G   V  M 
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Figure 8-8. The effect of atropine on the heart rate and ventilation rate of a metamorphosed axolotl. (24h post-surgery.) 
 
(F) Chart starts at 40 minutes post atropine injection. The heart rate was 26 bpm in this trace. The ventilation rate (V) decreased to 42 h
-1
, 
and the axolotl moved around a lot. The brady- / tachy-cardia resemble that seen before atropine injection (Figure 8(A)) with 
relatively long bradycardic episodes. The ventilation rate is still higher than with no drug intervention. The RB denotes rapid buccal 
movements; M –  movement.  
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Figure 8-9. The effect of propranolol on the heart and ventilation rate of a metamorphosed axolotl. Atropine was administered 75 
mins before propranolol. (25h post-surgery.) 
 
(A) Propranolol administration. The heart rate just before the injection was 28 bpm. Within 3 minutes of propranolol injection the heart rate 
reduced to 26 beats min
-1
. The ventilation rate (V) was 18 per hour. The interval between the ventilation was therefore longer at just 
over 3 minutes.  
 
          V                                                            V                                                                                    V   
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Figure 8-9. The effect of propranolol on the heart and ventilation rate of a metamorphosed axolotl. Atropine was administered 75 
mins before propranolol. (25h post-surgery.) 
 
 (B) The chart starts at 9 minutes post propranolol injection. The heart rate was at 22 bpm, and the ventilation rate in this axolotl reduced to 
12 per hour (marked V). 
 
                           V                                                         V    
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Figure 8-9. The effect of propranolol on the heart and ventilation rate of a metamorphosed axolotl. Atropine was administered 75 
mins before propranolol. (25h post-surgery.) 
 
(C) The heart rate remained at 22 bpm after 18mins post propranolol administration. There were no obvious bradycardia and tachycardia, 
except for the bradycardia at 2h 9m 40s that followed the deep ventilation. There were a few ventilation bouts (V) and the rate for this 
period was 24 per hour.  
 
                                     V                                                                 V             V                 V  
 
  
II. Neuroanatomy and Physiology of Cardiorespiratory Control  
 
248 
 
Figure 8-9. The effect of propranolol on the heart and ventilation rate of a metamorphosed axolotl. Atropine was administered 75 
mins before propranolol. (25h post-surgery.) 
 
(D) The heart rate remained at 22 bpm after 45 minutes post injection. There was a bradycardia (b) at 2h 39m (chart scale) following a deep 
ventilation (V), and there were 5 ventilations in total (30 hour
-1
) on this trace.  
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Figure 8-9. The effect of propranolol on the heart and ventilation rate of a metamorphosed axolotl. Atropine was administered 75 
mins before propranolol. (25h post-surgery.) 
 
(E) ECG trace at 54–64 minutes post propranolol injection. There was no change in the heart rate (22bpm). There are clear bradycardia (b) 
episodes following deep ventilation (V) and then tachycardia (t). The ventilation rate in this trace is 24 hour
-1
, but was 18 breaths per 
hour after 75 mins post injection (Figure 9(F) inclusive). (Some of the bradycardia and tachycardia are labelled to highlight their 
appearance on this trace.) 
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Figure 8-9. The effect of propranolol on the heart and ventilation rate of a metamorphosed axolotl. Atropine was administered 75 
mins before propranolol. (25h post-surgery.) 
 
 (F) Chart begins at 1hr 8 mins post propranolol injection. The heart rate has been unchanged since the first decrease 9 mins after the 
injection (Figure 9(B)) and remained at 22 beats min
-1
. Ventilation rate was 18 breaths per hour, thus unchanged since 75 mins post 
propranolol introduction. The upper chart is the raw ECG trace; the lower chart is derived (derivative function on ChartLab software) 
from the raw data and is presented as it shows the tachycardia/bradycardia (t, b) episodes more clearly when the RR spikes are almost 
the same height. (V – ventilation.) 
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Figure 8-10. Heart rate variability in the metamorphosed axolotl. This is the same animal as used in Figures 8 and 9. (8 days post-
surgery.) ECG trace showing a relatively long RR interval (bradycardia (b)) after ventilation (V). There was a short delay after the 
ventilation before bradycardia that was immediately followed by tachycardia (t). The vertical dashed lines in the upper chart are 
regular buccal movements (RB). These were marked to check they did not conflict with the ECG or ventilation traces. The top chart 
is digitally filtered (high-pass) and the lower chart is the derivative of the upper chart which is presented solely for ease of 
visualisation of oscillations.  
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Figure 8-11. The effect of atropine and propranolol on the heart rate of the neotenous 
and the metamorphosed axolotl (n = 5 each). Heart rate rose in both after atropine 
and decreased to lower than resting level following propranolol. 
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Means (±SE) are: 
 
Neotenous 
Normal heart rate 27.20 ± 0.92; atropinised 50.8 ± 2.4; propranolised 24.4 ± 2.9 
Paired t-test showed there was significant difference between normal and atropinised heart 
rate (p < 0.05), but not between normal and propranolised (p = 0.12)  
 
Metamorphosed 
Normal heart rate 34.47 ± 0.38; atropinised 41.6 ± 0.7; propranolised 24.4 ± 1.6 
Paired t-test showed there was significant difference between normal and atropinised heart 
rate (p < 0.05) and between normal and propranolised (p < 0.05)  
 
Unpaired t-test showed there was a significant difference in the resting neotenous and 
metamorphosed heart rates (p < 0.05). 
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Figure 8-12. Tachograms of the neotenous and metamorphosed axolotl.  
 
(A) The neotenous HR shows an oscillatory pattern that with a relatively high amplitude in 
the short term range (beat to beat) but in the long term range it is fairly stable at around 
3000 ± 1000 milliseconds, with the exception of beat 151, which may be an artefact caused 
by axolotl movement. Note that 161 beats would represent about 8 minutes of recording in 
the neotenous. 
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Figure 8-12. Tachograms of the neotenous and metamorphosed axolotl.  
 
 (B) The RR-intervals for the metamorphosed axolotl are less fluctuating over the same 
number of beats. The HR appears to be under more regulation in comparison to the 
neotenous. Note that 161 beats would represent about 4 minutes of recording in the 
metamorphosed.  
 
 
 
 
(C) When the y-axis is expanded a „drifting‟ RR-interval is evident, indicative of some 
regulatory mechanism that attempts to maintain homeostasis. Note that 161 beats would 
represent about 4 minutes of recording in the metamorphosed.  
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Figure 8-12.  Tachograms of metamorphosed and neotenous axolotl.  
 
(D) The arrows indicate where the animal ventilated. Over the short term, between ventilation bouts, there is a brief increase in the RR-
interval, indicative of bradycardia. This follows tachycardia/bradycardia oscillations. The ventilation bouts occur approximately every 88 
beats, which is around every 2 minutes. This long term trace (571 beats, ~ 14 minutes) shows variation in RR-intervals of 1550 ± 1000 ms, 
similar to the neotenous, but the variation is of a „drifting‟ nature.  
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Figure 8-13. Power spectrum analysis of a neotenous axolotl. The data was taken 
from tachogram (Figure 8-12(A)). 
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Figure 8-14. Haematoxylin and eosin staining of neotenous and metamorphosed 
axolotl hearts. The neotenous heart has a „spongy‟ ventricle with generally 
disorganised myofibrils. Since the neotenous axolotls have gills and can respire 
cutaneously too, it is not so important that the heart be as functionally effective as a 
metamorphosed axolotl. The metamorphosed axolotl becomes a committed lung 
breather and so would need a more robust pump to circulate oxygenated blood. 
Consequently, the metamorphosed heart shows more organised myofibrils and an 
increase in trabeculation in comparison with the neotenous. (See Appendix for 
staining details.) 
 
      Neotenous ventricle          Metamorphosed ventricle 
  
 
 
 
 
 
 
 
 
 
 
Boxed areas in the upper images are the enlarged sections in the lower images. 
 
90 µm 
500 µm 
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CHAPTER NINE 
 
 
CONCLUDING REMARKS  
AND 
FUTURE DIRECTIONS 
 
 
In Part I of the thesis the embryonic axolotl (Ambystoma mexicanum) heart was found to 
be a very useful model in which to study the role of tropomyosin in myofibrillogenesis. 
The hearts of cardiac mutant axolotls are an ideal system for studying myofibrillogenesis 
in vitro because they are deficient in the sarcomeric tropomyosin protein, which results in 
the disarray of myofibrils. Furthermore, the mutant embryos survive for a short period of 
time without establishing normal circulation. Tropomyosin is a ~70 kDa coiled dimer that 
acts in close association with actin and troponin units. Together, these proteins are 
involved with contraction and relaxation of myofibrils. Three isoforms of axolotl 
tropomyosin have been identified and were used (ATmC-1, ATmC-2, ATmC-3).  
 
A delivery system, using cationic liposome transfection was found to be an effective tool 
for the introduction of nucleic acids into the embryonic cardiac cells. The use of anti-sense 
oligonucleotide mediated inhibition of mRNA expression has proven useful in determining 
what role a particular protein may play in cellular functions. Thus, this method was used to 
either promote, when using mutant hearts, or block, in wild-type hearts, the expression of 
the tropomyosin isoforms. Thus it was found that tropomyosin has a significant role in the 
promotion of myofibrillogenesis. Axolotl tropomyosin isoforms were found to be heart 
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region specific. The ATmC-1 isoform affected the outflow tract area and ATmC-3 is 
important in ventricular myofibrils and functional beating of the heart. 
 
The structure-function role of tropomyosin was also examined, i.e., did alterations in 
tropomyosin structure affect myofibrillogenesis? Previous studies focused on modification 
of just one end of the tropomyosin protein. In this study, both, the 5‟ and 3‟ ends, were 
modified and it was found that it did not affect myofibrillogenesis. 
 
With the finding of the novel human tropomyosin isoform TPM1κ (TPM1 gene), and now 
knowing that it can effect myofibrillogenesis in the axolotls, means that the cardiac mutant 
model can be used for the study of heritable cardiomyopathies in man that are caused by 
mutated tropomyosin. For instance, a mutation in one of the alleles of the TPM1 gene is 
known to cause familial hypertrophic cardiomyopathies, and, moreover, a subset of these 
causes sudden death in young adults. 
 
 
Part II of the thesis looked at the cardiorespiratory interactions associated with 
metamorphosis. The neuroanatomy work showed that there is a new group of vagal 
preganglionic neurones in the ventral lateral location post metamorphosis. It is not 
definitive to know from this study if these cells are de novo (by mitosis, perhaps?) or 
indeed they are the immature, blast-like cells that have migrated from the central grey and 
differentiated. A more specific marker for both migration and mitosis would be useful to 
use in the future in order to find out. 
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The heart rate work showed that the metamorphosed axolotls (now obligate lung breathers) 
do indeed show heart rate variability which is caused by fluctuations in vagal tone. 
However the pattern was not the same as that seen in humans where upon inspiration the 
heart rate rises. In the metamorphosed axolotl there appeared to be a bradycardia before the 
tachycardia.  
 
For both Part I and Part II there is plenty of scope for more work for greater understanding. 
The embryonic heart work could be clinically significant in the future, but also on an 
academic level to understand how exactly the tropomyosin promotes myofibrillogenesis. 
The heart rate variability of the metamorphosed axolotls is most intriguing and has not 
been studied in close detail before. Further work could look at the causes of the oscillatory 
bradycardia and tachycardia seen between the ventilation bouts. It is likely that, as of yet 
unknown, mechanoreceptors and chemoreceptors that would contribute to the fine tuning 
of cardiorespiratory control required for an obligate lung breather.  
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APPENDIX 
 
Haematoxylin and Eosin Staining Method  
The five to six inch long salamanders, Ambystoma mexicanum, were obtained from the 
Indiana Axolotl Colony. To induce metamorphosis the axolotls were intraperitoneally 
injected with thyroxin (Sigma) at a concentration of 2g per gram body weight. The 
control neotenous axolotls were not injected. Complete metamorphosis was determined by 
the total loss of gills and the axolotls spending most, if not all, its time on land. This 
change took 30 days and resulted in a 30% loss in weight. During the same period the 
neotenous axolotls gained a 30% body weight. The mid-metamorphic stage was 
determined visually by observation of the length of gill stub which reduced to 0.5cm. This 
stage took 18 days and resulted in a 10% weight loss. 
 
Tissue preparation 
Hearts were dissected and immediately fixed in 4% paraformaldehyde and left o/n. The 
following day they were transferred into 10% sucrose made in phosphate buffer (pH 7.2) 
and left o/n. The hearts were placed in embedding media (OCT) and cooled gently over dry 
ice and then transferred to –20‟C o/n. They were then stored in –70‟C until ready for use. 
Sections were cut at 14 m using a 2800 Frigocut N cryostat. 
 
H & E staining 
Heart sections were stained using a standard H&E staining protocol with Gills No.1 
Haematoxylin (6 mins) and Chromotrope 2R (3 mins). The sections were mounted using 
Permount
©
. 
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